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ABSTRACT
Corneal dystrophies are inherited bilateral diseases that compromise the transparency of 
the cornea. They are difficult to treat and re-occur in corneal transplants. A number of 
anterior stromal and Bowman’s layer dystrophies have been linked to keratoepithelin. This 
is an extracellular matrix protein, synthesised and secreted by the epithelium and 
deposited in the accumulations found in the epithelial and stromal areas of the affected 
individuals. Keratoepithelin binds to different types of integrins on the cell surface and 
has been shown to regulate migration, proliferation adhesion and tumourgenicity. The 
gene encoding keratoepithelin, |3ig-h3, is induced by growth factor TGF-p and has been 
involved with growth, differentiation, development and wound healing. The aim of this 
study was to explore the effects the wild type and mutant forms of this gene and protein 
have on primary corneal cells.
pig-h3 cDNA was synthesised from fibroblast mRNA and in vitro mutagenesis was carried 
out to produce mutant constructs encountered in dystrophies Granular Groenouw Type I 
and Thiel Behnke, R555W and R555Q respectively. Replication deficient adenoviruses were 
constructed to achieve overexpression of the wild type and mutant {3ig-h3 genes in 
cultured cells. Native recombinant keratoepithelin protein was expressed and purified 
corresponding to the wild type and mutant cDNA sequences. Primary corneal epithelial 
cells and keratocytes were cultured in the presence of the recombinant constructs and the 
effects on adhesion, proliferation, migration and apoptosis were monitored.
Wild type recombinant keratoepithelin promoted significantly the adhesion of both 
epithelial cells and keratocytes (p<0.001). The mutant proteins had the same effect as the 
wild type on epithelial cell adhesion, but keratocytes showed a decreased adhesion 
(p>0.05). The corneal epithelial cells overexpressing wild type pig-h3 adhered significantly 
better (p<0001) than the control and the keratocytes showed higher adhesion (p<0.001) 
during overexpression of the mutant R555W pig-h3.
Epithelial proliferation was increased in response to the recombinant proteins (50.27 
±1.93% in the wild type compared to 35.59 ±6.26% in the control) and overexpression of 
pig-h3 genes (p<0.001), whereas the keratocyte proliferation was unaffected. R555W 
mutant protein was associated with slower migration rate of epithelial cells compared to 
wild type protein, whereas the keratocytes migration did not seem to be affected in any
2
case. Difficulties were encountered when using adenoviral constructs to assess the effects 
of overexpression of pig-h3 transgenes on cell migration and proliferation.
Annexin-V and propidium iodide staining suggested there may be an increase in the 
apoptosis of cells in the presence of the mutant recombinant proteins and adenoviruses. 
However, the apoptosis assay could only provide an indication of the effect of the 
recombinant constructs since the data could not be accurately quantified and analysed, 
due to a discrepancy on the setup of the FACS analyser.
These findings indicate the feasibility of using recombinant keratoepithelin proteins and 
pig-h3 overexpressing adenoviruses to assay their effects on primary corneal cells. The 
diversity of the behavioural responses of corneal cells to mutant and wild type 
keratoepithelin and (3ig-h3 gene can provide useful insight in the pathology of the anterior 
corneal dystrophies.
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1. CHAPTER ONE - General Introduction
1.1 CORNEA
The cornea is the most important ocular structure to come into contact with the 
environment. It is a transparent structure, convex on the outside and concave 
inside. It appears elliptical from the front and forms part of an organ which is 
almost a sphere. The average dimensions of the human cornea are 11.7mm 
horizontally wide and 10.6mm vertically, with a 0.52-0.67mm thickness (Kaufmann 
et al, 1998). A special characteristic of the structure of cornea is the lack of 
vascularisation, a property that makes it an ideal model for organ culture.
Sdera 
Iris 
Cornea 
Pupil 
Lens 
Conjunctiva
Figure 1.1: Ocular Tissues
Illustrated by Mark Erickson. (Source: http://www.stlukeseye.com/Anatomy.asp)
The position of the cornea assigns it a double protective role: The corneal 
epithelium and the overlying tear film form an effective barrier, which protects 
the eye from the outside environment. At the same time, due to its strong 
collagenous composition, the cornea resists the internal ocular pressure. Water 
from the aqueous humour is retained out of the cornea by the endothelium which 
separates these two different structures. In this relatively dehydrated state the 
corneal layers are maintained and both swelling and clouding are prevented.
The transparency of this organ is conferred by the organisation of collagen fibrils as 
well as their regular packaging (Maurice, 1957). Transparency is a prerequisite for 
the performance of its main function, which is the refraction of light into the eye. 
The cornea is the most important refractive structure of the eye due to its smooth 
surface and its regular curvature.
Vitreous
Choroid
Optic nerve
Macula
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The cornea is composed mainly of water, which constitutes 78% of its total mass. 
20% of the structure is occupied by proteins, 15% being constituted by collagen 
types I and VI. The remaining 5% comprises other proteins such as laminin, keratin, 
integrin, talin, vinculin etc. Glycosaminoglycans (keratan sulphate 
chondroitin/dermatan sulphate and hyaluronic acid) constitute 1% of the total mass 
and another 1% is contributed by salts (Muthiah et al, 1974, Muczar et al, 1973).
1.2 TEAR FILM
The preocular tear film is not part of the cornea, but lies in close contact with its 
anterior epithelial surface. The thickness of the tear film is still debated, but it is 
generally accepted that mucus extends more anteriorly than previously assumed. 
The tear film has been described as a hydrated mucin gel, with a viscosity that 
declines towards its surface (Dilly, 1994) rather than two distinct aqueous and 
mucin layers. The tear film is spread by the blinking of the eyelids and maintains a 
moist and smooth corneal surface. Tears leave the eye by drainage through the 
nasolacrimal gland, evaporation and conjuctival absorption.
The anterior lipid layer delays the evaporation of the aqueous tear film. It also 
protects from polar lipid contamination (Holly, 1978) and acts as a hydrophobic 
barrier to prevent the overflow of tears. It is secreted by meibomian glands and 
consists of esters, triacylglycerols, free sterols, sterol esters and fatty acids 
(Nicolaides et al, 1981).
The aqueous layer is produced by the lacrimal glands and contains salts, 
electrolytes, proteins, enzymes and other components. Metabolic products, such 
as oxygen and carbon dioxide are also present in this layer and are transported to 
and from the cornea. Tears contain several substances which protect against 
bacterial and viral infection and provide a route by which white blood cells may 
reach the eye. Lysozyme, lactoferrin and beta lysin are all antibacterial enzymes 
which have been identified in the tears (Fleming, 1922; Broekhuyse, 1974; Ford et 
al, 1978). All of the immunoglobulins have been found in tears, with IgA being 
present in a much higher concentration. Antibodies specific to several viruses 
(Vinogradova et al, 1979; Mull et al, 1970) have also been described, but their 
exact role remains uncertain.
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The ocular surface is naturally wettable due to the presence of a surface 
glycocalyx, the fibrillar glycoprotein which coats the outer membranes of the 
microprojections of epithelial surface cells. The increased area on the epithelial 
cell surface formed by the microprojections and the glycocalyx help the adherence 
of mucoproteins, which form a hydrophilic coating (Nichols et al, 1985). A mucin 
gel, is also present in the intervening space and consists of mucoproteins, which 
are secreted by conjunctival goblet cells.
The main function of the cornea is the refraction of light. Projecting microvilli 
from the epithelial layer can potentially degrade the resulting image. The tear 
film forms a smooth surface and most of the refraction of light occurs in the 
tear/air interface.
1.3 CORNEAL STRUCTURE
The cornea consists of 5 distinct layers, which can be seen in a meridional section. 
These are, from top to bottom: Epithelium, Bowman’s layer, stroma, Descemet’s 
membrane and the endothelium.
Ep
BZ
K
DM
Figure 1.2: Meridian section of human cornea
(a) Epithelium and anterior stroma, (b) endothelium and anterior stroma 
Ep-Epithlium, BZ- Bowman’s zone, K-keratocytes, DM-Descement’s membrane, En- 
Endothelium. (Source: The Cornea, Smolin G and Thoft RA, 1994)
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1.3.1 Epithelium
The corneal epithelium consists of 5-6 layers of cells and is stratified, squamous 
and non-keratinised. The thickness of the epithelium has been estimated to be 
around 50.7pm (Reinstein et al, 1994). The deepest layer of cells, the basal cells, 
are attached to the basal lamina. These cells, which are columnar with flat bases 
and rounded tops, constitute the germinative layer of the epithelium. The second 
layer of the epithelium consists of the wing or umbrella cells. These cells, like the 
next 2-3 layers, are polyhedral. The layers near the anterior surface of the cornea 
consist of progressively flatter cells. The top layer is comprised of cells with the 
maximum surface area, flattened nuclei and projecting microvilli.
The epithelial cells contain a cytoplasmic meshwork of intermediate filaments 
called tonofibrils (Sun and Vidrich, 1981) and composed of polymers of keratin 
subunits. These filaments are involved in a system that connects neighbouring 
cells to one another and to the extracellular matrix and provides great tensile 
strength. In vivo keratins are coexpressed and paired to form heterodimers 
consisting of a basic and an acidic molecule. The K12/K3 pair is found in the 
corneal epithelium of a variety of species and is important for the function of this 
layer. Meesmann’s hereditary juvenile dystrophy is an autosomal dominant 
disorder that causes fragility of the anterior corneal epithelium and manifests with 
tiny epithelial vesicles. Missense mutations in K3 or K12 occurring in highly 
conserved keratin helix boundary motifs have been identified as the genetic 
defects in affected families.
Figure 1.3: Meesmann’s Dystrophy
(Courtesy of Prof. GCM Black)
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Intercellular attachment of the basal cells is achieved by desmosomes (Fawcett, 
1966) and hemidesmosomes attach these cells to their underlying basal lamina. 
Desmosomes keep the membrane of contiguous cells close together by interaction 
of protruding cadherin proteins, which are contributed by both cells. The 
transmembrane linker proteins in hemidesmosomes are integrins and they interact 
with proteins of the basal lamina. These anchoring junctions must be labile to 
allow migration of the proliferating basal cells to the surface of the epithelial 
sheet. Less desmosomal structures are found between wing cells, whereas 
adjacent epithelial cells at the surface are connected with tight/occluding 
junctions (Tonjum, 1974). These junctions make cells selectively impermeable by 
preventing diffusion of membrane proteins and leakage of water-soluble molecules 
between the cells. This facilitates the maintenance of an intact epithelial layer 
even in the presence of the overlying tear film.
The most superficial cells have projecting microvilli 0.5pm high and 0.3pm wide, 
which are thought to be important for the retention of the precorneal tear film. 
The older of these superficial cells are eventually shed (Hoffman, 1972) and 
replaced with cells from below. The germinative stem cells are not found at the 
basal epithelial layer of the central cornea, but at the limbus (Davanger and 
Evensen, 1971; Bron, 1973), an area which borders the periphery of the cornea. 
Limbal stem cells are slowly dividing and give rise to transiently amplifying cells, 
which then migrate towards the centre of the cornea. These cells undergo a series 
of divisions, which result in their differentiation and progressive movement to the 
surface of the layer before, ultimately being shed (Tseng, 1989).
The basal cells are responsible for the secretion of the components of the 
underlying basal lamina and the production of the hemidesmosomes (Kenyon, 
1969). Hemidesmosomes consist of the cytoplasmic anchoring plaque, where 
integrins a* and p6 traverse the cell membrane and associate with the basal 
lamina. This is an extremely strong attachment that protects the corneal 
epithelium from detachment (Khodadoust et al, 1968).
The lamina consists of two distinct layers, the lamina lucida and the lamina densa. 
The former is comprised of kalinen filaments associated with laminin. The lamina 
densa contains heparan sulphate proteoglycan (HPSG) and globular Type VII 
collagen. Anchoring fibrils consisting of helical collagen VII and glycoproteins arise
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from the lamina densa and integrate into the Bowman’s layer, where they firmly 
attach in anchoring plaques (globular VII collagen and laminin).
1.3.2 Bowman’s layer
This is a structure which is largely restricted to the human cornea. While a similar 
structure can be found in some avian and reptile species as well as primates, it is 
not present in other mammals. Bowman’s is an acellular layer, 8- 14pm deep, 
consisting of fine collagen fibres (Type V) in a ground substance. The anterior side 
is in contact with the basal lamina of the epithelium. On the anterior side of the 
layer the fibrils become more ordered and extend into the substantia propria, 
where they merge with the stromal proteins.
Bowman’s layer is resistant to both mechanical and infectious trauma, but if 
destroyed it is replaced by scar tissue (Duke-Elder and Wybar, 1960). In 
pathological cases such as corneal dystrophies and oedema or after death the 
epithelium detaches from Bowman’s layer. In corneal dystrophies of the Bowman’s 
layer (Reis Buckler’s and honeycomb) this layer is partially or completely lost and 
replaced by granular deposits or honeycomb-shaped opacities (Okada et al, 1998).
1.3.3 Substantia propria (stroma)
This layer is 500|im deep and constitutes 90% of the corneal thickness. It is a 
transparent fibrous structure, which consists of compact lamellae of collagen 
fibres. The lamellae are embedded in a ground substance of proteoglycans, their 
arrangement being more regular towards the posterior surface. There is a low 
density cell population, the keratocytes, scattered throughout the lamellae. The 
sensory protection of the cornea is achieved by sensitive nerve endings, which do 
not compromise its transparency. The nerve axons and Schwann cells are present 
in the anterior and middle stroma.
Collagen fibrils are responsible for the special structural properties of the cornea, 
such as transparency and mechanical resistance to intraocular pressure (Newsome 
et al, 1980; Maurice, 1984). The bundles of polymerised collagen in the stroma run 
parallel to each other and to the corneal surface, from limbus to limbus and at 
varying angles and levels. The lamellae are surrounded by extracellular matrix, 
which is secreted by the keratocytes and maintains the distance between the fibrils 
(Kuwabara, 1978). Loss of the extracellular matrix (e.g. in oedema) results in
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changes in the interfibriUar distance and results in loss of corneal transparency. 
Keratan and chondroitin sulphate are the major glycosaminoglycans of the matrix, 
with keratan sulphate being more concentrated in the central stroma and 
chondroitin sulphate in the peripheral cornea. The extracellular matrix interacts 
with individual collagen fibrils, but it is not known exactly how.
Keratocytes make up 3-5% of the stromal volume (Langham and Taylor, 1956). 
Their main function is to produce the collagen and extracellular matrix of the 
stroma during development and maintain it thereafter. Precursors of collagen and 
glycosaminoglycans can be seen in the area around keratocytes. The cell bodies of 
the keratocytes are thin, long and flat, running parallel to the collagen fibrils. 
Interactions between neighbouring keratocytes are believed to be important in the 
regulation of their cell function (Assoulline et al, 1992).
Keratocytes also have receptors for growth factors, which are important in 
response to wound healing. Repair of the stroma after injury results in keratocyte 
activation, migration and transformation into myofibroblasts. Scar tissue is formed 
which consists of collagen fibrils of larger diameter and reduced regularity 
(Schwarz, 1953b). Over time this tissue undergoes remodelling, which involves 
thinning and rearrangement of fibrils as well as increase in corneal transparency 
(Cintron and Kublin, 1977). In some pathologic situations, keratocytes produce 
large amounts of basal lamina and similar material that can result in opacification 
of the cornea (Kuwabara, 1978).
Other cell types sporadically found in normal human cornea are lymphocytes, 
macrophages and polymorphonuclear leucocytes.
1.3.4 Descemet’s membrane
In contrast to Bowman’s layer, which is a modified zone of the anterior stroma, 
Descemet’s membrane is a thick basal lamina secreted by the corneal endothelium. 
It is a distinct structure found at the base of the stroma. Appearing at the fourth 
month of gestation, it is 3-4jim at birth and develops to 10-12pm in adult life. This 
basal lamina comprises two layers: the anterior banded and the posterior 
nonbanded layers. It is the anterior layer that appears first, before birth, the 
posterior developing later.
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Attachment sites and short fibrils extending from the stroma into Descemet’s 
membrane have been observed with the electron microscope (Binder et al, 1991). 
The anterior layer consists of a hexagonal array of collagen bundles. In cross 
section the bundles appear irregular and have intervals of 110nm. The major 
protein is collagen IV, but other basal laminar components, such as fibronectin 
have been identified (Newsome et al, 1981). The posterior part of the membrane 
comprises more recently produced fibrillogranular material and is attached to the 
endothelial cells by modified hemidesmosomes.
If endothelial cells are stimulated they produce excess amounts of basal lamina 
material and focal thickenings occur, called guttae. Peripheral guttae are known 
as Hassell-Henle warts and are common in ageing corneas (Lorenzetti et al, 1967). 
Central warts, however, are indicative of endothelial cell dysfunction. Central 
cornea guttata that spread peripherally, thickening and folding of the Descement’s 
membrane and stromal oedema are all symptoms of Fuchs’ endothelial dystrophy, 
an autosomal dominant disease. Eventually the endothelium is disrupted and 
epithelial oedema develops leading to epithelial bullae that may rupture.
Another difference of this layer from Bowman’s layer is the healing process that 
takes place after injury (trauma or disease). Endothelial cells spread and produce 
new basal lamina identical to normal Descemet’s layer.
1.3.5 Endothelium
This is a single layer of hexagonal cells, 4-6pm thick, which are generally 
considered amitotic. The surface that comes in contact with Descemet’s 
membrane is uneven due to the interdigitation of adjacent cells. The posterior 
surface is thought to be coated with a viscous substance, in a similar way 
epithelium is coated with a mucin, which "adjusts” it in the wet environment 
(Wolf, 1968; Sperling et al, 1980).
The endothelium is essential for the maintenance of corneal structure and 
function. It serves as a barrier, protecting the cornea from oedema and allowing 
passage of salts and metabolites. Acting as a fluid pump it prevents excessive 
aqueous humour entering into the stroma.
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Endothelial cells maintain tight physical contact with one another through the 
membranes of contiguous cells interdigitating one another and forming a marginal 
fold. Neighbouring cells are bound together by cell junctions (usually anchoring 
and seldom occluding), elaborate junctional complexes and gap junctions. ZO-1, a 
protein closely associated with the cytoslic surface of tight junctions, is distributed 
around the apical borders of endothelial cells (Barry et al, 1995), but the 
distribution of this protein around the cells is discontinuous with the largest gaps 
occurring between adjacent cells. All of the above result in a firmly sealed layer 
of cells that interconnect and convey chemical signals to each other.
Endothelial cells are very active metabolically in order to perform their substantial 
role. Whenever there is a demand for additional workload (e.g. during growth, 
ageing cell loss, intraocular surgery or trauma) they meet these requirements by 
enlarging. Therefore some degree of endothelial cell loss can be overcome by this 
process, but there is a limit below which the endothelium fails to maintain its 
integrity and decompensation occurs. Corneal oedema and visual loss follow. This 
minimum limit is 400cells/mm2 contrasted with the normal average 
2,000cells/mm2.
1.4 CORNEAL DYSTROPHIES
Corneal dystrophies are primary, bilateral, inherited conditions that affect vision 
and can change the transparency and refraction of cornea ( Bron, 2000). They are 
distinct from corneal degenerations, which are age-related changes of the cornea 
accompanied by other ocular diseases. Most of them are autosomal dominant with 
early or late onset and character variations (symptoms, clinical presentation, and 
progression) can be observed within the same and between different families.
The dystrophies have been extensively studied and characteristic histopathologic 
and immunological findings have been revealed by light and electron microscopy. 
The dystrophy can occur in any of the several layers of the cornea. According to 
the anatomic classification there are dystrophies of the epithelium, epithelial 
basement membrane, Bowman’s layer, stroma and endothelium (Table 1.1). 
Corneal dystrophies have been classified in several different ways, but it seems 
that the best way to classify them is by defining the gene with the defect. It is not 
rare for patients who have similar clinical symptoms and/or histological findings to 
have different mutations and for patients suffering from different diseases to have
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mutations in the same position of the same gene. Determination of the genetic 
cause can be helpful for understanding and distinguishing each dystrophy. Only the 
dystrophies which are known to involve mutations in the (3ig-h3 gene will be 
described in this chapter.
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Corneal Location Dystrophy
Recurrent Erosion
Meesman’s
Epithelium Stocker-Holt
Rosette
Map-Dot Fingerprint
Anterior Crocodile Shagreen
Grayson-Wilbrandt
Thiel-Behnke
Bowman’s Layer
Reis Buckler’s
Inherited Band
Anterior Mosaic
Familial Comeal Scarring
Subepithelial Mucinous
Granular (Groenouw type 1)
Avellino (Granular Type II)
Macular (Types 1, IA, II)
Lattice (Types 1, II, III, IIIA, IIIB, IV)
Gelatinous Drop-Like
Central Crystalline (Schnyder’s)
Stroma
Marginal Crystalline (Bietti)
Marginal Crystalline (Barraquer)
Fleck
Polymorphic Amyloid Degeneration
Speckled
Progressive
Central Cloudy
Congenital Hereditary
Pre-Descement’s
Posterior Amorphous
Posterior Polymorphous
Congenital Hereditary (Type 1 and II)
Endothelium Comeal Guttata
Late hereditary Endothelial (Fuch’s)
Table 1.1: Corneal Dystrophies of the different layers of the cornea
(Modified from Bron, 2000)
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1.4.1 Keratoepithelin related corneal dystrophies
A number of anterior stromal dystrophies have been found to be associated with 
defective keratoepithelin. The following are the dystrophies, which have been 
reported to date to involve and be caused by defective (3ig-h3 gene. They all share 
the same inheritance pattern, which is autosomal dominant.
1.4.1.1 Granular Corneal Dystrophy (Groenouw type I)
This is one of the classically recognised autosomal inherited corneal dystrophies 
(Groenouw, 1933). It has an early onset in life but remains asymptomatic for 
years. Discrete, focal, milky, granular deposits in the anterior central stroma (and 
progressively with age in the deeper stroma) are defined from remaining clear 
areas. With progression, the stroma develops a ground-glass appearance. The 
lesions do not extend to the limbus but can protrude anteriorly through breaks in 
Bowman’s layer.
Figure 1.4: Granular corneal Dystrophy
A. Photograph from the cornea from a Granular dystrophy patient. B. Red Masson’s staining 
(Courtesy of Prof. GCM Black)
Microscopically, the granular material is hyaline and stains bright red with Masson’s 
trichrome stain.
An electron dense material made up of rod or trapezoidal shaped deposits 
immersed in an amorphous matrix is seen ultrastructurally (Akiya et al, 1970). 
Biochemical and immunohistochemical analysis reveals excess phospholipids and 
microfibrillar protein (Rodrigues et al, 1983). Stromal keratocytes appear normal 
or at various stages of degeneration.
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The dystrophy is slowly progressive with vision rarely dropping below 20/200, 
therefore most patients do not require treatment initially. Recurrent erosions are 
rare. Lamellar keratoplasty is useful for alleviating the superficial symptoms. 
When visual acuity is affected penetrating keratoplasty is carried out. Recurrence 
in the graft anteriorly and centrally may occur with time (Santo et al, 1995, Inoue 
et al, 2002 and Ellies et al, 2003).
1.4.1.2 Avellino Corneal Dystrophy
This is a variant of granular dystrophy, which was described in a small number of 
families who trace their roots to Avellino, Italy. In spite of this, the mutations on 
the pig-h3 gene in families affected by this dystrophy have arisen independently 
and do not reflect a putative founder effect (Korvatska et al, 1998).
Figure 1.5: Avellino Dystrophy
(Courtesy of Prof GCM Black)
The affected patients have a granular as well as a lattice dystrophy both 
histologically and clinically (Ferry et al, 1997; Folberg et al, 1998). Discrete 
subepithelial granular deposits are seen in young affected individuals. Mid and 
posterior stromal retractile lines develop in the third decade, while the granular 
lesions progress. As the lattice phenotype is manifest later in life, a lot of the 
affected individuals are diagnosed as granular dystrophy patients (Stewart et al, 
1999).
Older patients have anterior stromal haze between deposits, which reduces visual 
acuity (Holland et al, 1992). Recurrent erosions are more frequent than in granular 
dystrophy patients. Pathologically, both the hyaline deposits typical of granular 
dystrophy and the amyloid deposits of lattice dystrophy are seen. Granular 
deposits re-appear in corneal grafts (Ellies et al, 2002 and 2003).
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1.4.1.3 Lattice Dystrophy
This disease has a variable expression. The corneal changes, those of classic 
branching lattice lines, vary significantly in different cases. Retractile lines, 
central and subepithelial ovoid white and diffuse anterior stromal haze appear. 
Initially, the white dots have a similar appearance to granular dystrophy. The 
stroma can take on a ground-glass appearance.
Figure 1.6: Lattice corneal dystrophy
(Courtesy of Prof. GCM Black)
This disorder is a primary localised corneal amyloidosis. The following three types 
of lattice dystrophy have been linked with keratoepithelin (apart from type III, 
which is recessive an the gene has not been mapped yet):
Type I (Biber-Haab-Dimmer)
This is a classic lattice dystrophy. Onset is in early childhood. Young patients are 
asymptomatic showing anterior retractile dots, filamentary lines and subepithelial 
white spots and corneal haze. Others might exhibit only recurrent erosions. In 
older patients the lines spread to involve the stroma and recurrent erosions result 
in irregularity of the epithelial surface and decreased visual acuity. Progressive 
clouding and scarring may result in opacities and in extreme cases vascularisation. 
Histopathologic examination reveals an irregular epithelium, with degenerating 
basal cells and thickened basement membrane. The basal lamina lacks 
hemidesmosomes and Bowman’s layer is often fragmented. A thick layer composed 
of amyloid and collagen usually separates this layer from epithelial basement 
membrane. The stroma contains large and irregular deposits, which distort the 
regular lamellar pattern. Type AA amyloid has been identified in the cornea of 
several patients. The deposition of amyloid is observed in all levels of stroma,
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especially in the anterior two thirds. There is no systemic amyloid deposition 
(Frayer et al, 1959).
Type III
This is a late onset dystrophy, arising in the fifth decade or later in life and has 
been reported in Asian patients (Hida et al, 1987). These deposits are midstromal 
and larger than the deposits in age-matched individuals with type I. The observed 
subepithelial and stromal opacities, deposits and haze are less prominent. Type III 
deposits are type AP amyloid in contrast to type AA in type I. The inheritance 
pattern is autosomal recessive and the gene has not been mapped yet. Recurrent 
erosion is uncommon in patients with this type of dystrophy.
Type IIIA
A variant described as type IIIA is similar to type III, except that recurrent erosions 
are common, inheritance is autosomal dominant and type IIIA is seen in white 
patients (Stock et al, 1991). The lattice lines in this case are deeper, ropy, 
branching and near to limbus.
Figure 1.7: Lattice corneal dystrophy type IIIA
(Courtesy of Prof. GCM Black)
Amyloid stains rose to orange red with Congo red dye and metachromatically with 
crystal violet dye. Several cases with visual loss resulting from corneal dystrophy 
are treated with penetrating keratoplasty. Recurrence of the dystrophy in the 
cornea graft (usually in 2 to 12 years) occurs more frequently than granular or 
macular dystrophy (Stock et al, 1991).
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1.4.1.4 Reis Buckler’s Dystrophy (Corneal Dystrophy of Bowman’s layer I)
This is a progressive dystrophy that appears in the first few years of life with 
recurrent attacks of photophobia and irritation. It is a severe disorder that results 
in anterior corneal opacification, irregular astigmatism, anterior stromal oedema 
and subsequent early loss of vision.
It mainly affects Bowman’s layer, most of which is disrupted and replaced by 
granular deposits that correspond to confluent subepithelial opacities. The surface 
of the epithelium appears irregular and of varying thickness. The opacities are 
more dense in the central cornea, whereas there is a fine haze extending to the 
limbus (Paufique et al, 1966). Biomicroscopy reveals a superficial, gray-white 
reticular opacification. The epithelial cells show degenerative changes and a 
prominent subepithelial layer contains fragments of Bowman’s layer, fibroblasts 
and fibrous tissue (Rice et al, 1968, Akiya et al, 1971 and Kuchle et al, 1995). The 
posterior cornea appears normal, but in advanced cases the anterior scarring can 
lead to surface irregularity. The fibrocellular deposits are stained red with 
Masson’s trichrome and are arranged in a lamellar pattern.
Figure 1.8: Reis Buckler's corneal dystrophy
(Courtesy of Prof. GCM Black)
Initial treatment is aimed at the recurrent erosions. Superficial keratectomy, 
lamellar keratoplasty, excimer excision, or rarely penetrating keratoplasty may be 
performed. Recurrence in the graft is common.
1.4.1.5 Honeycomb (Thiel and Behnke) Dystrophy
Also known as Corneal Dystrophy of Bowman Layer II, to distinguish from Corneal 
Dystrophy of Bowman’s layer I (another name for Reis Buckler’s Dystrophy).
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Honeycomb dystrophy appears early in childhood and develops progressively with 
painful recurrent erosions and gradual moderate deterioration in vision (Weidle, 
1999). Characteristics of this disorder are the subepithelial honeycomb-shaped, 
asymmetrical opacities, which are manifested in the second decade of life. In 
later stages the opacities affect mostly the central rather than the peripheral 
cornea at the level of Bowman’s layer. The corneal surface is smooth and corneal 
sensation is not significantly decreased. Recurrence in the graft following 
keratoplasty is common.
Figure 1.9: Honeycomb corneal dystrophy
A. Photograph of the cornea from a Thiel-Behnke patient. B. H&E staining 
(Courtesy of Prof. GCM Black)
Histopathological findings include thickened, split epithelial basement membrane 
and a fibrillogranular subepithelial layer with protrusions to the overlying 
epithelium (Okada et al, 1998). Deposits of curly fibers in the subepithelial region 
and superficial stroma are identifiable only by Electron Microscopy (Weidle, 1989).
1.4.1.6 Map-dot-fingerprint Dystrophy
This is a bilateral dystrophy of possibly dominant inheritance due to incomplete 
penetrance and lack of obvious inheritance patterns. It has not been attributed to 
mutations on the pig-h3 gene, but it is suspected to be linked and is currently 
under investigation. Symptoms vary from recurrent epithelial erosions to blurred 
vision. The dystrophy is characterised by three types of lesions which occur in the 
epithelium and the adjacent basement membrane:
i) Fingerprint lines. These are thin hairlike lines.
ii) Map lines. Same as the above, with the exception that they are thicker, 
more irregular and surrounded by a haze.
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iii) Dots/microcysts. They are gray-white intraepithelial spaces with 
discrete edges. When these are prominent they are described as Cogan’s 
microcystic dystrophy, (Cogan et al, 1964).
iv) Net and bleb patterns arise from thickenings of the basal lamina at the 
basal aspect of epithelial basal cells (Laibson et al, 1975).
Fingerprint and map lines comprise strips of epithelial basement membrane. Dots 
consist of the debris of epithelial cells that have collapsed before reaching the 
surface.
Figure. 1.10: Map Dot Fingerprint dystrophy
(Courtesy of Prof. GCM Black)
Histopathologically there is thickening of the basement membrane with extension 
to the epithelium, abnormal epithelial cells with microcysts, fibrillar material 
between the basement membrane and Bowman’s layer.
Treatment includes lubricating drops, epithelial scraping, anterior stromal 
puncture, removal of damaged epithelium (Laser).
1.5 KERATOEPITHELIN
1.5.1 Terminology
Both the gene and the protein have been described in the literature with various 
different names. To avoid confusion, in this report the gene will be termed (3ig-h3 
and the resulting protein, keratoepithelin.
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1.5.2 Gene and protein
The gene encoding for keratoepithelin, was first cloned and sequenced by Skonier 
et al, 1992, while trying to identify novel genes induced by Transforming Growth 
Factor-p (TGF-p). It was isolated from a cDNA library constructed from human 
adenocarcinoma cell line A549, which had been treated for 3 days with TGF-p. The 
gene was named after the clone it was derived from: TGF-p induced gene-human 
clone 3, i.e. pig-h3.
pig-h3 was mapped by in situ hybridisation on chromosome 5q31 (Skonier el al,
1994) and the nucleotide sequence was found to be 86% homologous with the 
murine equivalent, pig-m3, which is located on mouse chromosome 13 region B/C1.
DNA sequencing analysis revealed that pig-h3 encodes a 683 amino acid protein 
(Skonier et al, 1992). The protein has a 23 amino acid NH2-terminal secretory 
sequence, which indicates that it is an extracellular protein. Dermal fibroblasts 
grown on a three-dimensional Vicryl scaffold secreted keratoepithelin into the 
extracellular matrix (LeBaron et al, 1995). An Arg-Gly-Asp (RGD) sequence is 
located in the carboxy-terminal but is possibly removed by post-translational 
processing since it is not present in secreted protein (Skonier et al, 1994). RGD 
sequence usually serves as a ligand recognition site for integrins (Ruoslahti et al, 
1989).
Keratoepithelin has internal repeated domains, which have highly conserved 
sequences found in some secretory and membrane proteins of several species, like 
periostin/osteoblast-specific factor-2 (OSF2) (cross-species, like keratoepithelin), 
fasciclin-l (Drosophila) and MPB70 (Mycobacterium tuberculosis). Drosophila’s 
fasciclin-l, is found in nerve fibers (Zinn et al, 1988), associates with membranes 
and serves as a “homophilic adhesion molecule” (Elkins et al, 1990). The 
homologous domains of the above proteins have been designated fas-1, from 
fasciclin-l homologous domain. Keratoepithelin, like fasciclin-l and periostin, has 4 
fas-1 domains whereas MPB70 has only one. Each fas-1 domain is characterised by 
two highly conserved sequences of about 10 amino acids, H1 and H2.
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Repeat Amino acids Length
1 139-275 137
2 276-410 135
3 411-537 127
4 538-670 146
Table 1.2: Fas-1 repeat sequences (in amino acids) in keratoepithelin
Keratoepithelin is conserved between species and this has aided the identification 
of homologues in other species. The murine protein is 90.6% similar to human 
(Skonier et al, 1994) and the rabbit 92% (Rawe et al, 1997). A 66kD collagen fiber- 
associated protein (RGD-CAP) isolated from a fiber-rich fraction of pig cartilage 
was found to be 93% homologous with human and mouse keratoepithelin 
(Hashimoto et al, 1996). RGD-CAP is also homologous with OSF2 and fasciclin 1, 
like keratoepithelin. The bovine homologue MP78/70 has been extracted from 
fetal calf ligament and is thought to associate with microfibrils in ECM (Gibson et 
al, 1996).
Other characteristics of the keratoepithelin protein include no apparent predicted 
N-glycosylation sites, no disulfide-bonded dimer in solution and a heterologous 
charge: pi 6.2-6.71 (Escribano et al, 1994).
1.5.3 Tissue distribution
Since its discovery, several experimental procedures have been carried out to 
understand more about this gene and its expressed protein. One of the first steps 
(Escribano, 1994 and Skonier, 1994) was the identification of tissues where pig-h3 
is expressed. pig-h3 transcripts were detected in the total RNA extracted from a 
variety of tissues: Heart, breast, testes, prostate, duodenum, epidermis, dermis, 
adrenal, ovary, liver, pancreas, parathyroid and spleen. Whereas, without any prior 
treatment several cell lines express pig-h3 the levels of the mRNA transcripts are 
usually low. Exception to this observation are human primary foreskin fibroblasts, 
which constitutively produce and secrete unusually high levels of keratoepithelin 
(LeBaron et al, 1995). In contrast, the brain and cerebellum showed consistently 
no pig-h3 expression.
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Antibodies raised to synthetic human pig-h3 identified extracted MP78/70 and 
immunohistochemistry localised it in a variety of bovine tissues, including 
developing nuchal ligament, aorta, lung, kidney, mature cornea and foetal spleen 
(Gibson et al, 1997). The protein, the bovine homologue to keratoepithelin, was 
found in the region of interstitial collagen fibers and in association with some 
basement membranes. The staining pattern resembled collagen IV and double 
staining revealed localisation around collagen IV microfibrils, which are also found 
in association with the cell surface and attached to several basement membranes 
(Maier and Mayne, 1987; Rittig et al, 1990; Zhu et al, 1994).
Keratoepithelin is one of the molecules that have been identified in association 
with fibrillin-containing microfibrils in developing tissues. pig-h3 mRNA was found 
abundantly in both the extracellular matrix of human trabecular bone and in 
osteoblast cell culture (Kitahama et al, 2000).
The gene expression must be regulated by the cell shape and environment, since 
lung fibroblasts have a low level of keratoepithelin compared to the high level of 
expression in primary dermal fibroblasts. Keratoepithelin has been 
immunohistochemically localised in the human skin, where it is found in the 
papillary dermis, especially in the granular layer of epidermis (LeBaron et al,
1995).
pig-h3 is also expressed in the normal kidney. In diabetic rats, where there is an 
increased glucose concentration, TGF-p, collagen VI and pig-h3 transcription is 
increased 2-3 fold. Also in vivo, elevation in glucose levels leads to induction of 
TGF-p, which in turn causes overexpression of pig-h3 (Gilbert et al, 1998). The 
opposite happens in older rats, where the level of pig-h3 mRNA decreases in the 
kidney (Lane et al, 2001), possibly in response to the decreased amount of active 
TGF-P! available in these rats. pig-h3 has been used a marker for active TGF-p! in 
the kidney by Langham et al, 2001.
Immunohistochemistry of rat aortas localised keratoepithelin on endothelial cells, 
smooth muscle cells and in the matrix between elastic fibers (Ha, 2003). Diabetic 
aortas were more heavily stained. TGF-P! increased keratoepithelin levels in a 
dose-dependent manner in vascular smooth muscle cells. High glucose increases 
keratoepithelin and TGF-p! production. Conversely, neutralising antibodies to TGF-
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pi block glucose induced keratoepithelin elevation, thus upregulation of 
keratoepithelin under high glucose concentration is mediated by TGF-p!.
pig-h3 is transcribed almost exclusively in the corneal epithelium as shown by in 
situ hybridisation (Kublin and Cintron, 1996) and is preferentially expressed on the 
external surface of corneal epithelial cells (Escribano et al, 1994). It is a 
component of the stroma where it is found with collagen VI (Rawe et al, 1995; 
Hirano et al, 1996).
It is noteworthy that in the cornea, where the expression of keratoepithelin is high, 
TGF-p! and TGF-p2 transcripts are low. Conversely in the lens where TGF-Pi and 
TGF-p2 levels are high there is little or no keratoepithelin. As in many pathologic 
cases (Genini et al, 1996, Kim et al, 2000, Hu et al, 2001), the pig-h3 expression is 
altered in lens as well. Lens epithelial cells express abundant keratoepithelin in 
anterior polar, but not in nuclear cataracts (Lee et al, 2000).
1.5.4 Function
Despite extensive work on the genetics of pig-h3, it is not clear yet what the exact 
role of this protein is. Assumptions and hypotheses have been made, based on the 
experimental findings. One of the areas it is implicated with is cellular 
proliferation, since it is induced by a growth factor. Transfection of Chinese 
Hamster Ovary (CHO) cells with expression vector carrying pig-h3 resulted in 
alterations in the shape, growth rate and tumourgenicity of these cells (Skonier et 
al, 1994).
Recombinant keratoepithelin promotes the adhesion and spreading of fibroblasts in 
a time and concentration-dependent fashion. This property is also exhibited by 
collagen VI, which is involved in several cellular and matrix interactions (Doane et 
al, 1992). Adhesion, spreading, migration and proliferation of vascular smooth 
muscle cells was mediated by immobilised keratoepithelin (Ha et al, 2003)
(3ig-h3 was first implicated in wound development and healing by O’Brien et al 
(1996) who were studying vascular lesions. TGF-p is overexpressed during coronary 
atherosclerosis and restenosis after balloon angioplasty. pig-h3 seems to be 
expressed in normal vascular tissue and overexpressed during the development of 
atherosclerosis and restenosis in human vascular lesions. Normal expression is seen
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in epithelial cells, whereas in pathological lesions stellate-shaped smooth muscle 
cells (SMC), and in more severe conditions, macrophages also express this gene, 
the product of which is accumulated in ECM. Overexpression of both TGF-p and 
pig-h3 may cause excessive tissue repair and the formation of abundant scar tissue.
The mouse pig-h3 has been characterised extensively. Its structure and the 
number of exons are similar to human (Schorderet et al, 2000). To gain an insight 
into its physiological role, the embryonic expression was determined at different 
developmental stages. During embryogenesis pig-h3 is seen in tissues derived from 
mesoderm, like developing bones, cartilage, blood vessels, thymus, kidney, and 
peribronchial structure. It is highly expressed in developing heart and pancreas. In 
the fetal eye expression starts at the optic stalk and progresses towards the sclera 
and the choroid and finally reaches the cornea. Although the physiological role 
remains unknown it seems that pig-h3 is an important component of the 
mesenchyme and plays an important role in the development and maintenance of 
many organs.
Both native and recombinant form of the porcine homologue, RGD-CAP, bind to 
collagen. The triple-helical three-dimensional conformation of collagen seems to 
be crucial for this interaction, since RGD-CAP would not bind to collagen that had 
been boiled for 5 minutes (Hashimoto et al, 1997). The in vitro interaction 
between keratoepithelin and collagen VI is non-covalent (Hanseen et al, 2003). 
The keratoepithelin binding site is located close to the N-terminal end of triple 
helical region of collagen VI.
During the development and wound healing in the cornea, pig (rabbit gene) 
transcription is increased together with type VI and XII collagen and p-actin. This 
increase is observed during the first two weeks of wound healing and decreases 
during the following 4 weeks (El-Sabrawi et al, 1998). mRNA levels of pig are 
higher than type VI collagen in the early stages, which reflects differences in the 
deposition of these proteins in the extracellular matrix and the distinct roles they 
play in these processes.
The mRNA transcripts of pig, the rabbit homologue, are found to be located 
primarily in the corneal epithelium, but during development and healing they are 
found in the stroma as well (Rawe et al, 1997). The intensity of labelling changes
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during development and healing, which suggests that the site, level and timing may 
vary at different stages.
pig-h3 mRNA is upregulated by TGF-p! but not by EGF in corneal epithelial cells in a 
cell density-dependent way. When these cells reach confluence the levels of pig- 
h3 drop, which indicates a decrease in the magnitude of TGF-Pi induction (Wang, 
2002). It is possible that pig-h3 expression is enhanced in response to TGF-p! at 
early stages of wound healing, but is later downregulated through a cell-cell 
contact inhibitionary autoregulatory mechanism, as happens with TGF-pi (Kaji et 
al, 2000) and a variety of other genes involved in the wound healing process.
Immobilised and soluble recombinant keratoepithelin, with and without the RGD 
sequence inhibits bone nodule formation in a dose-dependent manner, like 
fibronectin (Kim et al, 2000). The same observation was reported on the effects of 
exogenous keratoepithelin on periodontal ligament cells (Ohno et al, 2002). In 
addition downregulation of collagen I was inhibited, which collectively implicates 
keratoepithelin as a negative regulator of mineralisation and osteogenesis. In the 
periodontal ligament, keratoepithelin is expressed as a >200kDa product under 
non-denaturing and ~70kDa under reducing conditions, which suggests the presence 
of multimers in the native form (Ohno et al, 2002). The presence of cystein near 
the carboxy-terminus could be responsible for the multimerisation of the protein 
via the formation of disulfide bonds.
Staining for keratoepithelin varies during cartilage development of chick embryos 
(Ohno et al, 2002). Recombinant RGD-CAP in the presence of cyclohexamine, 
which inhibits synthesis of growth factors, promotes adhesion and spreading of 
mesenchymal stem cells and inhibits the mineralisation of hypertrophic 
chondrocytes. Therefore keratoepithelin plays an essential role in early cartilage 
development by enhancing adhesion and growth of pre-chondrogenic cells and 
acting as a negative regulator of mineralisation at the terminal stage of 
chondrogenic differentiation.
The effect of mechanical stimuli on the expression of keratoepithelin was 
investigated by Doi et al in 2003. pig-h3 mRNA and the corresponding protein were 
increased in periodontal ligament from orthodontic force and cells cultured under 
mechanical tensile force. This increase was abolished by neutralising antibodies
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against TGF-p!. Therefore pig-h3, induced by TGF-p! is upregulated in response to 
mechanical stimuli, possibly by contributing to remodelling and homeostasis of 
periodontal ligament tissue.
Although the brain is a tissue where pig-h3 expression was found to be non-existent 
under normal conditions (Skonier el al, 1994; Escribano et al, 1994; Aitkenhead, et 
al 2002), the pattern changes in response to injury. Astrocytes express significant 
amounts of pig-h3 at the site of a stab wound in the cerebral cortex of adult rats. 
Also cultured human and mouse astrocytes produce increased amounts of pig-h3 
mRNA and protein in response to TGF-Pi induction (Yun et al, 2002). Other 
cytokines including TGF-p2, TNF-a, PDGF, IL-6 and IFN-y had no effect on pig-h3 
expression.
All the findings are suggestive that keratoepithelin is involved in growth, 
development, differentiation and wound healing. It is a component of the 
extracellular matrix, where it is associated (structurally/functionally) with collagen 
and cells. It probably binds to cell-surface components in conjunction with other 
ECM molecules and might be required for signal transduction or as a surface 
recognition/anchoring protein.
1.5.5 Integrins
Integrins are cell surface receptors composed of a and p-chain transmembrane 
heterocomplexes, which mediate interactions between the cell and the ECM 
proteins. The functional interaction between these receptors and ECM molecules is 
responsible for the transduction of bi-directional signals which ultimately regulate 
adhesion, differentiation, proliferation and tumour progression (Giancotti and 
Ruoslahti, 1999). Keratoepithelin is a component of the ECM and it is thought to 
interact with cells through various integrins, which seem to vary with the cell type.
Recombinant RGD-CAP (porcine keratoepithelin) promotes the spreading and 
attachment of a variety of chondrocytes and fibroblasts but not pulp-derived 
odontogenic cells and the reason for this was speculated to be different types of 
integrins expressed on the surface of the different cell types via which the 
attachment could be mediated (Ohno et al, 1999). Supportive of this speculation 
was the fact that spreading was inhibited by EDTA and required divalent cations, 
which is the case for integrins (Lallier et al, 1992; Garratt et al, 1995). Previously
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keratoepithelin had been immunologically co-localised with integrin pi, but it had 
been impossible to establish a cross-linking product (Escribano et al, 1994). 
Furthermore, neutralising antibodies against a variety of integrins demonstrated 
that cii and Pi suppress the keratoepithelin mediated spreading. Therefore c^pi 
integrin is important for keratoepithelin, which is probably a ligand for it.
The same experiment as described above was repeated with human corneal 
epithelial (HCE) cells (Kim et al, 2000) and keratinocytes (Bae et al, 2001) and a 
different integrin-receptor was identified for these cells, a3pi. Recombinant 
keratoepithelin does not only promote skin keratinocyte adhesion and spreading, 
but also enhances migration, which implicates it in wound healing.
Although both corneal epithelial cells and fibroblasts express a3p! and avps 
integrins, each one of them interacts through a different binding site in 
keratoepithelin mediated adhesion. HCE cells adhere through a3Pi and fibroblasts 
through avp5 (Kim et al, 2002). This suggests that keratoepithelin may mediate 
various cell functions through multiple cell-adhesion motifs that interact with 
diverse integrins on different cell types.
Keratoepithelin mediates vascular smooth muscle cell adhesion via av integrin (Ha 
et al, 2003).
Immobilised keratoepithelin promotes adhesion of astrocytes and this interaction 
requires divalent cations and is blocked by RGD peptides, suggesting the 
implication of an integrin. The combined results from blocking monoclonal 
antibodies against integrin subunits and expression profile of integrins on the 
astrocyte cell surface indicate that keratoepithelin mediates adhesion on these 
cells through (Kim et al, 2003). For the first time keratoepithelin was 
associated with a signalling process: astrocyte interaction with keratoepithelin is 
dependent on signalling through the src kinase. Also focal adhesion kinase (FAK) 
and paxillin are Tyr phosphorylated upon this interaction and the phosphorylation 
is blocked by anti-p4 integrin. Thus a6P4 evokes keratoepithelin mediated cell 
changes through FAK activation. Since pig-h3 is upregulated in astrocytes after 
injury (Yun et al, 2002) its binding on may initiate cytoskeletal reorganisation 
of astrocytes during CNS repair.
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Human umbilical cord endothelial cells (HUVEC) bind to keratoepithelin and each 
one of its fas-1 domains through integrin avp3 which is more predominant on HUVEC 
surface than avp5 (Nam, 2003). This binding takes place in a dose-dependent 
manner.
1.5.6 Identification of functional domains
It is interesting that aiPi integrin does not recognise the RGD sequence and 
therefore another sequence from keratoepithelin is responsible for ligation to aipi 
(Ohno et al, 1999).
In order to identify the keratoepithelin motif responsible for integrin binding, 
different recombinant peptides were used to compare the adhesion of the HCE 
cells, each one corresponding to each fas-1 domain. The 2nd and 4th fas-1 domains 
mediated adhesion like the wild type protein and were also blocked by a3 and fa 
antibodies (Kim et al, 2000). Therefore a sequence other than H1 and H2 must be 
responsible for the interaction with the integrin. Computer homology search 
among the fas-1 domains revealed aspartic acid and isoleucine, near H2, conserved 
in the 2nd and 4th domains. Mutant proteins for these two amino acids and 
synthetic peptides indicated that aspartic acid and isoleucine are essential for 
adhesion through a3pi.
Different deletion mutants of the 4th fas-1 domain indicated that fibroblast 
adhesion was mediated by a sequence not yet identified. Two conserved amino 
acids, tyrosine (Y571) and histidine (H572) play an important role in avPs adhesion, 
but also other flanking amino acids seem to be important for this interaction, such 
as isoleucine and leucine (Kim el al, 2002).
The above YH amino acids and the flanking isoleucine and leucine are also required 
for HUVEC adhesion on recombinant keratoepithelin (Nam, 2003). An 18 amino 
acid peptide including YH mediates endothelial and fibroblast adhesion and 
migration through interaction with a vp3 and avPs respectively. The same peptide 
inhibits angiogenesis in vitro and in vivo.
Integrins ctvp3 and a vp5 share some ligands and both bind to RGD peptide. It is 
possible that both YH and RGD interact with both of these integrins in a similar
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manner, but have different binding affinity for each or the affinity may depend on 
the activation state of the integrin (Nam et al, 2003).
1.5.7 Tumourigenesis
Throughout the last 8 years pig-h3 has been mentioned in various papers (sections
1.5.7.1 and 1.5.7.2 below) that examine the changes in gene expression of 
malignant cells. Further research on the protein itself and the way it interacts 
with cells defined a more specific role in tumourigenesis.
Downregulation Upregulation
ERMS
HeLa x fibroblast hybrid 
Melorheostosis 
Non-senescent HUVEC 
Malignant bronchial cells
ESCC 
Angiogenesis 
Glioma 
Lung cancer 
Pancreatic cancer
Table 1.3: Altered expression of pig-h3 in various tumour or growth associated 
conditions
1.5.7.1 Downregulated in tumour
The chromosomal position of (3ig-h3, 5q31, is also a region deleted in all 
leukaemias and some carcinomas and it has been suggested that this region 
may contain a tumour suppressor gene (Skonier et al, 1994).
Overexpression of pig-h3 in CHO cells resulted in alterations in their shape, growth 
rate and tumourgenicity (Skonier et al, 1994). This was the first time it was 
suggested that pig-h3 might be a non-DNA binding anti-oncogene that may exert its 
function by interacting with cell surface integrins and ECM molecules.
Purified protein was also found to inhibit the attachment of A549, HeLa and human 
lung fibroblast (WI-38) cells to plastic in serum-free media, presumably by causing 
cell-cell aggregation. Cell attachment and migration are important for tumour 
progression.
Embryonal rhabdomyosarcoma (eRMS) is a skeletal muscle malignancy, where p53 
tumour-suppressor gene and ras oncogene are mutated (Stratton et al, 1990; Felix,
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1992). pig-h3 is one of ECM proteins downregulated and consistently differentially 
expressed in RMS cells (Genini et al, 1996). The expression of pig-h3 by myoblasts 
and the loss of expression in the malignant cells suggests that pig-h3 plays a role in 
normal cell growth.
pig-h3 is also one of 17 genes differentially expressed in non-tumorigenic 
HeLaxfibroblast hybrids (Tsujimoto et al, 1999). Some of the other genes which 
have similar expression, e.g. collagen I a-2 chain, have also been associated with 
suppression of tumourgenicity.
Subtractive hybridisation of mRNA from early passage and senescent HUVEC 
demonstrated that pig-h3 is upregulated in senescent cells (Grilliari et al, 2000). 
Therefore increased expression of |3ig-h3 and some other ECM proteins, including 
PAM, fibronectin and IGFBP-3 may contribute in the growth arrest of senescent 
cells.
Melorheostosis is a rare condition characterised by hyperostosis of the cortex, pig- 
h3 is the most dramatically downregulated gene in melorheostosis skin fibroblasts 
(Kim et al, 2000). It has already been described that keratoepithelin is involved in 
early stage bone formation where it plays a negative role as regulator of 
osteoblastic differentiation (Ohno et al, 2002). Therefore reduced expression of 
pig-h3 may contribute to the excessive growth that characterises this disorder. 
Other adhesion proteins downregulated in this experiment include fibronectin, 
OSF-2 and osteonectin, which together with pig-h3 reflect the negative regulation 
they exhibit on the cell growth rate.
An asbestos-induced bronchial malignant cell line showed a 7-8 fold decrease in 
pig-h3 expression, which was accompanied by loss of half chromosome 5 (Zhao et 
al, 2002). pig-h3 overexpression in these cells resulted in limiting their ability of 
anchorage-dependent growth and tumourgenicity. 14 human tumour cell lines 
tested by these researchers demonstrated decreased pig-h3 expression, which 
suggests that loss of keratoepithelin contributes to the cancerous phenotype.
Loss and gain of specific integrins is involved with malignant transformation, 
tumour progression and metastasis (Mizejewski, 1999). Depending on the cell and
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tumour type, integrins act either as promoters or inhibitors of carcinogenesis. It 
was found that a5pi is upregulated in the malignant bronchial cell line used above 
(Zhao et al, 2003), whereas pig-h3 is downregulated (Zhao et al, 2002). a5Pi is 
actually upregulated in a variety of cancer cells and protects from apoptosis in 
vitro by inducing anti-apoptotic Bcl-2 (Zhang et al, 1995). Therefore pig-h3 may 
play a role in the regulation of expression of receptor.
The first report that attempted to provide an explanation for the anti-proliferative 
effect of pig-h3 was by Kim et al in 2003. The research was based on the fact that 
RGD peptides cause anoikis, a form of apoptotic response due to the absence of 
cell matrix interactions. RGD peptides are thought to block the integrin-ligand 
interactions and thus the signals for cell survival. Wild type keratoepithelin 
undergoes C-terminal cleavage after secretion and releases RGD peptides. Several 
cell lines that were transfected with wild type pig-h3 undergo apoptosis in contrast 
with the RGD peptide mutant transfectants, which grow normally. Therefore 
keratoepithelin may mediate its apoptotic effect by releasing soluble RGD 
peptides.
1.5.7.2 Upregulated in tumours
Even though all the above findings associate pig-h3 with an apoptotic character, a 
number of cancers have also been described where pig-h3 is significantly 
upregulated.
pig-h3 is one the 13 genes that were upregulated >2fold in 2 Esophageal Squamous 
Cell Carcinomas (ESCC). Normal esophageal epithelium expresses pig-h3, but in 
low amounts (Hu et al, 2001).
Angiogenesis plays an important role in a number of physiological and pathological 
processes including tumour formation (Yancopoulos et al, 2000). Aitkenhead et al 
in 2002, determined angiogenic genes from endothelial cells that form tubes in 3D 
collagen gels and pig-h3 was found to be 5.3 fold differentially upregulated. 
Aggressive tumours are associated with high angiogenesis (Tas et al, 2000). pig-h3 
expression levels were consistently increased in a variety of tumour samples (from 
breast, uterus, colon, stomach and rectum), in some cases up to 70-fold. Antisense 
oligonucleotides to pig-h3 dramatically decreased tube formation in 3D, but had no
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effect on 2D cultures. No significant correlation was made between pig-h3 and the 
angiogenic state due to broader expression of this gene (O’Brien et al, 1996).
Although the pig-h3 transcript is not detectable in normal adult brain, it is 
increased in brain tumours (Golembienski et al, 2002). cDNA array demonstrated 
that pig-h3 is switched on by SPARC (Secreted Protein Acidic and Rich in Cystein), 
which is also upregulated in human gliomas. pig-h3 increased expression is not 
reversed by removing the SPARC effect.
Another tissue where pig-h3 mRNA is elevated during tumour is the lung. It was 
examined whether pig-h3 could be used as a marker for advanced lung cancer but 
the correlation between expression levels and survival rates was not significant, 
although pig-h3 levels increased with the stage of cancer (Sasaki et al, 2002).
In normal pancreas the levels of pig-h3 mRNA are moderate compared with the 
high levels (32.4 fold elevation) observed in pancreatic cancer (Schneider et al, 
2002). pig-h3 is induced in this tissue by TGF-ps, which exert their effects via 
divergent signalling pathways.
1.5.8 In the cornea
The first association of corneal dystrophies with chromosome 5q was made in 1994 
by Stone et al. The pedigrees of eight families affected with three different types 
of corneal dystrophies (Lattice corneal dystrophy I, Granular dystrophy and 
Avellino) were studied. Chromosome linkage analysis with highly polymorphic 
markers mapped all three dystrophies to chromosome 5q. At that time Skonier et 
al had not published the results of their research, mapping pig-h3 on 5q31. 
Therefore the nature of the unknown gene was attempted to be explained from the 
scope of the clinical and histopathological findings associated with the above 
dystrophies. It was hypothesised that the abnormal protein was synthesised by 
epithelial cells or keratocytes and transported /diffused to the corneal stroma, 
where it deposited forming insoluble aggregates. These hypotheses were more or 
less confirmed by further research that was carried out on several types of corneal 
dystrophies. |3ig-h3 was extracted from normal human corneas (Klintworth et al, 
1994), but more research was carried out before it was associated with the 
dystrophies.
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Further fine chromosomal mapping refined the genetic localisation of corneal 
dystrophies between known markers (Eiberg et al, 1995; Gregory et al, 1995, Small 
et al, 1996 and Korvatska et al, 1996). A YAC contig of the linked region was 
generated (Munier et al, 1996) and cDNA selection identified a clone with 100% 
homology with the pig-h3 gene. This gene was considered as a good candidate, 
due to its chromosomal location and its preferential expression in both corneal 
epithelium and stromal keratocytes (Skonier et al, 1994; Escribano et al, 1994).
In 1997 Munier et al discovered that four distinct corneal dystrophies, Lattice type I 
(LCDI), Granular Groenouw type I (CDGGI), Reis Bucklers (CDRB) and Avellino (ACD) 
were caused by mutations in the pig-h3 gene. All of the mutations are amino acid 
substitutions which were hypothesised to result in distortion of the three- 
dimensional shape of the keratoepithelin molecule. LCD1 and ACD had a common 
amino acid substitution on codon 124. LCDI had a C to T transition at nucleotide 
position 417 (R124C) and Avellino had a G to A transition at nucleotide position 418 
(R124H). Likewise, CDGG1 and CDRB had mutations on codon 555; CDGG1 
exhibiting a C to T transition at nucleotide 1710 (R555W) and CDRB having a G to A 
transition at position 1711 (R555Q).
Screening of 10 additional families from different ethnic groups affected with the 
above four types of corneal dystrophies, confirmed these mutations and indicated 
that they occurred independently and were responsible for the phenotypic 
manifestations of these diseases (Korvatska et al, 1998). Therefore, it was 
concluded that CpG dinucleotides at amino acids R124 and R555 represent hot 
spots for mutations.
Another interesting observation is that both amyloid-related phenotypes, ACD and 
LCD1, were mutated in the R124 hotspot and that both non-amyloid phenotypes, 
CDGG1 and CDRB, were defective in R555. It could be possible that the position of 
the mutated amino acid determines the pathogenesis of the resulting dystrophy, 
depending on how it affects the three-dimensional conformation and function of 
the mutant protein. R555 is located in the predicted coiled-coil domain and a 
mutation could alter it by impairing binding to stromal proteins, such as collagen 
(Hirano et al, 1996). According to the same principle, R124 would remove a 
putative phosphorylation site and could modify the structure of the protein.
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However mutations solely in R124 can result in variable phenotype, depending on 
the amino acid alteration that has taken place. Thereby R124C results in amyloid 
deposition, R124H has mixed amyloid and granular deposits, or in the case of many 
Japanese patients only granular deposits. R124S is associated with CDRB (Stewart 
et al, 1999) and has non-amyloid deposits. Therefore apart from the position of 
the protein that has been affected by the mutation another important factor in 
determining the dystrophic phenotype is the nature of the amino acid substitution.
Corneas with granular dystrophy have accumulations of keratoepithelin. Whereas 
the ratio of albumin/keratoepithelin is 3:1 in normal corneas, in corneas with 
granular dystrophy the ratio is 1:4 (Klintworth et al, 1998). The deposits in the 
stroma of the affected corneas reacted with anti-(3ig-h3 antibody, but the 
epithelium did not stain.
Corneal dystrophies have an autosomal dominant inheritance pattern, so even one 
copy of the mutated gene is enough to exhibit the diseased phenotype. It seems 
that the phenotype for the affected individuals who are homozygous is more severe 
than the heterozygous patients. This was demonstrated by Okada et al (1998) who 
studied a family affected with Granular Dystrophy Groenouw type I, where there 
was a consanguineous marriage. Mutation R555W was found by Single Stranded 
Conformational Polymorphism (SSCP) and the homozygous patient had a very early 
onset (6 years of age) and a severe placoid type of corneal dystrophy with early 
recurrence after surgery. The same author selected five patients from different 
families to study their genotype. All the patients were affected with a rare and 
severe form of granular corneal dystrophy characterised by juvenile onset and 
confluent superficial opacities. All were found to be homozygous for the same 
mutation in keratoepithelin: R124H. As mentioned above, this mutation is 
responsible for Avellino corneal dystrophy.
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Figure 1.11: Avellino corneal dystrophy in a homozygous patient
(Courtesy of Prof. GCM Black)
Another illustration that the homozygous phenotype is more aggressive was 
provided by Inoue et al, in 2002. They showed that the recurrence-free interval 
after phototherapeutic keratectomy (PTK) in patients with R124H mutations was 
9.5±3.1 months for homozygous and 38.4±6.2 months for heterozygous eyes. Also 
the clinical features and the intensity of the recurrence differed between the two 
groups.
Reis Buckler’s Dystrophy has always been confused with Thiel-Behnke Dystrophy 
and patients diagnosed with the same dystrophy were frequently found to have 
different pattern of severity and opacification. The reason for this is the fact that 
the two dystrophies have very similar clinical appearance, but differ histologically 
and genetically (Weidle et al, 1995). Extensive light and microscopic examination 
of several corneas concluded that there are two distinct autosomal dominant 
dystrophies that affect the Bowman’s layer (Kuchle et al, 1995). Further 
distinction between the two diseases came when their genotypes were established. 
Different mutations are responsible for each type of dystrophy, but both of the 
mutations are found on the mutation hotspots described previously (Korvatska et 
al, 1998). Reis Bucklers was caused by R124L mutation and Thiel-Behnke was 
related with R555Q. These mutations were again single nucleotide changes, 
resulting in single amino acid substitution. RBCD has been proposed to be the same 
as superficial GCD (sCGD) (Mashima et al, 2000).
Ethnic differences seem to play a role in the genotype-phenotype correlation of 
each dystrophy. The classic form of granular dystrophy in Japanese patients was 
reported to be R124H, which has been associated with Avellino Dystrophy in
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Caucasians. 1 out of 10 Japanese patients diagnosed with granular dystrophy has 
R555W and 9 have R124H mutations (Konishi et al, 1998).
Similarly, Reis Buckler's dystrophy in two families with a common ancestor in 
Sardinia was found to be caused by a mutation other than R555W. Linkage and 
sequence analysis on the two families revealed a novel mutation on keratoepithelin 
responsible for the usual RB phenotype. A deletion of a single amino acid at 
position 540 (AF540) was the mutation found in all affected members of both 
families (Rozzo et al, 1998). The same mutation was diagnosed as LCDIIIA by 
Munier et al in 2002.
Keratoepithelin is mutated in positions other than the two hotspots R555 and R124. 
A mild form of deep stromal lattice corneal dystrophy was encountered in Japanese 
patients (Fujiki et al, 1998). The deposits varied in size and shape and amyloid was 
found in the corneal base between posterior stroma and Descemet’s membrane. 
The genetic defect responsible for this disorder was a single amino acid change in 
keratoepithelin; L527R.
A case of an Asian patient suffering from typical granular dystrophy, with later 
onset than classical Groenouw Type I was reported by Stewart et al (1999). DNA 
analysis with SSCP defined the causative mutation on keratoepithelin hot spot, 
R124. A single nucleotide substitution (C417A) causes amino acid substitution 
R124S. It is interesting that different substitutions of the same amino acid, R124, 
result in quite distinct phenotypes (see table1.4).
Mutation analyses of as many members as possible from kindreds affected with 
corneal dystrophies, reveals more genotypes. LCDI, which has been linked almost 
exclusively with the R124C genotype, has recently been reported to have arisen 
from a different mutation in an American family. All the affected individuals are 
heterozygous for the point mutation L569R which affects pig-h3 exon 13 (Warren et 
al, 2003).
It may also be more efficient to classify the dystrophies according to their 
causative mutations, rather than the histological or clinical findings, which show 
significant variation. Mutation analysis of three kindreds with corneal dystrophy 
IIIA unveiled two new mutations in keratoepithelin (Stewart et al, 1999), N622H
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and H626R. The same type of dystrophy (according to the conventional 
classification system) in Japanese patients was associated with keratoepithelin 
mutation P501T (Yamamoto et al, 1998). More recent mutations that attribute the 
LCDIIIA phenotype are: T538R, V627 (which is a frameshift mutation due to a 
nucleotide deletion) and A546T (Munier et al, 2002; Dighiero et al, 2000).
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Mutation Mutation Dystrophy Reference
(nucleotide) (amino acid)
417 R124C LCDI Munier et al, 1997
CGC -> TGC P-+UP Mashima et al, 
1997
418 R124H ACD Munier et al, 1997
CGC -> CAG P->PP GCD Mashima et al, 
1997
418 R124L CDBI Mashima et al,
CGC -> CTC P -» NP SGCD 1999
Stewart et al, 1999
417 R124S CDGG1 Stewart et al, 1999
CGC -► AGC PP-+UP
1710 R555W CDGG1 Munier et al, 1997
CGG -> TGG P -*  NP Yamamoto et al, 
2000
1711 R555Q CDBII Munier et al, 1997
CGG -► CAG P-»UP Okada et al, 1998
1618-1620 AF540 CDRB Rozzo et al, 1998
TTT -> - NP deleted LCDIIIA Munier et al, 2002
1627 L527R LCD Mashima et al,
CTG -► CGG NP P 2000
1548 P501T LCDIIIA Yamamoto et al,
CCA -> ACA NP -> UP 1998
1911 N622H LCDIIIA Stewart et al, 1999
AAT -> CAT UP->PP
1924 H626R LCDIIIA Stewart et al, 1999
CAT -► CGT PP->P Chau et al, 2003
1926 V627 LCDIIIA Munier et al, 2002
GTC -► TC NP
1600 L518P LCDI Endo et al, 1999
CTG CCG NP -> NP
1678 N544S LCDI Mashima et al,
AAT -> AGT U P^U P 2000
1915 G623D RBCD Afshari et al, 2001
GGC -► GAT NP -> N
1683 A546T LCDIIIA Dighiero et al,
GCC -> ACC NP -► UP 2000
1939 V631D CDL-deep Munier et al, 2002
GTT ->GAT NP N
1661 T538R CDLI/IIIA Munier et al, 2002
ACA -► AGA UP-»P
414 D123H GCD Ha et al, 2003
GAC -> CAC N ^  P (atypical)
1753 L569R LCDI Warren et al, 2003
CTG -> CGG NP P
Table1.4: Nucleotide and amino acid changes in (3ig-h3 related corneal dystrophies.
PP-positive polar, UP- uncharged polar, NP- nonpolar, P- positively and N- negatively 
charged referring to amino acids
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1.5.9 Insights into mutations
The role of keratoepithelin and the mechanism by which it results in the formation 
of a great variety of phenotypes in the cornea has been one of the main areas of 
interest. How do the mutations described in the table above give rise to amyloid 
or granular deposits? The approaches that were taken to answer this question 
include examination of corneas with dystrophies and application of recombinant 
DNA technology.
It has been suggested that keratoepithelin is expressed by the corneal epithelium 
and diffuses to the stroma where it covalently binds collagen VI (Bron, 2000). 
There is an anterior to posterior progression of CDs, as determined by the initial 
confinement of the recurrences after PTK. However, it has been demonstrated 
that both epithelium and corneal fibroblasts express keratoepithelin (Korvatska, 
1999 and Escribano, 1994). Also the clinical and histopathological observations of 
recurrent LCDI were milder, comprising of anterior haze and subepithelial 
opacities, lacking lattice lines and amyloid in stroma. This may be because the 
keratocytes in the donor stroma produce wild type keratoepithelin (Snead et al,
2002). In the case of corneal transplant patients, the mutant keratoepithelin is 
derived from the patient limbus, which progressively provides the epithelium layer 
for the donor cornea. This layer expresses mutant keratoepithelin which could 
contribute to the recurrence of the milder subepithelial opacities.
The normal cornea, is characterised by diffuse staining for keratoepithelin in the 
Bowman’s layer, stroma and less at Descemet’s membrane (Streeten et al, 1999). 
In GCD cornea, keratoepithelin is a major component of the deposits but the 
question is if the deposits are comprised of the mutant or also wild type protein. 
The distribution of aggregates resembles the picture of normal corneas: Heaviest in 
Bowman’s layer and between lamellar tissue.
Korvatska et al in 1999 used 2 different polyclonal antibodies, that were made 
against the N and C-terminal of keratoepithelin, to immunolocalise it in dystrophic 
corneas. Although both GCD and ACD reacted with both of the antibodies at the 
site of the deposits, in LCD corneas the N-terminal antibody gave no or weak 
staining. This is either because the N-terminal part of the protein is not accessible 
or due to presence of truncated mutant protein in amyloid deposits. Amyloid
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diseases are characterised by extracellular deposition of abnormally folded protein 
precursors that form fibrils.
The normal cornea contains the following species of keratoepithelin: 68, 64, 57, 47 
and 29 kDa (Korvatska et al, 2000). These species have the same sequence with N- 
terminal deletions, and therefore may be proteolysis products. 68kDa comprises 
the majority of keratoepithelin in the cornea. In mutated corneas there is an 
overall increase in keratoepithelin, especially at deposits, alteration in the amount 
of some species and accumulation of unusual sized fragments, possibly due to 
abnormal proteolysis (Hedegaard et al, 2003).
Light and electron microscopy of 22 amino acid synthetic peptides with R124 and 
C124 revealed fibrillar material of amyloid nature for C124, but not R124 (Schmitt* 
Bernard et al, 2000). Also C124 has more propensity to form amyloid. Cys is prone 
to disulfide bonding and may stabilise the peptide and play a role to its amyloid 
transformation.
Cells transfected with R124C and R555W mutant pih-h3 had a higher rate of cell 
death than wild type transfectants (Morand et al, 2003). It is thought that caspase 
-3 is more activated in the presence of mutant overexpression and that the 124 
amino acid C-terminal keratoepithelin sequence is important for mediating 
apoptosis. However Kim et al in 2002 reported that the biochemical properties of 
wild type and mutant recombinant keratoepithelin are similar. No differences 
were observed during their interaction with other ECM molecules and the 
mediation of cell adhesion.
A very important finding was reported when the skin from an R124C patient was 
screened to check for amyloidosis. No deposits were found suggesting that another 
factor, possibly locally determined is responsible for the precipitation of deposits 
in the cornea (Schmitt-Bernard et al, 2000). This is supported by the fact that 
patients with corneal dystrophies do not appear to have any systemic 
abnormalities. There has already been described, another eye disease where the 
gene (REP-1) interacts with a retinal specific protein (Rab27) to produce the 
disease (Seabra et al, 1995).
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1.5.10 Structure
Fasciclin-I, the protein which possesses the domain fas-1 found in many secreted 
and membrane-bound proteins, was crystallised (Clout et al, 2003). It was actually 
the 3rd and 4th fas-1 domains of this protein that were crystallised since previous 
attempts to determine the structure of the full-length protein had failed.
A novel domain fold is observed in fasciclin, consisting of the two globular fas-1 
motifs (3rd and 4th) located on different poles. The two motifs are similar, with 
hydrogen bonds reinforcing the fold at key positions, but there are no stabilising 
disulfide bridges. Despite the determination of this novel fold it was not possible 
to predict how the homophilic adhesion is exerted by fasciclin-1. Fas-1 domains 1 
and 2 may be required for resolving this.
Figure 1.12: Cartoon representation of Fasciclin-I
3rd and 4th domains structure (green and blue, respectively. (Source: Clout et al, 2003)
An alignment of the determined a-helixes and p-sheets with keratoepithelin fas-1 
sequence was carried out in an attempt to predict the effect of mutations on 
keratoepithelin structure. Based on the fasciclin-1 structure and the sequence 
alignment, the 4th fas-1 domain of keratoepithelin was modelled (Clout et al,
2003).
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Leu518 His626
Arg555 Thr538
L527
Figure 1.13: Cartoon representation of the model of 4th fas-1 keratoepithelin domain
Location of missense mutations (yellow spheres). (Source: Clout et al, 2003)
Asn544
Asn622
Ala546
Val631
It has therefore been feasible to determine the position of the corneal dystrophy 
mutations and the residues that have been implicated in integrin binding on this 
hypothetical 3-dimensional model of keratoepithelin. The most common mutation 
hotspots, R1241 and R555, are located on the predicted surface of the 
keratoepithelin structure and therefore it is unlikely that a mutation in these 
hotspots would result in misfolding. However the altered protein solubility of the 
secreted mutant protein could result in extracellular aggregates. The binding 
properties of the mutant keratoepithelin could be changed or abolished, which 
would affect downstream protein-protein interactions.
The less common mutations, which are generally associated with the milder forms 
of corneal dystrophies, are found in the core of 4th fas-1 domain and are more 
likely to cause misfolding of the mutant protein.
1 Predicted by sequence alignment, since R124 is located in the 1st fas-1 repeat of 
keratoepithelin
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terminus C-terminu:
Figure. 1.14: Space filling representations of the 4th domain of keratoepithelin.
The two views are related by a 180° rotation on a vertical axis. The N- and C-termini are 
coloured pink and the hypothetical integrin binding domains are in yellow (Carbon) and red 
(Oxygen). (Source: Clout et al, 2003)
The aspartic acid and isoleucine amino acids that have been described as essential 
for a3pi integrin binding (Kim, 2000) are located on the surface of the 4th fas-1 
domain. It seems more possible that these amino acids interact with the 3rd 
domain rather than being involved with an integrin. Although on the surface, 
aspartic acid is structurally important due to a formation of a hydrogen bond 
between p6 and a5.
Tyrosine and histidine have also been implicated to have an important role in otvPs 
adhesion (Kim et al, 2002). Histidine is located in the fas-1 domain core and is 
tightly conserved, so it is unlikely to be involved with integrin binding. Tyrosine is 
more exposed but there are no additional surface features implying the existence 
of a protein-protein interface.
From the predicted structure of keratoepithelin it seems unlikely that real integrin- 
binding sites have been identified. The discrepancy in the results between the 
modelling and the cell-adhesion experiments can be due the peptides that were 
used for determination of the above amino acids. Cells adhered in the way that 
has been described with the primary structure of synthetic peptides, but it is 
possible that these interactions deviate from the ones that take place between the 
cells and the native, tertiary structured protein. Another feature that remains to 
be examined is the involvement of RGD with avp5 integrin.
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1.6 Gene Transfer
The ability to transfer genes into a particular cell type of tissue is invaluable in 
terms of studying and treating the genetic disorders. There are various ways 
available to deliver genes into specific target cells, both in vitro and in vivo 
(Ledley, 1994). These can be broadly divided into viral and non-viral. Viruses are 
the major tool of gene therapy, the most common of which are retroviruses, 
adenoviruses, adeno-associated viruses (parvoviruses), herpes simplex virus and 
vaccinia. Non-viral methods of gene transfer include: calcium phosphate 
transfection, electroporation, ballistic DNA injection, microinjection, liposomes, 
peptides, cationic lipids, polymers, virosomes, proteosomes, hydrogel, ligand 
mediated.
1.7 ADENOVIRUSES
1.7.1 Structure
Adenoviruses are icosahedral particles 70-100nm in diameter, containing 13% DNA, 
87% protein and trace carbohydrate. They comprise a protein outer shell, capsid, 
which encloses the DNA, a linear double-stranded molecule. The capsid is 
composed of 240 hexons and 12 pentons. Projecting fibres from the surface of the 
virion and associated with the pentons, determine the serotype of the virus. There 
are 47 human adenovirus serotypes and more in other mammals and birds. The 
serotypes used as vectors for gene transfer are based on human serotypes 2 and 5.
Figure 1.15: Electron micrograph of human Adenovirus
(Source: Linda Stannard, of the Department of Medical Microbiology, University of Cape 
Town)
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Adenoviruses have a genome of about 36kb, for which the complete sequences of 
Ad5 and Ad2 are available. The viral DNA is associated with four polypeptides in 
the capsid. The DNA has inverted terminal repeat sequences that range from 100 
to 140bp and enable single strands of DNA to circularise and replicate.
1.7.2 Genome organisation
The genomes from all serotypes of adenoviruses have the same general 
organisation. Thus there are specific positions where the genes encoding each 
specific protein are located. The adenoviral genetic material is a single linear DNA 
molecule containing two identical origins of replication, one in each terminal 
repeat. The chromosome carries five early transcription units (E1A, E1B, E2, E3 
and E4) two delayed early units (IX and Iva2) and the major late unit, which 
generates five families of mRNA (L1-L5) transcripts. Adenoviruses operate a 
cascade system for replication. The first genes to be expressed following infection 
are in the E1 gene region. They are responsible for activating transcription of the 
early genes E2-E4, which in turn drive the expression of the delayed and late 
genes. (Shenk et al, 1995). Adenoviruses compensate for their small genomic size 
by using a complex system of post transcriptional processing. Each of the 
adenoviral genes transcribed by RNA polymerase II produces multiple mRNAs that 
are differentiated by alternative splicing and the use of different poly (A) sites. 
Proteins derived from the same transcription unit have some or even no sequence 
in common.
1.7.3 Replicative Cycle
The adenoviral cycle has been extensively studied, especially in serotypes 2 and 5. 
The cycle can be separated in two stages, early and late. The events that occur 
during infection are: entry in to the host cell, activation of early viral genes, 
activation of host cell to enter the S phase, DNA replication, activation of late viral 
genes, virus assembly and release from the cell.
1.7.3.1 Entry
Adenoviral infection is a highly complex process. It is initiated by the virus binding 
to the cellular receptor. The binding is a double process since it involves 
interaction of both the viral fiber protein with an unknown cellular receptor 
(Devaux et al, 1987) and the RGD sequence of the penton base protein with 
integrins (Wickham et al, 1993). Internalization occurs via receptor-mediated
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endocytosis (Chardonnet et at, 1970). The overall process is not extremely 
efficient since 85% of the virus that binds on the surface of susceptible cells is 
internalized. Half of the absorbed virus moves to the endosomes and 90% of this 
reaches the cytosol within 5 minutes, and manages to escape it before a lysosome 
is formed (Mellman et al, 1992). After endosomal release, the virus particles travel 
across the cytoplasm to the nucleus, possibly by interaction of hexon with 
microtubules (Dales et al, 1973). The viral capsid undergoes disassembly as it 
migrates to the nuclear pore. Entry of the viral DNA into the nucleus is followed by 
capsid dissociation, and the viral DNA does not integrate into the host genome but 
remains in an episomal state. Once the viral genome has reached the host nucleus 
there are 3 goals to be scored:
1. Induction of the host cell to enter the S phase of cell replication 
(transformation)
2. Protection of the infected cell from antiviral defence
3. Synthesis of viral proteins essential for DNA replication
1.7.3.2 Early transcription
The next phase includes transcription of the early viral gene, E1A, which is 
controlled by a constitutive promoter. Transcription of E1A produces two 
phosphorylated proteins, 12S and 13S, known as trans-activators since they can 
activate other viral genes. These two proteins have the same 5’ and 3’ termini, 
but different internal sequences. Their ability to bind to a variety of cellular 
transcription factors and regulatory proteins results in alterations in the expression 
of cellular genes in order to promote transcription.
13S binds to TATA binding protein (TBP), which is part of the transcription factor 
TFIID, an important element for DNA replication. 13S also displaces tumor 
suppressor protein p53 from TBP. 12S binds to a transcription inhibitor (Drl) and 
prevents it from inactivating TBP.
E2F is a transcription factor that is inhibited by the binding of retinoblastoma 
tumor suppressor protein, pRB. pRB inhibits cell cycle progression by binding to 
E2F and blocking transcriptional activation. E1A proteins bind to pRB and 
therefore dissociate it from E2F. Liberated E2F can promote the cellular entrance 
to the S phase.
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The second protein transcribed is E1B, which together with E1A and independently 
of other virus proteins are capable of transforming primary cells in vitro. E1A can 
immortalize primary cells in vitro, whereas E1B does not transform cells on its own, 
but "co-operates" with E1A to stably transform cells.
E1B targets p53, a protein which activates the genes that prevent entry to the S 
phase. The transforming effects of E1A proteins induce cellular proliferation, 
which can trigger p53 activation and apoptosis. E1B protein prevents apoptosis by 
binding to p53.
Ad12 E1A hinders class I MHC expression, possibly allowing proliferating cells to 
escape destruction by Cytotoxic T Lymphocytes.
Another early viral protein is E4, which binds to E2F and activates early and late 
adenoviral promoters.
1.7.3.3 DNA Replication
Adenovirus DNA replication has been studied extensively both in vivo, using mutant 
viruses and in vitro. The most important viral gene in DNA replication is E2. It 
produces at least 3 different proteins:
1. TP, a 55kD terminal protein, which acts as a primer for initiation of 
synthesis. It is active in the initiation of DNA replication and is found 
covalently attached to the 5’ ends of the viral chromosome.
2. Ad DNA Pol, a 140 kD distinct DNA-dependent polymerase, which contains 
both a 5’ to 3’ polymerase activity and a 3’ to 5’ exonuclease proofreading 
activity.
3. Ad DBP, a 59kD DNA-binding, phosphorylated protein.
In addition, many cellular proteins in the nucleus also participate in replication of 
the genome (e.g. NFI, NFII, topoisomerase I).
When the E2 viral gene products accumulate viral replication starts. First the 
synthesis is initiated at either termini of one of the two DNA strands and results in 
a double stranded (consisting of a parental and a daughter strand) and a single 
stranded DNA molecule. The latter circularizes through its self-complementary 
termini and replicates.
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1.7.3.4 Late Transcription
The late genes are transcribed from the major late promoter at the onset of DNA 
replication. The activity of this promoter is low in the early stages of infection, 
but increases by several hundredfold at late stages (Shaw et al, 1980). The late 
regions are transcribed into a single large primary transcript of about 29,000 
nucleotides (Evans et al, 1977). Alternative splicing generates at least 18 distinct 
mRNAs, which have been classified into five families, L1 TO L5. L4 100kD protein 
stimulates viral translation (Adam et al, 1987) and is selectively activated during 
this stage.
A complex of two viral proteins, E1B 55kD and E4 34kD, inhibit accumulation of 
cellular mRNA and facilitate cytoplasmic accumulation of viral mRNA, where 
translation of viral proteins occurs.
1.7.3.5 Assembly and release from the cell
Assembly occurs in the nucleus, but it begins in the cytoplasm when individual 
monomers form into hexon and penton capsomers. Assembly is facilitated by the 
late protein L4 (100kD), which acts as a scaffold. Empty, immature capsids are 
assembled from these protomers in the nucleus, where the core is formed from 
genomic DNA and associated core proteins.
Several viral proteins make the assembly and packaging possible by their variable 
functions, but a lot of them remain unknown. L1 52-55kD protein assists the 
encapsidation process (Hasson et al, 1989) and is not found in mature virions. L3 
codes a proteinase, which releases mature polypeptides and terminal proteins from 
the associated DNA (Tihanyi et al, 1993).
Although host cell macromolecular synthesis ceases earlier in the infection, 
infected cells can remain intact and do not lyse. Virus particles tend to accumulate 
in the nucleus and are visible in the microscope as eosinophilic crystals, inclusion 
bodies. Adenovirus can persist for years in a host, which appears normal. There 
are three adenoviral proteins, which antagonize the antiviral responses of the host. 
Viral infection results in the induction of interleukin 5, a protective cytokine. 
However this seems to activate viral E2 coded DNA binding protein, which in turn 
activates E1A and E3 promoters. E1A products inhibit cellular response to a and (3
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interferons. E3 proteins protect cells from cytotoxic T lymphocytes and tumor 
necrosis factor (Williams et al, 1990).
Viral proteinases, such as E1B 19 kD polypeptide, facilitate viral release from the 
cell. They disrupt intermediate filaments by acting on its components, e.g. 
vimentin and cytokeratin (D’Halluin et al, 1978). Cell lysis and release of the 
progeny virus ensue.
1.7.4 ADENOVIRUSES IN GENE THERAPY
While most of the viral genome is essential for virus growth, replication deficient 
recombinant adenovirus can be constructed with transgene insertion into E1, E3 or 
E4 regions. Replication-deficient adenovirus vectors can be constructed by 
deletions in the E1 region, but may carry additional deletions or mutations in the 
genome. These viruses are propagated in a helper cell line, which provides the 
deleted E1 gene, such as the 293 cell line. In normal mammalian cells the 
recombinant adenovirus is taken up and transported to the nucleus, but no progeny 
copies of the virus are produced due to the missing E1 region. The desired gene 
has been inserted into the virus under the control of constitutive promoters and 
therefore is expressed using the cellular transcription system.
Adenoviruses can be used to achieve high levels of transgene expression in a 
variety of cell types and tissues (Shering et al, 1997; Castro et al, 1997). The 
advantages of using adenoviruses are that the virus replication does not require the 
host cells to be dividing and also replication deficient adenoviruses can be 
constructed. The recombinant viruses can be grown to high titres (up to 1012 
plaque forming units per ml). The expression of the transgene can be controlled by 
selecting and using the appropriate promoter. They do not give rise to mutations 
by random integration into the host genome. Target cells can be infected with 
more than one recombinant adenovirus, if necessary. However there are also some 
disadvantages of adenoviral vectors: expression is transient since the viral DNA 
does not integrate into the host and adenoviral proteins are expressed in the host 
following infection. Moreover, in vivo delivery may be hampered by prior host 
immune response since adenoviruses are common human pathogens.
68
1.7.5 CORNEAL GENE TRANSFER
Transfer of marker genes to several parts of the eye has been demonstrated by 
various investigators. Gene transfer to the anterior part of the mouse, rat, rabbit 
and human eye has been successful (Larkin et al, 1996; Malecaze et al, 1999; 
Budenz et al, 1995; Fehervani et al, 1996; Arancibia-Carcamo et al, 1998; Oral et 
al, 1997, Abraham et al, 1995, Seitz et al, 1998). Recently the cornea has been 
the subject of many studies, but the layer that is usually reported to be 
transfected following adenoviral transfection is the endothelium (Arancibia- 
Carcamo et al, 1998; Larkin et al, 1996; Budenz et al, 1995; Fehervani et al, 1996, 
Oral et al, 1997).
The experiments that have used pieces or whole organ cultured corneas for gene 
delivery suggest that it is more laborious to achieve transfer of genes to the 
corneal epithelial and stromal layer, but not impossible, as several researchers 
have shown (Tsubota et al, 1998; Abraham et al, 1995; Seitz et al, 1998). 
Epithelial layer transfection was accomplished both in vitro  and in vivo by Abraham 
et al, 1995. A rabbit epithelial cell line was infected with a recombinant 
adenovirus in vitro. For the in vivo transfection the virus was administered with 
intracameral, intra-vitreal and subretinal injection. RNA extraction and RT-PCR 
analysis demonstrated that the corneal epithelium was transfected strongly with 
the intracameral and weakly with the intra-vitreal injection. Other ocular tissues 
transfected with this method were: iris, lens, retina, and corneal endothelium. 
Incubation of corneal epithelium ex vivo with recombinant adenovirus for 2 days 
resulted in gene transfer. The recombinant adenovirus carried the lac Z gene and 
staining with X-gal demonstrated efficient transfection (Tsubota et al, 1998). 
Transfection of stromal keratocytes, both on frozen sections and on cultured 
trephine sections of de-epithelialised corneas, was carried out with a retroviral 
vector (Seitz et al, 1998).
The distribution of integrins is associated with the efficiency of adenoviral 
infection. Adenoviruses infect the eyes and indeed are one of the causes of viral 
keratoconjuctivitis. Adenoviral entry into the cells involves two stages: one is the 
attachment of the virus via the fibril receptor (Bergelson et al, 1997) and the other 
is the internalisation via interaction between the RGD peptide sequence on av 
integrins and the penton base of the adenoviral coat protein. It has been 
demonstrated that expression of avps integrins is necessary for efficient
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adenovirus-mediated gene transfer to the human airway (Goldman et al, 1995). 
Therefore the presence of av integrins might be important for the transfection of 
corneal tissue with adenoviruses.
Distribution of integrins avp5 and av in the normal human cornea has been studied 
(Rayner et al, 1998) and it was concluded that both the epithelial and the 
endothelial layers possess these integrins and should allow viral entry. However, 
the observed higher efficiency by which endothelial cells are transfected may be 
due to either of the following reasons:
o Endothelial cells are more active metabolically than epithelial cells, 
o Epithelial cells proliferate (in contrast with the non-mitotic endothelial) 
and therefore stable transfection cannot be achieved, 
o The epithelial layer is overlayed by a protective tear film and mucus layer, 
which are both physical and chemical barriers protecting the cornea from 
entry of foreign bodies, 
o The epithelial superficial cells are susceptible to desquamation 
Epithelial stem cells, in contrast, can provide a more stable means of transfection 
with adenoviruses, which do not integrate with the cellular genome.
An alternative method to transferring transgenes to the cornea is by the use of 
lipoadenofection. This is delivery of the gene to the target cells by using a 
combination of liposomes, adenovirus and a plasmid vector carrying the transgene. 
It has been observed that lipoadenofection is an efficient method to deliver 
reporter genes to the cornea and that use of adenovirus and plasmid DNA alone is 
less efficient (Arancibia-Carcamo et al, 1998). Although overall a highly effective 
method, transgene expression was restricted to corneal endothelium. Exception to 
this is the case reported by Abraham et al (1995), where the recombinant 
adenovirus carrying the transgene was mixed with liposomes and injected directly 
to the intracameral space. The corneal epithelium was positive for transgene 
expression after this application.
Gene transfer to the cornea has not only been achieved by adenoviruses, but with 
other vectors as well. Retroviral vector transfected the stromal keratocytes and 
keratocyte cell culture (Seitz et al, 1998). Nonviral systems have also been 
designed. A system based on synthetic peptides containing an integrin-binding 
segment for cellular targeting and a polylysine segment for DNA binding was used
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to transfect corneal endothelial cells (Shrewing et al, 1997). Activated 
polyamidoamine dendrimers comprise another nonviral vector system. They are 
synthetic spherical macromolecules with radiating branches, which terminate at 
charged and uncharged amino groups and bind to negatively charged DNA to form a 
complex. Corneal endothelium has received reporter genes with this system 
(Hudde et al, 1999). Injection of plasmid DNA to the anterior chamber in 
conjunction with electric pulse resulted in transfection of corneal endothelial cells 
only (Oshima et al, 1998; Sakamoto et al, 1999).
1.8 SUMMARY OF INTRODUCTION
The cornea is a vital part of the outer eye whose critical functions include 
transparency, refraction and protection. The inherited corneal dystrophies 
compromise its function. Treatment is mediated by corneal transplantation, but it 
is common for the dystrophies to re-appear in the corneal graft. Understanding the 
underlying defects allow an analysis of molecules critical to corneal integrity. 
Recent definition of the gene (3ig-h3 underlying a number of dystrophies has 
demonstrated a protein, keratoepithelin whose function appears to be important in 
epithelial attachment, wound healing and repair. Adenoviruses have been 
extensively studied in the laboratory and used as tools for gene transfer. Some of 
the ocular tissues, including corneal epithelium can be transfected with 
recombinant adenoviruses. The study of this protein with the aid of adenoviruses 
and recombinant proteins will improve our understanding of its function and 
implication in corneal dystrophies. This might even lead to the 
treatment/prevention of these diseases at the genomic level, using tools of gene 
therapy.
1.9 Aims of the study
The aim of this study was to examine the role of keratoepithelin in corneal 
dystrophies. Hence the thesis was divided in 5 chapters which are intended to 
investigate and develop the following:
1. Cloning the wild type |3ig-h3 cDNA and synthesising the equivalent corneal 
dystrophy mutants
2. Constructing recombinant adenovirus expressing wild type and mutant pig-h3
3. Producing recombinant wild type and mutant keratoepithelin protein
4. Assessing the effects of overexpression wild type and mutant (3ig-h3
5. Assessing the effects of recombinant protein on corneal cells
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2. CHAPTER TWO 
0ig-h3 cDNA synthesis, cloning sequencing and in vitro mutagenesis
2.1 INTRODUCTION
A number of corneal dystrophies (Granular, Lattice, Bowman’s layer) are caused by 
mutations in the 0ig-h3 gene on chromosome 5q31 (Munier et al, 1997). The gene, 
which is comprised of 17 exons, encodes keratoepithelin, a 683 amino acid protein. 
This protein is an extracellular matrix molecule, which is ubiquitously expressed. 
However its function in the cornea - in particular in the corneal epithelium - 
remains uncertain although it is known to influence cell adhesion, migration and 
also would healing.
Therefore one of the primary aims of the project is to study the role of 
keratoepithelin in vitro, comparing the effects of mutant and wild-type forms of 
the protein both in primary and immortalised cell culture as well as developing a 
method for studying the effects of the protein of epithelial cell behaviour in ex- 
vivo corneal organ culture.
Total RNA was extracted from fibroblasts and was converted to cDNA by reverse 
transcription polymerase chain reaction (RT-PCR). The coding nucleotide sequence 
of 0ig-h3 was published by Skonier et al in 1992. Based on this sequence we 
created primers for PCR amplification of cDNA sequence and this fragment was 
used for cloning into prokaryotic vectors, transformation into competent 
Escherichia coli cells and plasmid preparation. DNA sequencing, using external and 
internal primers, confirmed that the correct nucleotide sequence had been 
amplified. Finally in vitro mutagenesis enabled us to give rise to two mutant 
versions of the 0ig-h3 cDNA, R555W and R555Q, which have been associated with 
granular and Thiel-Behnke corneal dystrophies, respectively.
2.2 METHODS
2.2.1 DEPC treatment
RNAse is very resistant to heat inactivation and is therefore removed with DEPC. 
DEPC reacts with an active-site histidine residue on RNase, forming a carbamate 
and liberating a molecule of carbon dioxide and ethanol. After treatment solutions 
have to be incubated at 120°C to destroy DEPC and evaporate ethanol.
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2.2.1.1 Water and solutions
DEPC was added to water to a final concentration of 0.1%. This was done in a fume 
cupboard. The water was shaken well and was allowed to stand overnight. The 
following day it was autoclaved. The same procedure is also used for solutions, 
apart from Tris containing, which are prepared by DEPC treated and autoclaved 
water in RNA se free glassware.
2.2.1.2 Glassware
Glassware was either treated at 200°C overnight or according to the following if 
delicate: Rinse with 95% IMS, soak in 3% aqueous hydrogen peroxide for 10 minutes, 
rinse in DEPC treated water and dry.
2.2.2 RNA EXTRACTION
The frozen cell pellets of primary human fibroblast and lymphoblast cells were 
obtained from the Immunogenetics Department, St Mary’s Hospital, Manchester. 
The approximate content per pellet was 107 cells. TRIzol™ Reagent (Gibco BRL) 
was used for total RNA extraction, i.e. isolation of a variety of RNA species of large 
and small molecular size (Chomczynski and Sacchi 1987). All plastic and 
glassware as well as H20 were DEPC treated to ensure RNAse elimination. The 
entire procedure was performed on ice to minimise the rate of RNA degradation.
2.2.2.1 Homogenisation
The cells were rapidly thawed at 37°C and briefly vortexed. Cell lysis followed 
with addition of 1ml TRIzol™ Reagent, repetitive pipetting and subsequent 
vortexing.
2.2.2.2 Phase Separation
The samples were then incubated at room temperature for 5-10 minutes in order to 
dissociate protein complexes. 0.2ml chloroform was added to precipitate protein 
and the tubes were capped, wrapped with cling film and shaken for 15 seconds. 
This was followed by 5-10 minutes incubation on ice. The tubes were vortexed and 
their contents transferred to 2ml centrifuge tubes and spun at 12,000 x g for 50 
minutes at 4°C in a Micro 24-48R Hettich Centrifuge. After the centrifugation 3 
separate layers should be seen: Lower red (phenol/chloroform phase), an 
interphase and a colourless upper aqueous phase, where RNA is found.
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2.2.2.3 RNA Precipitation
The aqueous phase was transferred to a fresh 1.5ml tube, 0.5ml isopropanol was 
added, the tube was vortexed and RNA was precipitated at -80°C for at least Vi 
hour or overnight. The samples were centrifuged at 12,000 x g for 45 minutes at 
4°C. RNA can be seen as a gel-like pellet on the side/bottom of the tube.
2.2.2.4 RNA Wash
The supernatant was removed and 1ml 75% ethanol was added. The tube was 
vortexed for 2 minutes and centrifuged at 7,500 x g for 40 minutes at 4°C.
2.2.2.5 Redissolving the RNA
As much ethanol as possible was removed and the pellet was air-dried for 
approximately 15 minutes. RNA was treated with DNase before it was redissolved 
in 20pl RNAse-free H20 by passing through the pipette tip a few times. The 
samples were subsequently incubated at 55-60°C in a water bath, vortex-mixed and 
stored at -80°C. The quality of RNA was determined spectrophotometrically at 260 
and 280nm and calculating the A260/A28o. A260 is frequently used to measure
DNA/RNA concentration and A280 is used to measure protein concentration. A ratio 
of A260/A280 > 1.8 suggests little protein contamination in a DNA/RNA sample.
2.2.3 Reverse Transcription
The conversion of RNA to single-stranded cDNA was achieved with AMV Reverse 
Transcription System (Promega). The reverse transcription reaction was carried 
out according to the supplier’s instructions and the newly synthesised cDNA was 
stored at -20°C.
2.2.4 Design of pig-h3 PCR primers
The design of the PCR primers was based on the online sequence of (3ig-h3 cDNA 
from the NCBI Nucleotide Database (NM 000358) (Fig. 3.1). 9 forward and reverse 
oligonucleotides were selected from the online sequence of |3ig-h3 cDNA to serve as 
PCR primers. The primers were carefully selected so that they did no show any 
complementary regions with other primers that were going to be paired with or 
with self. The GC content was preferably not more than 50%. All primers were 
ordered for synthesis from MWG-Biotech AG and were delivered in freeze-dried 
form. Addition of the appropriate volume of sterile distilled water and 
resuspension by vortexing provided a stock of 100pmol/pl (100pM), which was
74
stored at -20°C. The primers synthesised for PCR amplification of pig-h3 are 
summarised on the following table together with the number indicating their 
nucleotide position on the cDNA.
1 gcttgcccgt cggtcgctag ctcgctcggt gcgcgtcgtc ccgctccatg gcgctcttcg
61 tgcggctgct ggctctcgcc ctggctctgg ccctgggccc cgccgcgacc ctggcgggtc
121 ccgccaagtc gccctaccag ctggtgctgc agcacagcag gctccggggc cgccagcacg
181 gccccaacgt gtgtgctgtg cagaaggtta ttggcactaa taggaagtac ttcaccaact
241 gcaagcagtg gtaccaaagg aaaatctgtg gcaaatcaac agtcatcagc tacgagtgct
301 gtcctggata tgaaaaggtc cctggggaga agggctgtcc agcagcccta ccactctcaa
361 acctttacga gaccctggga gtcgttggat ccaccaccac tcagctgtac acggaccgca
421 cggagaagct gaggcctgag atggaggggc ccggcagctt caccatcttc gcccctagca
481 acgaggcctg ggcctccttg ccagctgaag tgctggactc cctggtcagc aatgtcaaca
541 ttgagctgct caatgccctc cgctaccata tggtgggcag gcgagtcctg actgatgagc
601 tgaaacacgg catgaccctc acctctatgt accagaattc caacatccag atccaccact
661 atcctaatgg gattgtaact gtgaactgtg cccggctcct gaaagccgac caccatgcaa
721 ccaacggggt ggtgcacctc atcgataagg tcatctccac catcaccaac aacatccagc
781 agatcattga gatcgaggac acctttgaga cccttcgggc tgctgtggct gcatcagggc
841 tcaacacgat gcttgaaggt aacggccagt acacgctttt ggccccgacc aatgaggcct
901 tcgagaagat ccctagtgag actttgaacc gtatcctggg cgacccagaa gccctgagag
961 acctgctgaa caaccacatc ttgaagtcag ctatgtgtgc tgaagccatc gttgcggggc
1021 tgtctgtaga gaccctggag ggcacgacac tggaggtggg ctgcagcggg gacatgctca
1081 ctatcaacgg gaaggcgatc atctccaata aagacatcct agccaccaac ggggtgatcc
1141 actacattga tgagctactc atcccagact cagccaagac actatttgaa ttggctgcag
1201 agtctgatgt gtccacagcc attgaccttt tcagacaagc cggcctcggc aatcatctct
1261 ctggaagtga gcggttgacc ctcctggctc ccctgaattc tgtattcaaa gatggaaccc
1321 ctccaattga tgcccataca aggaatttgc ttcggaacca cataattaaa gaccagctgg
1381 cctctaagta tctgtaccat ggacagaccc tggaaactct gggcggcaaa aaactgagag
1441 tttttgttta tcgtaatagc ctctgcattg agaacagctg catcgcggcc cacgacaaga
1501 gggggaggta cgggaccctg ttcacgatgg accgggtgct gaccccccca atggggactg
1561 tcatggatgt cctgaaggga gacaatcgct ttagcatgct ggtagctgcc atccagtctg
1621 caggactgac ggagaccctc aaccgggaag gagtctacac agtctttgct cccacaaatg
1681 aagccttccg agccctgcca ccaagagaac ggagcagact cttgggagat gccaaggaac
1741 ttgccaacat cctgaaatac cacattggtg atgaaatcct ggttagcgga ggcatcgggg
1801 ccctggtgcg gctaaagtct ctccaaggtg acaagctgga agtcagcttg aaaaacaatg
1861 tggtgagtgt caacaaggag cctgttgccg agcctgacat catggccaca aatggcgtgg
1921 tccatgtcat caccaatgtt ctgcagcctc cagccaacag acctcaggaa agaggggatg
1981 aacttgcaga ctctgcgctt gagatcttca aacaagcatc agcgttttcc agggcttccc
2041 agaggtctgt gcgactagcc cctgtctatc aaaagttatt agagaggatg aagcattagc
2101 ttgaagcact acaggaggaa tgcaccacgg cagctctccg ccaatttctc tcagatttcc
2161 acagagactg tttgaatgtt ttcaaaacca agtatcacac tttaatgtac atgggccgca
2221 ccataatgag atgtgagcct tgtgcatgtg ggggaggagg gagagagatg tactttttaa
2281 atcatgttcc ccctaaacat ggctgttaac ccactgcatg cagaaacttg gatgtcactg
2341 cctgacattc acttccagag aggacctatc ccaaatgtgg aattgactgc ctatgccaag
2401 tccctggaaa aggagcttca gtattgtggg gctcataaaa catgaatcaa gcaatccagc
2461 ctcatgggaa gtcctggcac agtttttgta aagcccttgc acagctggag aaatggcatc
2521 attataagct atgagttgaa atgttctgtc aaatgtgtct cacatctaca cgtggcttgg
2581 aggcttttat ggggccctgt ccaggtagaa aagaaatggt atgtagagct tagatttccc
2641 tattgtgaca gagccatggt gtgtttgtaa taataaaacc aaagaaacat a
Figure 2.1: pig-h3 cDNA sequence (NM 000358)
Highlighted sequences correspond to primers on table 2.1
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P r im e r  F o r w a r d  o r  Reverse  Po s it io n  ( b p)
Prom 1 Forward 9-28
Seq 6 Forward 340-358
Seq1 Forward 543-562
Seq7 Forward 851-869
Seq2 Forward 1022-1042
Seq2R Reverse 1022-1042
Seq8 Forward 1339-1361
Seq 3 Forward 1518-1539
Seq3R Reverse 1518-1539
Seq9 Forward 1887-1907
3primer Reverse 2131-2150
Table 2.1: List of primers for 0ig-h3 
(Highlighted on Figure 2.1)
2.2.5 Polymerase Chain Reaction (PCR)
Amplification of DNA cDNA was performed with PCR (Saiki et a/., 1985 and 1988) on 
a thermal cycler. Several PCR systems and reaction conditions were tested in 
order to obtain the optimum reaction product.
Each system comprised a different DNA polymerase, dNTP mix and reaction buffer 
(RB). Premix (Advanced Biotechnologies) and MegaMix (Helena Biosciences) are 
ready-to-use PCR mixes containing Taq, dNTPs, buffer and stabiliser. Extensor 
Long PCR (Advanced Biotechnologies) is a system that allows amplification of long 
DNA sequences by the use of a combination of DNA polymerases (Enzyme mix). 
Two buffers are supplied with the system, Buffer 1 6t 2, for PCR products shorter 
and longer than 12kb respectively. PFU Taq is a proofreading polymerase with an 
exonuclease activity. It was used with either PFU reaction buffer or with Anglian 
Buffer. The following table summarises the main PCR reactions carried out.
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Premix M egaM ix Extensor  
Lo ng  PCR
PFU Taq COMBINED
DNA 25-1OOng 25-1OOng 25-1OOng 25-1 OOng 25-1 OOng
20mM dNTPs - - 3.5pl 3 pi 3.5pl
10 x RB - - 2pl Buffer 1 2pi A / PFU 2pl Buffer 1
10pM PF 2pl 2pl 1.5pl 2pl 1.5pl
10pM PR 2pl 2pl 1.5pl 2pl 1.5pl
Enzyme 10pl mix 13jil mix 1 pi enzyme 0.1 pi PFU 0.1 pi PFU
mix Taq Taq
dh2o Up to 20pl Up to 20pl Up to 50pl Up to 20pl Up to 50pl
Table 2.2: List of PCR reactions
The size of the PCR products depended on the primer pair that was used and varied 
from 500 to 2150bp (for list of (3ig-h3 primers see materials). Two standard cycling 
conditions were used: 1, for products 1000bp or larger and 2, for less than 1000bp.
1
Initial Denaturation
Denaturation
Annealing
Extension
Final Extension
95°C for 5mins 
94°Cfor1min  ^
56°C for 2mins 
72°C for 5mins 
72°C for 10mins
95°C for 5mins 
94°C for 1 min 
35x 56°Cfor1min 
72°C for 1min 
72°C for 10mins
28-30x
2.2.6 Agarose gel electrophoresis
One way of visualising and displaying PCR products and generally DNA is agarose gel 
electrophoresis. Electrophoresis grade agarose was mixed with 1xTBE buffer and 
microwaved on low power for 2Vi minutes. The resulting gel had 0.8-1.5% agarose 
depending on the size of the DNA fragments that were to be checked. 9pl 
10mg/ml Ethidium Bromide was added to the gel before it was set and it was 
poured in a tray with a comb to form wells. After the gel had set, the comb was 
removed and the gel was immersed into a tank containing 1xTBE buffer. 6-10pl 
DNA sample mixed with 2pl 5xGlycerol Loading Dye were loaded in each well. 
2.5pl of a 0.5pg/pl 100bp or 1000bp DNA ladder (Gene Ruler™ - MBI Fermentas)
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was also loaded on the gel as a size reference. Mass Ruler™ High Range DNA ladder 
(MBI Fermentas) was used for quantitative analyses. The gel was electrophoresed 
at 100-120V until adequate separation of DNA bands. The gel was visualised on an 
ultraviolet transilluminator, where DNA fluoresced due to the intercalated 
ethidium bromide. A picture was captured by a camera and previewed from the 
connected monitor. The photograph was printed by a video copy processor 
(Mitsubishi).
2.2.7 PCR purification
After a PCR the reaction tube contains: Amplified DNA, leftover dNTPs and primers, 
DNA polymerase. In rare cases even after the optimisation of the conditions more 
than one size of DNA product (multiple bands) appears on the gel. In such cases it 
is important to purify the desirable PCR product from everything else present in 
the tube, before proceeding to more sensitive applications such as cloning and 
sequencing. Three systems were used for such purposes according to the protocols 
described in the operating manual: Centricon Concentrators (Amicon Inc), QIAGEN 
PCR Purification kit (QIAGEN) and QIAquick Gel Extraction Kit (QIAGEN).
2.2.8 Cloning
2.2.8.1 Bacterial Culture And Storage
All bacterial work was carried out in a Biosafety Level 1 Laminar Flow 
Microbiological cabinet and all plastic, glassware and media were sterile.
2.2.8.2 Bacterial growth
All liquid cultures were grown at 37°C on a mechanical shaker at 225rpm. All 
plates were incubated inverted overnight at 37°C. Liquid cultures were grown in 
Luria Bertani (LB) medium and plates were made with LB agar. The appropriate 
antibiotic was added to the media when necessary according to the following 
(final) concentrations:
Ampicillin 100pg/ml 
Chloramphenicol 20pg/ml 
Kanamycin 25pg/ml
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2.2.8.3 Storage of bacterial cells
For long term storage of bacterial cells at low temperatures glycerol stocks were 
made by mixing 1.3ml of overnight culture with 200jil sterile glycerol. Glycerol 
stocks were stored at -80°C.
2.2.8.4 TOPO™ TA Cloning
Direct cloning of PCR products into a plasmid vector was achieved with TOPO™ TA 
Cloning Kit (Invitrogen).
Taq polymerase amplified PCR products have incorporated single deoxyadenosine 
(A) residues on their 3’ ends due to the nontemplate-dependent terminal 
transferase activity of this enzyme. TOPO™ TA Cloning provides a linear plasmid, 
with single 3’ deoxythymidine (T) bases and a Topoisomerase I molecule covalently 
attached to each end of the plasmid.
A 5-minute incubation of the following at 25-30°C in a water-bath:
results in ligation of the PCR product with the pCR®2.1-TOPO vector and release of 
Topoisomerase I. The PCR product is inserted in the lacZ gene of the vector, which 
allows blue/white colony selection on agar plates.
TOPO TOP10F’ One Shot™ competent cells were retrieved from -80°C and were 
placed on ice to thaw slowly. 2pl 0.5M {3-mercaptoethanol was added to the 
competent cells and mixed gently with the pipette tip. 2pl of the ligation reaction 
was also mixed with the cells, which were kept on ice for 30 minutes. 
Transformation of the cells with the plasmid was carried out by heat-shock at 42°C, 
in a water-bath, for 30 seconds. The cells were then transferred on ice for 2 
minutes, 250pl of SOC medium was added to them and incubation followed at 37°C 
in an orbital shaker at 225rpm for 1 hour. In the meantime 20pl 250mg/ml IPTG 
and 40pl 40mg/ml Xgal were spread on LB-kanamycin plates. The plates were left 
to dry for 15 minutes in the laminar flow cabinet and were then placed in the 37°C 
oven for 30-60 minutes to allow solutions to diffuse. 60 1^ of the shaken cells were
Purified PCR product 
Sterile H20  
pCR®2.1-TOPO vector
3jxl (20ng) 
1pl
1pl (10ng)
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spread on 4 large (150mm) LB-kanamycin plates and were allowed to grow at 37°C 
overnight. The plates were examined the following day for white colonies.
2.2.8.5 Restriction Digestion
Another way of cloning a DNA fragment into a vector is by cutting the two DNA 
species with Restriction Endonucleases, which produce complementary cohesive 
ends and ligating them with T4 DNA ligase. Two main restriction digestions were 
performed for the purposes of cloning:
Reaction components RE1: Spel RE2: Xbal RE1: Mlul RE2: Xhol
DNA 5pg 5pg
NEB 10x Buffer 5pl Buffer 2 5pl Buffer 3
10mg/ml BSA 0.5pl 0.5pl
40mM spermidine 1pl 1pl
10U/pl RE1 3pl 3pl
20U/pl RE2 1.5pl 1.5pl
dH20 Up to 50pl Up to 50pl
Table 2.3: Restriction Digestions
Complete digestion took place at 37°C, in a water bath, for 2 hours and was 
verified by agarose gel electrophoresis.
The reaction was heated at 65°C for 30 minutes to inactivate the restriction 
enzymes.
2.2.8.6 Dephosphorylation of digested plasmid DNA
If the plasmid vector is digested with a single enzyme or with two different 
enzymes that produce the same cohesive ends, it will tend to recircularise during 
ligation. Therefore it must be dephosphorylated with an enzyme such as Calf 
Intestinal Alkaline Phosphatase (CIAP), which removes the 5' phosphate groups 
from cohesive termini and renders self-ligation impossible. The standard 
dephosphorylation reaction is:
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Components Volume (pi)
Linearised plasmid DNA (I pmol of ends)*
10x CIAP Buffer 4
1U/pl CIAP 1
dH20 Up to 40
Table 2.4: Dephosphorylation Reaction
*1 pmol of ends = (pg/kb) x 3.08 x N 
where N is number of restrictions per plasmid
Dephosphorylation is carried out at 37°C, in a water bath, for 30 minutes. 
Following this, a heat-inactivation step takes place at 65°C for 15 minutes.
2.2.8.7 DNA Clean-up
Before digested DNA is used in a ligation reaction it must be cleaned from
a. restriction digestion reagents (buffers, enzymes)
b. other DNA fragments products of the restriction digestion which are not wanted 
for ligation.
Depending on which category the digested DNA belongs to, the appropriate clean­
up step is carried out. For simple removal of enzymes and salts either the Wizard ® 
DNA Clean up System (Promega) or the QJAquick PCR Purification Kit (QIAGEN) was 
used according to the instructions of the manufacturer's protocol. For purification 
of a digestion fragment from the rest of the reaction products, the whole of the 
restriction digest was run on an agarose gel and the band corresponding to the 
desired fragment was excised from the gel and recovered with QIAquick Gel 
Extraction kit (QIAGEN).
In both of the cases purified DNA was resuspended in dH20  which has been pre­
warmed at 65°C. This increases the yield of recovered DNA.
2.2.8.8 DNA Ligation
When performing a ligation between a DNA fragment and a plasmid vector it is 
important to find the molar ratio insert:vector that gives optimal results. 
Therefore the following insert:vector molar ratios were used for every ligation that
was carried out; 1:3, 3:1, 1:1. The formula which describes the conversion of 
molar ratios to mass ratios is
Molar ratio insert/vector = ng of insert x kb size of vector/ng of vector x kb size of 
insert
A typical ligation reaction was made up with the appropriate volumes of vector and 
insert DNA, mixed with 4pl 5x Ligation Buffer and 1pl 1U/ jj.IT4 DNA Ligase (Gibco 
BRL). H20 was added to 20pl. The reaction was incubated at either 23-26°C for 3 
hours or at 16-4°C overnight. A heat inactivation step was carried out at 65°C for 
15 minutes before proceeding to transformation.
2.2.8.9 Preparation of competent cells
Two protocols were used for generating chemically competent E. coli cells which 
will serve as hosts for the plasmid DNA cloning.
2.2.8.9.1 Modified Calcium Chloride method
This protocol, a variation of the method described by Cohen et al (1972), generates 
competent cells with transformation efficiencies 5x106-2x107 cfu/pg of supercoiled 
DNA (Maniatis et al, 1984).
Cells were streaked on a LB agar plate and incubated overnight at 37°C. A single 
colony was inoculated into 100ml LB medium in a 1 Lt flask and shaken at 160rpm at 
37°C for 2.5 hours. Culture was poured into two chilled 50ml tubes and was 
centrifuged at 4,500 x g for 10 minutes at 4°C in a Sorvall Centrifuge. Supernatant 
was discarded and cells of each tube were resuspended in 10ml ice-cold 0.1M 
CaCl2. Centrifugation was carried out under the same conditions as before, 
supernatant was removed and cells were resuspended in 2ml 0.1M CaCl2. Cells 
were combined and left on ice until use or overnight at 4°C to increase 
competency.
2.2.8.9.2 Modified Rubidium Chloride Method
This protocol, which is an adaptation of the method described by Carswell et al 
(1989) gives rise to competent cells with better transformation efficiencies.
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Cells were streaked on LB agar plates and incubated overnight at 37°C. A single 
colony was inoculated in 2.5ml LB broth in a 20ml sterile universal tube and 
incubated overnight at 37°C with shaking at 225rpm. 250ml LB medium containing 
20mM MgS04 was inoculated with the 2.5ml overnight culture in a 1 Lt flask. Cells 
were grown at 37°C shaker for 3-5 hours, until O D 60onm = 0.4-0.6. The culture was 
transferred to two GSA pots and centrifuged at 4,500 x g for 5 minutes at 4°C. The 
supernatant was discarded and the cells of each pot were resuspended in 50ml ice- 
cold TFB1 Buffer. The cells were combined and incubated on ice for 5 minutes. 
Centrifugation was repeated as before, supernatant was discarded and cells were 
resuspended 10ml ice-cold TFB2 Buffer. Cells were left on ice for 15-60 minutes 
and then 100pl aliquots were made in 1ml cryogenic tubes, quick frozen in liquid 
nitrogen and stored at -80°C. Competent cells prepared by this method are stable 
3-6 months (ES1301) to 1 year (JM109).
2.2.8.10 Transformation of competent cells
Chemically competent cells were heat-transformed with the ligated DNA as 
described on the following protocol.
Sterile 17x100mm polypropylene tubes were placed on ice. Competent cells were 
removed from -80°C and were placed on ice to thaw. The tube was flicked to mix 
and 100pl competent cells were transferred to each polypropylene tube. Ligated 
DNA was added* and mixed by stirring gently with the pipette tip. Tubes were kept 
on ice for 10-30 minutes (depending on bacterial strain and transformation 
efficiency). Up-take of DNA was facilitated by heat-shocking the cells at 42°C for 1 
minute. The tubes were replaced on ice for 2 minutes and 900pl SOC medium or 
LB was added to each transformation reaction and they were incubated at 37°C for 
60 minutes by shaking at 225rpm. 100pl of each reaction was spreaded in
duplicate on a 150mm plate containing the appropriate antibiotic and incubated at 
37°C overnight.
*The following volumes of each ligation reaction were used to transform competent 
cells: 5pl, 10pl, 5pl and 10pl of 1:50 dilution.
2.2.8.11 Streaking positive clones on a gridded plate
After the overnight incubation the plates were checked for colonies of transformed 
cells. If plasmid allows blue/white screening then the white colonies were
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selected. Otherwise single colonies (approximately 10 per transformation) were 
streaked on a 150mm gridded plate containing LB agar and the appropriate 
antibiotic. Grids were numbered, in order to refer to specific clones.
2.2.8.12 Subculturing of bacterial clones
Gridded clones were streaked on fresh antibiotic containing plates and incubated 
overnight to get individual colonies.
2.2.8.13 Plasmid preparation
This method was used to extract plasmid DNA from the subcultured clones. The 
QIAGEN Plasmid Mini Purification Kit enables separation of plasmid from genomic 
DNA and other cellular components and it was used according to the following 
protocol.
A single colony was transferred to a sterile 20ml universal tube containing 5ml LB 
and the appropriate antibiotic. The bacterial culture was grown overnight at 37°C 
until O Deoonm  = 1-1.5. 1.5ml of the overnight culture was transferred to 2 1.5ml 
tubes and centrifuged at 10,000 x g for 5 minutes at 4°C in a Micro 24-48R Hettich 
Centrifuge. Supernatant was discarded and both pellets were thoroughly 
resuspended in 0.5ml Resuspension Buffer P1 and pooled in the same centrifuge 
tube. 0.5ml Lysis Buffer P2 was added and tube was inverted gently 4-6 times and 
incubated at room temperature for 5 minutes. 0.5ml chilled Buffer P3 was also 
added, the tube was inverted several times and placed on ice for 5 minutes. 
Centrifugation followed at 10,000 x g for 10 minutes at 4°C. In the meanwhile a 
QIAGEN tip-20 column was shaken and equilibrated with 1ml Equilibration Buffer 
QBT. The supernatant was transferred to a clean 1.5ml tube and was centrifuged 
as before. The new supernatant was applied to the column and allowed to enter 
the resin by gravity flow. The column was washed 4 times with 1ml Wash Buffer 
QC and allowed to drain. QIAGEN tip-20 was transferred to a clean 1.5ml tube 
where DNA was eluted by applying 0.8ml Elution Buffer QF prewarmed at 65°C. 0.7 
volumes room temperature isopropanol was added to DNA and the sample was 
centrifuged at 10,000 x g for 30 minutes. The supernatant was carefully decanted 
and DNA pellet was washed with 1ml 70% ice-cold ethanol and then with 1ml 70% 
room temperature ethanol. Ethanol was removed and the pellet was allowed to 
air-dry at room temperature for no longer than 5 minutes. Plasmid was 
resuspended in 25pl sterile dH20  by stirring with the pipette tip. If necessary
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sample was warmed to 50°C for 10-15 minutes to ensure complete resuspension. 
1jil of the plasmid preparation was electrophoresed on an agarose gel against a 
Mass Ruler for determining concentration. The rest of the preparation was stored 
at -20°C.
2.2.9 In Vitro Mutagenesis
Site directed mutagenesis (Hutchinson et al, 1978) involves alteration of a specific 
part of the sequence of a cloned gene by hybridising it with mismatch-containing 
synthetic oligonucleotides.
Altered Sites ®ll Mammalian Mutagenesis System (Promega) was used to perform in 
vitro mutagenesis. This system makes use of pALTER-MAX, a plasmid vector with 
two antibiotic resistance genes: chloramphenicol and ampicillin. Of these two 
genes, ampicillin is inactivated by a point mutation. The DNA to be mutated was 
inserted into the multiple cloning site of the vector with restriction digestion of 
both the insert and the vector DNA followed by T4 DNA ligation.
The mutagenesis reaction takes place by hybridising two mismatch oligonucleotides 
with pALTER-MAX containing the cloned DNA insert. One oligonucleotide produces 
the desired mutation on the cloned gene (mutagenic oligo) and the other repairs 
the inactivated ampicillin gene (repair oligo). A mutagenic strand is formed by T4 
DNA polymerase, with two (or more if more than one point mutations are induced) 
mismatches. DNA ligase seals the nicks and the double stranded product 
transforms a suitable E.coli host. Ampicillin selection serves as a screening method 
for the mutant plasmids. The mutagenic oligonucleotide was synthesised by MWG- 
Biotech AG, whilst the Repair oligonucleotide was provided by the system’s 
manufacturer.
2.2.9.1 Cloning into the mutagenesis vector
Plasmid pCR®2.1-TOPO containing (3ig-h3 cDNA was subjected to restriction 
digestion with enzymes Spel and Xbal. This double digestion produces two 
fragments: one 2.2kb, which is the pig-h3 cDNA and a 3.9kb, which is the pCR®2.1- 
TOPO vector. Agarose gel electrophoresis resolved these two fragments and pig-h3 
was retrieved with QIAquick Gel Extraction Kit (QIAGEN). Furthermore, plasmid 
pALTER-MAX was linearised by digesting with enzyme Spel, dephosphorylated with 
CIAP and cleaned with QIAGEN PCR Purification kit (QIAGEN).
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pig-h3 cDNA was inserted into pALTER-MAX vector with the enzymatic action of T4 
DNA Ligase and the produced plasmids transformed into competent JM109 cells. 
The plasmid from the resulting clones was extracted with QIAGEN plasmid mini 
purification kit and it underwent restriction digestion to check for presence of 
desired insert.
2.2.9.2 Design and phosphorylation of mutagenic oligonucleotides
For mutations involving one mismatch the ideal oligonucleotide length is 17-20 
bases, with 8-10 nucleotides flanking either side of the mismatch. Also the 
sequence of the mutagenic oligonucleotide must be complementary to the same 
strand of the plasmid construct.
The sequence of the mutagenic oligonucleotides was derived from the online cDNA 
sequence of pig-h3 cDNA (Table 2.1). The oligonucleotides synthesised were 19 
bases long with the mismatch occurring on the 10th base. The following table 
summarises the three mutagenic oligonucleotides that were synthesised for 
performing the in vitro mutagenesis. The base in pink indicates the point of base 
change and mismatch.
AA
mutation
Nucleotide
mutation
Corneal Dystrophy Sequence (19mer)
R124C C417T LCDI 5 ’ ...TAC ACGG ACTGCACGG AG A... 3 ’
R555W C1710T CDGGI 5’ ...CCAAG AGAAT GG AGCAG AC...3 ’
R555Q G1711A CDTB 5 * ...CAAG AG AAC AG AGCAG ACT... 3 *
Table 2.5: pig-h3 mutagenic oligonucleotides
In order to assist nick sealing by DNA ligase after the polymerisation of the mutant 
strand, the mutagenic oligonucleotides were phosphorylated. This way they can 
provide a 5’ phosphate group for the formation of the phosphodiester bond:
Oligonucleotide 100pmol
Kinase 10x Buffer 2.5pl
T4 polynucleotide kinase 5U
10mM ATP 2.5pl
sd H20 up to 25pl
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pmol of oligonucleotide were calculated based on the formula
ng of oligonucleotide = pmol of oligonucleotide x 0.33 x N
where N is the length of the oligonucleotide in bases
The phosphorylation reaction was allowed to proceed at 37°C in a water bath, for 
30 minutes. Subsequent inactivation of the enzyme took place by heating the 
reaction at 70°C for 10 minutes. Oligonucleotides were stored at -20°C until 
further use.
2.2.9.3 Alkali denaturation of plasmid DNA
The plasmid DNA must be alkali denatured just before starting the mutagenesis 
reaction. Heat denaturation is not sufficient since DNA reanneals too quickly. The 
following reaction was set up in a 0.5ml tube:
where N is the length of dsDNA in bases
Incubation took place at room temperature for 5 minutes. 2pl 2M ammonium 
acetate pH4.6 and 75pl 100% ice-cold ethanol were mixed with the reaction. DNA 
was precipitated at -80°C for 30 minutes and pelleted by centrifugation at 10,000 x 
g for 20 minutes at 4°C. The pellet was washed with 200pl 70% ice-cold ethanol 
and re-centrifuged as before. It was allowed to air dry at room temperature and 
was redissolved in 100pl sdH20. A 10pl fraction was analysed by quantifying 
agarose gel electrophoresis.
Ds DNA template 
2M NaOH, 2mM EDTA 
sdH20
0.5pmol
2pl
up to 20pl
pmol of dsDNA were calculated based on the formula
ng of dsDNA = pmol of dsDNA x 0.66 x N
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2.2.9.4 Annealing reaction
During this step the mutagenic and antibiotic oligonucleotides anneal to the 
plasmid DNA. For this reason the oligonucleotides are used in excess according to 
the following molar ratios; oligonucleotidertemplate 5:1 for the antibiotic and 25:1 
for the mutagenic oligonucleotide.
The annealing reaction was set up in a sterile 0.5ml tube along side a control 
reaction:
Mutagenic reaction 
Template DNA 
Ampicillin repair oligo 
Mutagenic oligo 
Annealing 10x Buffer 
SdH20
~10pl (0.05pmol) 
1pl (0.25pmol) 
1.25pmol 
2pl
up to 20pl
Control reaction
pALTER-MAX 
Antibiotic repair oligo 
Antibiotic knockout oligo 
Annealing 10x Buffer 
SdH20
10pil (0.05pmol) 
1fil (0.25pmol) 
1pl (0.25pmol)
2 pi
up to 20pl
These reactions were transferred to a thermal cycler and annealed at 75°C for 5 
minutes. Temperature was dropped by 1°C per minute until 45°C was reached. 
Then by 2°C per minute to 22°C, minimising the nonspecific annealing of the 
oligonucleotides.
The synthesis of the mutagenic strand took place at 37°C for 90 minutes by mixing 
the following in the following order:
Annealing reaction 20pl
SdH20 5pl
Synthesis 10x buffer 3pl
T4 DNA polymerase 1pl (5-10U)
T4 DNA ligase 1pl (1-3U)
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2.2.9.5 Transformation of ES1301 mutS competent cells
After the synthesis of the mutant strand the plasmids are used to transform strain 
ES301, which is a repair minus strain of E. coli and does not select against the 
mismatched DNA.
17x100mm polypropylene tubes were chilled on ice and competent ES301 cells 
were transferred on ice to thaw. The cells were mixed gently by flicking the tubes 
and 100pl was transferred to each polypropylene tube. 1.5-3^1 of the 
mutagenesis/control reaction was added to each tube and the cells were kept on 
ice for 10 minutes. Uptake of plasmid DNA was facilitated by heat-shock treatment 
at 42°C for 50-60 minutes. Then the cells were returned to ice for two minutes. 
900|xl LB was added to each transformation and the cells were incubated at 37°C by 
shaking at 225 rpm for 30 minutes. Overnight cultures were set up by adding 500jnl 
of each transformation to 4.5ml LB containing the appropriate antibiotic, i.e. 
ampicillin. Incubation continued at 37°C and 225 rpm for 24 hours.
2.2.9.6 Plasmid purification
The above 24-hour cultures were harvested to purify the mutagenic plasmids. 
QIAGEN mini plasmid purification kit was used for this purpose.
2.2.9.7 Transformation of JM109 competent cells
The mutagenic plasmids purified from the overnight ES301 cultures are used to 
transform competent JM109 cells. Transformed cells were spread on LB-amp 
plates and incubated overnight. For transformation procedure see section 
2.2.8.10.
2.2.9.8 Analysis of transformants
The clones that grow on the LB-amp plates stand 50-90% possibility to have the 
desired mutation. Single colonies are transferred to overnight cultures and their 
plasmids are extracted. Sequencing analysis reveals whether the mutation is 
present or not.
2.2.10 DNA SEQUENCING
The DNA samples to be sequenced were either PCR products or Plasmid 
Preparations. Sequencing is a sensitive application and therefore requires DNA of 
maximum purity. Plasmid preparations are generally pure DNA samples, as
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determined by A260/A28o, but PCR products must be cleaned before being used in 
the Sequencing reaction.
2.2.10.1 SHRIMP-cleaning of PCR products
2 jj . I  1U/pl Shrimp Alkaline Phosphatase and 0.4pl 10U/pl Exonuclease I were used 
per 20 pi PCR product to be cleaned. The above were mixed, overlayed with one 
drop of mineral oil and transferred to a thermal cycler, where they were incubated 
at 37°C for 30 minutes and then heated to 85°C for 15 minutes.
2.2.10.2 Cycle Sequencing reaction (Thermo Sequenance II)
This sequencing reaction was carried out with Thermo Sequenance II dye 
terminator cycle sequencing Kit (Amersham Pharmacia Biotech Inc.), used for the 
ABI 373A DNA Sequencer.
The following were added in a sterile 0.2pl tube in the order described:
Components Volume (pi)__ _
DNA 4
5pM Primer 0.5
Sequenance II Premix 2
Table 2.6: Sequenance II Sequencing reaction
PCR product volume was varied depending on concentration assessed by agarose 
gel electrophoresis; H20  was adjusted to a final volume of 10pl.
The reaction tube was placed in a thermal cycler, where single strand 
amplification took place under the following conditions:
Initial Denaturation 96°Cfor1min
Denaturation 96°C for 30secs
Annealing 50°C for 15 secs
Extension 60°C for 1min
►30 x
2.2.10.3 Precipitation of Sequencing DNA
The sequencing reaction was transferred to a sterile 0.5ml tube containing 1.0pl 
1.5M Sodium acetate/250mM EDTA (pH>8) and 30pl 100% room temperature
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ethanol. The tube was vortexed and left at room temperature for no more than 15 
minutes. The sequencing reaction was centrifuged at 10,000 x g for 40 minutes at 
4°C in a Micro 24-48R Hettich Centrifuge. The supernatant was removed and 20pl 
70% room temperature ethanol was added. Centrifugation was repeated as before, 
supernatant was removed and DNA pellet was air dried at room temperature. DNA 
sequencing pellets were stored at -20°C until loading on the sequencing gel.
Before loading, the pellet was resuspended in 1pl fuschin loading dye, vortexed, 
briefly spun, denatured on a thermal cycler at 85°C for 5 minutes and placed on 
ice.
2.2.10.4 Preparation of Denaturing Sequencing Gel
The glass plates, spacers and comb were soaked in Alconox (Alconox Inc.). The 
surface of the plates was rinsed with warm tap water and then with dH20. The 
plates were air dried and then assembled, clamped and placed on a flat base 
surface. A 6% polyacrylamide gel was made by mixing 40ml Sequa-Gel-6 
acrylamide (National Diagnostics), 10ml Sequagel complete buffer and 0.4ml fresh 
10% ammonium persulphate. The mix was poured between the two plates, the 
comb was inserted and it was allowed to polymerise. The gel was assembled into 
the 373A DNA Sequencer according to the manufacturer’s instructions (Perkin 
Elmer Applied Biosystems). A plate-check and a pre-electrophoresis run were 
carried out. The wells were washed with 1xTBE buffer and the samples were 
loaded. The gel was run at 2500 Volts for 12 hours.
2.2.10.5 Data Analysis
The sequencing results were collected with ABI Prism 373 software and analysed 
with DNA Sequencing Analysis Software, version 3.3 (Applied Biosystem Division).
2.2.10.6 Cycle sequencing Reaction (BigDye)
This reaction is carried out with BigDye Terminator Mix and was used for DNA 
processed on the 377 DNA Sequencer.
The following reaction took place in a sterile 0.2ml tube:
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Components Volume (jil)
dH20 2
DNA 1
2jiM Primer 2.5
DMSO 0.5
BigDye Mix 4
Table 2.7: BlgDve Sequencing Reaction
The cycling conditions of the reactions were:
Initial Denaturation 96°C for 4mins
Denaturation 98°C for 305605^
Annealing 50°C for 15secs y 30 X
Extension 60°C for 4mins
2.2.10.7 Precipitation of Cycle sequenced products (BigDye)
The following were mixed in a sterile 0.5ml tube: 10^ 1 sequencing reaction, 90jxl 
sterile H20, 300^1 95% room temperature ethanol and 5|xl 3M sodium acetate pH 
5.2. The tube was incubated for 15-20 minutes at room temperature and 
centrifuged at 10,000 x g for 20 minutes. The supernatant was removed and the 
pellet was suspended in 100^1 70% room temperature ethanol and was left to stand 
for a minimum of 15 minutes. The sample was centrifuged as before, but only for 
5 minutes. The supernatant was removed and the tubes were left at room 
temperature for 5 minutes before removing all traces of supernatant and excess 
dye terminators. The pellets were air dried for at least 20 minutes.
DNA sequencing and data analysis were performed at the Biochemistry Department 
of the University of Manchester.
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2.3 RESULTS
2.3.1 Overview
In order to obtain pig-h3 cDNA, RNA was extracted from fibroblasts and reverse 
transcribed into cDNA. PCR allowed the amplification of pig-h3 cDNA, 2150kb 
fragment. This was cloned initially into pCR®2.1-TOPO plasmid vector and 
sequenced to check for any mutations or polymorphisms. In Vitro Mutagenesis was 
performed, in order to produce the mutant constructs of pig-h3. Before this step 
was carried out pig-h3 cDNA was inserted into plasmid pALTER-MAX, a mammalian 
expression vector.
2.3.2 Generation of cDNA
RNA was extracted from both fibroblast and lymphoblast control cell lines using the 
Trizol Reagent (Gibco BRL). A260/A280 was determined to be within the acceptable 
range 1.9-2.1. The RNA was stored at -80°C. Figure 2.2 represents electrophoresis 
of the extracted RNA where the two bands are visible.
1 2  3 4
B
28S
18 S
Figure 2.2: Agarose gel electrophoresis of RNA samples.
Lane 1 - 1jxl Fibroblast, Lane 2 - 1.5pl Fibroblast, Lane 3 - 1pl Lymphoblast, Lane 4 - 1.5pl 
Lymphoblast. The characteristic 18S and 28S ribosomal bands appear intact which suggests 
RNA integrity has not been compromised
A portion of the two RNA samples was transcribed to cDNA with AMV Reverse 
Transcription System. The stock cDNA was serially diluted 1:10, 1:20 and 1:50 in 
sterile distilled water and dilutions were stored at -20°C.
A control PCR was carried out with all serial dilutions as template DNA to assess 
quality of the cDNA samples. The primers used for this reaction, 4AB forward and
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reverse, were from exons 8-12 of versican (CSPG2) mRNA sequence. The result was 
amplification of an approximately 250bp part of the versican cDNA (figure 2.3). 
Fibroblast cDNA was amplified better than lymphoblast, which may be because the 
versican gene is expressed at higher levels in fibroblasts when compared to 
lymphoblasts (Perveen et al, 1999).
1 2 3 4 5 6 7 8
- >  250 bp 
Figure 2.3: Control PCR of cDNA.
Lane 1 - 100bp DNA ladder. Lanes 2-4 - Lymphoblast cDNA (1:10, 1:20 and 1:50).
Lanes 5-7 - Fibroblast cDNA (1:10, 1:20 and 1:50). Lane 8 - negative control
2.3.3 PCR optimisation
The whole pig-h3 cDNA is 2150bp long, which is a relatively quite large fragment 
for a PCR product. Before the whole (3ig-h3 cDNA sequence was amplified, internal 
primers were used for optimisation of conditions, such as cycling temperatures, 
amount of template required per reaction, selection of PCR system which seemed 
to be offering best results, selection of appropriate buffers. The system that made 
the amplification of the whole 2150bp possible (Figure 2.4) was the Extensor PCR 
System (ABgene). The DNA used for this reaction was 2-3pi from 1:10 fibroblast- 
derived cDNA dilution. The optimum PCR conditions of the reaction are listed in 
section 2.2.5.
1 2 3
KS3—^2Kb
Figure 2.4: PCR amplification of pig-h3 cDNA (2.1 kb) from fibroblast with the Extensor Long PCR 
system (Abgene) Lane 1 -1 kb DNA ladder, Lane 2 - with buffer 2, Lane 3 - with buffer 1
*
m
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It became apparent from the first few PCRs that cDNA derived from fibroblast cell 
line gave better results than lymphoblast-derived cDNA. PCRs using lymphoblast 
cDNA as template did not produce the expected size of DNA fragment. 
Specifically, amplification with primer pair Seq2-3prime gave two fragments 
corresponding to approximately 1000 and 370bp (figure 2.5). The expected PCR 
product for this primer pair is 1100bp. Similarly, amplification with primer pair 
Prom1-3prime resulted in a band corresponding to about 1200bp, compared with 
the 2150bp expected.
Figure 2.5: PCR amplification of lymphoblast cDNA with Prom1-3prime
(Lane 2) and Seq2-3prime (Lane 3) primers. Lane 1-1 kb DNA ladder
In order to check whether these PCR products were indicators of alternative 
splicing, which could be taking place in different types of cells, the above 
fragments were cloned into the pCR®2.1-TOPO vector, the cloned plasmids purified 
and the insert sequence amplified with the same primers used for the original PCR 
reaction. The resulting sequences were compared for homology with the pig-h3 
sequence. The comparison showed that there was no relation between pig-h3 and 
the produced sequence. A BLAST search found some EST sequences of MHC-related 
genes. Alternative splicing was excluded. The failure of lymphoblast cells to 
amplify pig-h3 cDNA may reflect the low levels of this gene expression in this cell 
type.
The 2150bp PCR product from fibroblast cDNA was cloned in a pCR®2.1-TOPO 
vector and the vector was purified. PCR using external and internal primers was
1 2 3
!-► 1000 bp
370 bp
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carried out on the recovered plasmid to confirm the presence of the correct insert. 
Sequencing was carried out with several primers in order to obtain the whole 
sequence. The resulting cloned pig-h3 cDNA was found to have two already 
reported (Tsujikawa, 1998) polymorphisms and several single base substitutions, 
which in some cases resulted in amino acid substitutions in the corresponding 
protein sequence. These base changes were found in random positions in the 
cDNA, were not associated with any of the known mutations and differed between 
different clones. Therefore it was concluded that the changes were resulting from 
failure of the Enzyme Mix in the Extensor Long PCR system to provide a 
proofreading, high fidelity Taq polymerase. Since the amino acid substitutions 
could affect the structure/function of the protein in later stages of the project, 
e.g. while expressing it in the cornea and trying to assess its pathophysiological 
effects, it was necessary to reclone the gene using other methods. The problem 
was that proofreading PFU Taq polymerase (Stratagene) would not amplify the 
2150bp pig-h3 cDNA neither with PFU nor with Anglian Buffer.
The buffers provided by the Extensor Long PCR System were used for the 
amplification of long PCR products using proofreading PFU Taq polymerase. This 
combined PCR provided a 2150 product, which after cloning, purification and 
complete sequencing was found to be identical with the normal pig-h3 cDNA and 
have no unwanted nucleotide changes.
2.3.4 In vitro mutagenesis
The next step after the pig-h3 cDNA had been cloned into a plasmid vector was to 
produce mutant constructs of this gene which would be related with the mutations 
encountered in patients with corneal dystrophies. In addition to the normal gene 
the following mutant versions were selected for construction:
Mutant name Mutation Corneal Dystrophy
Q
c/w
w
c
R555W
R124C
R555Q
Granular type I 
Lattice type I 
Thiel-Behnke
R124C & R555W Lattice St Granular
Table 2.8: In vitro mutagenesis products
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It was thought that the above dystrophies exhibit characteristic histological and 
ultrastructural findings that could be used as ideal models for studying the role of 
keratoepithelin.
The system that was used to perform the mutations on the cloned, wild type pig-h3 
cDNA, was the Altered Sites II Mammalian Mutagenesis System. This system 
utilises a plasmid, which can be expressed both in bacterial cells, (e.g. E. coli) and 
mammalian cells. Therefore this system is useful for the generation of mutants, as 
well as for their subsequent transfer into mammalian cells and cell lines.
2.3.4.1 Cloning into pALTER-MAX
Before the in vitro mutagenesis system was put into practice, (3ig-h3 cDNA was 
excised from the pCR®2.1-TOPO vector using restriction enzymes. Double digestion 
with Xbal and Spel cut on either side of the inserted cDNA gave rise to two 
fragments of different size: a 2.237 bp pig-h3 cDNA containing fragment and a 
remaining 3.813bp, which is the pCR®2.1-TOPO plasmid. The whole of the reaction 
was loaded onto an agarose gel and fractionated by electrophoresis (figure 2.6). 
The lower band corresponding to the 2.2kb cDNA to be cloned was excised and DNA 
was recovered using the QIAquick Gel Extraction kit.
(3ig-h3 +>pCR®2.1 -TOPO
Figure 2.6: Restriction digestion of pCR®2.1-TOPO clones with Xbal and Spel.
Top band is the vector (3.9kb) and lower band the cloned pig-h3 cDNA (2.2kb)
The recipient plasmid, pALTER-MAX was linearised by restriction digestion with 
enzyme Xbal (figure 2.7), for which it has only one restriction site. Xbal and Spel 
recognise different palindromes, but produce complementary overhangs:
Xbal 5\..TCTAGA...3’ 5\..T-0H P-CTAGA...3’
3’...AGATCT ...5’ 3’...AGATC-P 0H-T...5’
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Spel 5’...ACTAGT...3’ 
3\..TGATCA ...5’
5’...A-0" P-CTAGT...3’
3’...TGATC-P oh-A...5’
Therefore it is the same principle as using a single restriction enzyme.
1 2 3
Supercoiled
plasmid >  5.5 Kb
Figure 2.7: Xbal restriction digestion of pALTER-MAX.
Lane 1 - Non-digested plasmid. Lane 2 - digested plasmid. Lane 3 -1 kb DNA ladder
The presence of any pALTER-MAX plasmid that has not been linearised is unwanted, 
since the circular vectors of the minimum size will be favoured for entry in the 
competent cells. This increases the difficulty in finding clones that have been 
transformed with plasmid containing the gene of interest.
In order to maintain a high efficiency of ligation and at the same time ensure 
complete digestion of the plasmid and abolish the chance of self-ligation, the 
vector was digested in the presence of spermidine and was subsequently 
dephosphorylated with CIAP.
Ligation and transformation was carried out as described in sections 2.2.8.8 and 
2.2.8.10. The plasmids of the positive clones were purified and digested with a 
single cutting enzyme, for determination of the total size and with double cutting 
enzyme(s), for separation of the plasmid and vector DNA (figure 2.8).
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Supercoiled
nlasmid
5.5 Kb 
2.2 Kb
Figure 2.8: pALTER-MAX carrying the pig-h3 cDNA.
Lane 1 - non-digested. Lane 2 - Digested with Xhol and Mlul. (5.5kb pALTER-MAX and 2.2kb 
pig-h3). Lane 3 - Digested with Xhol (7.7kb). Lane 4 - 1kb DNA ladder
2.3.4.2 Generation of mutant 0ig-h3
The protocol of the In Vitro Mutagenesis procedure was followed (section 2.2.9) 
and selected clones were screened by direct sequencing. Figure 2.9 illustrates wild 
type versus mutant sequence.
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JCAC C A A G A G A A C G G A N C A T  AC T C TT  • 
40  150 ^  160
(a)
ICCAC CAAGAGAACAGAGCAGACTCTTGGG 
160 1/0  180
(b)
JCAC C A  A G A G A A T G G  A N C A T  AC T C T T *  
4 0  1 s a  160
(C)
Figure 2.9: Wild type versus mutant sequences
(a) Wild type R555 (CGG). (b) Mutant R555Q (CAG). (c) Mutant R555W (TGG)
R555w and R555Q mutant versions of (3ig-h3 cDNA have been produced by the 
described method of In Vitro Mutagenesis. The difficulty in producing R124C 
mutant may have been the sequence of the mutagenic oligonucleotide, which 
included a 6 nucleotide-long repeat (Figure 2.10).
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5\..TACACGGAC GCACGGAGA...3’
R t  R
Mismatch oligonucleotides
Figure 2.10: Schematic diagram showing mutagenic oligo R124C
R - repeat sequence
In order to overcome these problems the mutagenic oligonucleotides were 
redesigned, so that there would be no repeat sequence. However, it was again not 
possible to create any successful mutant clone, maybe this time due to the shifting 
of the mutagenic nucleotide from the centre of the sequence, which is the optimal 
position.
2.15 DISCUSSION
Human fibroblast cells were used to derive pig-h3 RNA and cDNA. The full human 
sequence is known and so far a number of mutations relating to the inherited 
corneal dystrophies has been described. The human pig-h3 gene has been studied 
more extensively than the corresponding homologues from other species. The 
human keratoepithelin has been compared with mouse (Skonier, 1994), rabbit 
(Rawe, 1997), pig (Hashimoto, 1996) and bovine (Gibson, 1996) homologues. The 
viral and nonviral constructs which will be developed from the wild type and 
mutant cDNA described in this chapter will be used on cultured: human epithelial 
cell line and human/bovine primary epithelial cells and keratocytes.
RNA was extracted from both human fibroblast and lymphoblast cells, but only the 
fibroblast RNA could adequately amplify the pig-h3 sequence. This might be a 
reflection of the variable expression profile of pig-h3 between different cell types. 
Fibroblasts have been reported to express high levels of keratoepithelin (LeBaron, 
1995) and in spite of the fact that a variety of tissues and cells have been screened 
for keratoepithelin expression, no data is available for lymphoblast cells. It is 
possible that lymphoblasts do not transcribe |3ig-h3.
101
Most of the corneal dystrophy mutations have a common characteristic: they are 
point mutations of a single nucleotide base, which gives rise to an altered amino 
acid on the protein sequence. The downstream process that takes place on the 
mutant protein in the cell and extracellular matrix has not been deciphered, but it 
is obvious from the dominant character of these disorders that a single amino acid 
change is enough for the emergence of the aberrant phenotype, at the clinical, 
histological, ultrastructural and molecular level. Moreover, new mutations are still 
being reported, which are associated with already known disease phenotypes. 
Thus it is imperative that there are no nucleotide alterations in the PCR amplified 
sequence.
The PCR amplification of |3ig-h3 cDNA was followed by DNA sequencing to detect 
and eliminate unwanted nucleotide changes. Published polymorphisms (Dota, 
1998, Tsujikawa, 1998, Schmitt-Bernard, 2000, Kim 2001) and silent mutations 
were taken into account. Several PCR systems were tried but the one that gave 
the most reliable sequence was the combination of proofreading PFU Taq 
polymerase with the buffer 1 set from the Extensor Long PCR system.
During examination of the effects of keratoepithelin overexpression in cultured 
cells and corneas, it is important to compare our findings with the effects of the 
dystrophy-related mutants. In vitro mutagenesis, by Altered sites II Mammalian 
Mutagenesis System was carried out based on the PCR amplified wild type pig-h3 
cDNA. Four mutant versions of pig-h3 were attempted: R124C, R555W, R555Qand 
R124C&R555W. The above mutations correspond to the two most common 
dystrophies, lattice and granular and Thiel-Behnke. These three dystrophies differ 
phenotypically. In granular dystrophy rod shaped bodies corresponding to 
aggregates of the mutant protein are found within the epithelium while in lattice 
dystrophy abnormal amyloid deposits are also found amongst epithelial cells. 
Finally in Thiel-Behnke dystrophy there is an extremely early tendency to epithelial 
recurrent erosions, which may reflect a significant reduction in epithelial cell 
attachment.
The amino acid positions of these mutations have been described as hotspots, due 
to the number of different substitutions that have been reported in them (Table 
1.3).
102
Mutants R555W and R555Q. have been successfully synthesised, however it has been 
impossible to give rise to the R124C mutant and the double mutant R124C&R555W. 
The position 124 on the keratoepithelin protein sequence could be laborious to 
mutate, possibly due to the presence of flanking repeat sequences (Figure 2.10). 
Different oligonucleotides sequences were designed and the conditions of the 
mutagenesis protocol were varied, but all the resulting clones were resistant to the 
nucleotide substitution TGC of the wild type sequence CGC. The two mutant 
versions of pig-h3 cDNA, which both lie at mutation hotspot R555, enable us to 
compare their effects with those of the wild type constructs and distinguish any 
differences that may reflect their dystrophic phenotype. It was therefore decided 
to progress with the R555W and R555Q mutants at this stage.
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3. CHAPTER THREE 
Construction of recombinant adenovirus carrying the 0ig-h3 gene
3. 1 INTRODUCTION
One of the strategies that was followed to reveal the role of |3ig-h3 was overexpression of 
this gene and monitoring its effect on cell behaviour. Recombinant adenoviruses were 
constructed to carry the wild type and mutant (3ig-h3 gene and facilitate their transport 
and overexpression in corneal cells.
Recombinant adenoviruses have been used to achieve high levels of transgene expression 
within a variety of cell types and tissues (Shering et al, 1997, Brown et al, 1997, Castro et 
al, 1997). Compared with non-viral gene transfer methods adenoviruses are more efficient 
in delivering the transgenes to the target cells. This is especially important when using 
primary cell cultures, which are more difficult to transfect than immortalised cell lines. 
However, transfection with adenoviruses is transient since the viral DNA does not integrate 
in the host genome therefore repetitive administration of the virus is essential, especially 
in dividing cells. Integration in the host DNA might result in unwanted changes of the 
target cells since this insertion is random and could affect the expression of vital host 
genes.
The method that was used in this study for the generation of adenoviruses was homologous 
recombination of adenoviral genomic DNA between two plasmids (pJM17 and pAE1-cl) in 
the presence of the helper adeno-transformed embryonic kidney cell line, 293. pJM17 
carries the entire genome of type 5 adenovirus, Ad5d1309, with a deletion on the viral E3 
gene and an insertion into the E1 region. When co-transfected with the left end shuttle 
plasmid, such as pAE1-cl, infectious viral vectors arise by in vivo recombination. The E1 
region is replaced eventually with the transgene cassette (Lowenstein et al, 1996) and the 
resulting recombinant adenoviruses are replication deficient.
The wild type and mutant (3ig-h3 transgenes were inserted downstream of the major 
immediate early human cytomegalovirus promoter (hCMV-MIE), a strong constitutive 
promoter, to facilitate their overexpression upon infection. The analysis of the effects of 
overexpression on corneal cells may elucidate the role of pig-h3 gene as well as the 
pathogenesis of corneal dystrophies.
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3.2 METHODS
All steps were conducted in a Laminar Flow Cabinet Safety level 2 under sterile conditions 
and with all the decontamination procedures administered.
3.2.1 The helper 293 cell line
Recombinant adenoviruses derived from vectors with deletion of the E1 gene were grown 
on cells which express this gene. The cell line used for this purpose was 293, which is 
derived from embryonic kidney cells transformed with sheared human adenovirus type 5 
DNA. These cells are sensitive to human adenoviruses and adenovirus DNA can be used to 
isolate transformation-defective host range mutants of human adenovirus type 5 and for 
titrating human adenoviruses.
3.2.1.1 293 ceil culture
A cryovial of liquid nitrogen frozen 293 cells was thawed rapidly at 37°C, in a water bath. 
The cells were added to a sterile 15ml Falcon tube containing 9ml 293 medium warmed to 
37°C and centrifuged at 160 x g in a Hettich Universal centrifuge for 5 minutes in order to 
remove DMSO from the freezing medium. Supernatant was discarded and cells were 
resuspended in 2ml 293 medium (see Materials) and transferred to a 25cm2 flask containing 
6ml 293 medium. The flask was incubated at 37°C in a 5% C02 humidified incubator. 24 
hours later the cells were examined microscopically for adhesion to the base of the flask. 
Incubation continued until cells were 80-90% confluent.
3.2.1.2 Splitting 293 cells
The medium from the 25cm2 flask containing 80-90% confluent cells was aspirated and cells 
were washed briefly in prewarmed sterile Dulbecco’s PBS. 1ml Trypsin-EDTA solution 
warmed to 37°C was added to the base of the flask ensuring even coating. The flask was 
warmed in the palm of the hand for 1-2 minutes and then was tapped repeatedly onto the 
bench to suspend the cells. 7ml prewarmed 293 medium was added and cells were 
pipetted to wash them off the flask base and triturate them. 2ml of the resuspended cells 
were added to each of 4 25cm2 flasks containing 6ml fresh 293 medium. Flasks were 
returned to the incubator.
3.2.1.3 Production of 293 stocks
A 25cm2 flask containing 293 cells of 80-90% confluency was trypsinised. 9ml 293 medium 
was added and the cells were triturated and transferred to a sterile 15ml Falcon tube. 
They were then centrifuged at 200 x g for 10 minutes. Supernatant was discarded and
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cells were resuspended in 1ml freezing medium and transferred to a 1ml cryo vial. The 
vial was wrapped in cotton and placed in a polystyrene container, which was kept at -80°C 
overnight. The following day the vial was stored in liquid nitrogen.
3.2.1.4 Transferring cultures to larger flasks
In order to scale up the replication-deficient adenovirus 293 cells must be infected in 
larger culture volumes. Therefore 293 cells must be cultured on 175cm2 flasks.
Starting from a 80-90% confluent 25cm2 flask, the cells were trypsinised and resuspended 
in 7ml 293 medium. They were then transferred to a 75cm2 flask containing 8ml fresh 293 
medium and incubated until 80-90% confluent. Following the same procedure the cells 
were subcultured to a 175cm2 flask and then passaged twice in a 1:3 ratio (1 —> 3 —> 9). 8 
of the 9 175cm2 flasks were split into 20 flasks by pooling together the cells of 4 flasks and 
splitting them in 10 flasks. The ninth 175cm2 flask was subcultured in 1:3 ratio to maintain 
an ongoing culture of 293 cells.
3.2.2 Generation of recombinant adenoviruses
3.2.2.1 Cloning
Wild type and R555W and R555Q mutants pig-h3 cDNA were cloned into the pAE1-cl 
plasmid vector. The ligated clones were transformed in competent JM109 cells, which 
were cultured in large volumes and plasmids were extracted with QIAGEN Plasmid MAXI 
Purification Kit. (See section 2.2.8 for cloning and transformation methods)
3.2.2.2 Plasmid preparation
Plasmid DNA was extracted from the subcultured clones with QIAGEN Plasmid MAXI 
Purification Kit according to the following protocol.
A single colony was transferred to a sterile 20ml universal tube containing 5ml LB and the 
appropriate antibiotic. The bacterial culture was incubated at 37°C in an orbital shaker at 
250rpm for 8 hours. The starter culture was diluted 1/1000 to inoculate 500ml LB medium 
and was allowed to grow at 37°C for 12-16hours in an orbital shaker at 250rpm. The 
bacterial cells were harvested by centrifugation at 6,000 x g for 15 minutes at 4°C in a 
Beckman JA-10 rotor. The supernatant was discarded and the pellet was resuspended in 
10ml buffer P1. After the mixture was homogeneous, 10ml of buffer P2 was added to lyse 
the cells and the contents were mixed by inverting the tube 4-6 times. The lysate was 
incubated at room temperature for 5 minutes. 10ml of chilled buffer P3 was added, the
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tube was inverted 4-6 times and incubated on ice for 20 minutes to allow precipitation of 
genomic DNA, protein, cell debris and SDS to take place. Following this the sample was 
mixed again and centrifuged at 20,000 x g in a Beckman JA-17 rotor for 30 minutes at 4°C. 
The supernatant containing the plasmid DNA was removed, placed in a clean 50ml 
polypropylene tube and centrifuged at 20,000 x g for 15 minutes at 4°C. In the meanwhile 
a QJAGEN-tip 500 was equilibrated by applying 10ml buffer QBT and allowing it to flow 
through the column by gravity. The supernatant from the last centrifugation step was 
loaded onto the column and after it had emptied the column was washed with 2x30ml with 
buffer QC. Finally the DNA was eluted with 15ml of buffer QF and collected in a clean 
50ml tube. The DNA was precipitated by adding 10.5ml (0.7 volumes) room-temperature 
isopropanol and centrifuging at 5,000 x g for 60 minutes at 4°C. The supernatant was 
carefully removed by pipetting and the pellet was washed with 5ml room-temperature 70% 
ethanol and centrifuged at 5,000 x g for 60 minutes at 4°C. The ethanol was removed and 
the pellet was allowed to air dry for 10 minutes. Plasmid DNA was redissolved in 2ml TE 
buffer pH 8.0 and was stored at -20°C.
3.2.2.3 Co-transfection in 293 cells
(Modified from Lowenstein et al, 1996)
293 cells were split the day before co-transfection so that the next day they are 50% 
confluent. 25cm2 flasks were used. The next day medium was aspirated and 5ml of 
prewarmed 293 medium was added to the cells immediately before transfection. 200pl 
low TE buffer was added to a 15ml tube. An equal volume of the two plasmids, pJM17 and 
pAE1-cl was added in the same tube, as well as 30pl of 2M CaCl2. The tube was 
centrifuged ensuring that the mixture was at the bottom. 240pl 2xHBS buffer pH 7.2 was 
added to a second tube. Whilst bubbling air through the HBS, using a Pasteur pipette, the 
DNA mix was added dropwise. The precipitate was allowed to form for 30 minutes and it 
was then added to the flask containing the 293 cells. The fine precipitate that formed on 
the cells was viewed at high magnification. The cells were incubated at 37°C in a 5% C02 
humidified incubator for 4-16 hours. The medium was aspirated and the cells were washed 
once with PBS and once with 293 medium. 6-10ml of fresh medium was added to the cells 
and it was replaced every 3 days or when it turned acidic.
When the co-transfection was successful plaques appeared after 6-8 days, which indicate 
assembled viral entities which can infected the 293 helper cell line. The medium was not 
changed after the first plaque appeared and cells were incubated until 100% cytopathic
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effect (CPE) occurred. CPE is observed by detachment of the cell layer from the bottom of 
the flask, cells appear rounded and the medium colour might turn yellowish.
3.2.2.4 X-gal assay
This assay was carried out to determine the number of cultured mammalian cells in a 
25cm2 flask expressing p-galactosidase upon transfection with control plasmid pMV12.
3-4 days post transfection the medium was aspirated from the cells and they were washed 
with prewarmed PBS. 5ml 4% paraformaldehyde solution was added to fix the cells for 15 
minutes. Following this the cells were washed twice with PBS for 5 minutes. 2ml 0.1% 
Triton X-100 in PBS was used to permeabilise the cells for 5 minutes. The cells were 
washed again twice with PBS for 5 minutes each wash. 10ml of staining solution containing 
X-gal was applied to allow development of blue colour for 1-3 hours. The wash with PBS 
was repeated and the flask was allowed to air dry.
3.2.2.5 Arclone extraction of adenovirus
The contents of the 25cm2 flask were transferred to a 15ml tube and centrifuged at 160 x g 
for 15 minutes. The supernatant was discarded and the cells were resuspended in 100- 
200pl PBS. An equal volume of Arclone P™ (ICI) was added to the cells and they were 
mixed thoroughly. Following a 30-minute centrifugation at 370 x g the mixture was 
separated in three layers, the top layer containing the recombinant adenovirus in PBS, the 
middle layer of cell debris and the bottom layer of Arclone P™. The top layer was 
removed carefully and it was quick-frozen in liquid nitrogen and stored at -80°C.
3.2.2.6 Plaque Purification technique
36 wells of a 96-well plate were inoculated with 8x103 293 cells per well. 24 hours post 
inoculation the cells were infected with appropriate serial dilutions of the virus in 100pl of 
fresh prewarmed 293 medium. Starting at a dilution 102 to 1011, each dilution was carried 
out in triplicate. The virus was circulated every 15 minutes for 90 minutes to ensure even 
distribution over the monolayer. 24 hours later a further 100pl of fresh prewarmed 
medium was added to each well and the medium was changed every 3 days or before if 
necessary.
The cells were monitored daily for evidence of plaque formation. After approximately 8 
days the end point well was found, i.e. the last well in the serial dilution with the 
formation of a single plaque. The cells in the end-point wells were harvested by
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resuspending in the media in the wells and were placed in cryovials. The cryovials were 
frozen and thawed three times to break the cells open and release the virus. The virus 
from this plaque purification round was used to carry out the second round of purification 
and the virus from the second round was used to carry out a third round of plaque 
purification. The virus from the third round was used for scaling up and production of viral 
stocks.
This technique was carried out three times to ensure that the virus was derived from a 
single entity before being expanded to produce a virus stock.
The virus from all three fractions was stored at -80°C. Storage of adenoviruses in optimal 
buffer (e.g. Buffer B, see Materials) containing 10% glycerol or in MEM culture medium 
supplemented with serum is stable for 1-2 years at -80°C.
3.2.2.7 Extraction of DNA from adenovirus-infected cells
293 cells were seeded in 25cm2 flasks the day before the infection. 20pl of the virus from 
the third round of plaque purification was added to the cells with 5ml of fresh prewarmed 
293 medium. The medium was changed the next day and the cells were incubated at 37°C 
in a 5% C02 humidified incubator until they appeared rounded. The contents of the flask 
were collected and centrifuged at 300 x g for 5 minutes. The cells were rinsed with 2ml of 
PBS and were centrifuged for a further 5 minutes at 300 x g. The pellet was resuspended 
in 700pl 1xTris-EDTA, pH 8.0, 25jnl 10% SDS, 8pl 0.5M EDTA, 8pl 20mg/ml proteinase K and 
was incubated at 37°C for 2 hours. After the addition of 100pl 5M NaCl the mixture was 
kept on ice (4°C) for 3-16 hours. The mixture was then centrifuged at 15,000 x g for 1 hour 
at 4°C and the supernatant was thoroughly harvested. An equal volume of phenol: 
chloroform: isoamyl alcohol (25:24:1) was added to extract the DNA and the mixture was 
centrifuged for 5 minutes at 15,000 x g. The DNA was precipitated once with 2 volumes of 
alcohol and centrifuged for 10 minutes at 15,000 x g. The pellet was washed with 70% 
ethanol and resuspended in 50pl dH20  containing 0.1 mg/ml RNase.
3.2.2.8 Scaling up adenovirus stocks
A 25cm2 flask of 70% confluent 293 cells was inoculated with 20pl of end point virus from 
the final round of plaque purification with fresh medium. The next day the medium was 
replaced and the cells were maintained at 37°C in a 5% C02 humidifed incubator until 100% 
cytopathic effect was observed. The cells were then harvested and centrifuged at 500 x g 
for 5 minutes. The supernatant was discarded and the pellet was resuspended in 500pl
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Dulbecco’s PBS. The cells were frozen and thawed three times to open them and the cell 
debris was pelleted by centrifuging for 5 minutes at 160 x g. This virus stock was used to 
infect the 20 175cm2 flasks for the Arclone purification step and it was stored at -80°C.
3.2.2.9 Arclone purification of adenovirus
20 70-80% confluent 175cm2 flasks of 293 cells were aspirated, and 18ml of fresh 293 
medium was transferred to each flask. 20pl of the virus up-scaled with the above protocol 
or 3 MOI of titrated adenovirus were used to infect each flask. Flasks were incubated until 
a total cytopathic effect occurred.
When the 100% cytopathic effect is observed, the 20 175cm2 flasks were harvested by 
transferring the flask contents in 50ml sterile polypropylene tubes and centrifuging them 
at 500 x g for 15 minutes. The supernatant was discarded and the cells were resuspended 
in 10ml PBS. An equal volume of Arclone P™ (ICI) was added and mixed with the cells. 
Centrifugation at 370 x g for 20 minutes produced three distinct layers: the top layer 
containing PBS and virus, the middle layer the cell debris and the bottom layer consisting 
of the Arclone. The top layer was removed carefully and transferred to a sterile 15ml 
falcon tube. The virus was quick frozen in liquid nitrogen and stored at -80°C.
3.2.2.10 Caesium Chloride Gradient purification of Adenoviruses
This protocol was used to purify and concentrate the Arclone preparation of the 
adenovirus. It is a modification of the procedure described in Virology: A practical 
approach (Mahy, 1991).
Two different concentrations of caesium chloride were prepared by dissolving CsCl in 5mM 
Trizma Hydrochloride, 1mM EDTA pH 7.8; 1.33g/ml and 1.45g/ml. Solutions were 
sterilised by passing through a 0.2pm filter.
2.5ml 1.33g/ml CsCl was pipetted in a 14ml Beckman centrifuge tube. Using a wide bore 
syringe 1.5ml 1.45g/ml CsCl was pipetted slowly on the bottom of the tube to form the 
gradient. Approximately 4ml of Arclone virus solution was applied on the gradient and 
mineral oil was layered to the top of the tube. Tubes were balanced to an identical 
weight (up to two decimal points) and placed in the rotor and sealed prior leaving the 
Safety cabinet. Velocity density gradient centrifugation took place in a Beckman 
ultracentrifuge at 90,000 x g (22,500rpm for the SW40 rotor) for 2 hours at 4°C (Accel=1, 
Decel=7). The tubes were opened in the safety cabinet and the following three bands (top
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to bottom) could be observed: Debris, defective virus, “functional” virus. The 
“functional” virus was removed with a wide bore syringe, which was inserted in the side, 
wall of the tube approximately 1cm below the band.
The retrieved virus was diluted in half a volume of sterile TE buffer pH7.8. A second CsCl 
gradient was prepared as before, but this time with 1ml of 1.45g/ml CsCl and 1.5ml 
1.33g/ml CsCl. The gradient was layered with the diluted virus, topped with mineral oil, 
balanced and centrifuged at 100,000 x g (23,800prm for the SW40 rotor) for 18 hours at 
4°C. The viral band was recovered as before and transferred to 10cm treated dialysis 
tubing, which was clipped at both ends. The virus was dialysed twice against 1L Buffer A 
for 1 hour and once against Buffer B (see Materials section) for 2 hours. 1 Ojj.1 aliquots were 
transferred into sterile 0.5ml tubes and the purified virus was stored at -80°C.
3.2.2.11 Preparation of Dialysis Tubing
The dialysis membrane was cut into 10cm long pieces and boiled in 500ml 2% Sodium 
bicarbonate and 1mM EDTA for 10 minutes. The tubing was rinsed thoroughly in distilled 
water and boiled in 500ml 1mM EDTA for 10 minutes. It was allowed to cool in the EDTA 
containing beaker, covered with foil and stored at 4°C ensuring it was always submerged. 
Before use the membrane was removed from the storage buffer in the laminar flow safety 
cabinet and washed thoroughly in distilled water.
3.2.2.12 Adenovirus Titration
A 96-well plate was inoculated with 5-10,000 cells per well in 100^1 293 medium and 
incubated for 24 hrs. The following day 22 serial dilutions of the virus were made from 
102 down to 7.63x1 O'12 in a 24-well plate. 100pl of each dilution was added to 4 well from 
the 96-well plate that was inoculated the previous day.
After one day’s (16-24hrs) incubation, 100pl fresh pre warmed medium was added to each 
well. Medium was aspirated after 3-4 days and replaced with 100|il fresh medium. 6 days 
after infection the wells were monitored for plaque formation. Results were recorded for 
CPE, plaques, single plaque, uncertain and none. 8 days after infection the well with the 
single plaque should be identified. This is the end point of the titration and determines 
the pfu/ml of the virus, according to the following table.
I l l
Well Dilution Pfu/ml
1 10" 1x105
2 10'3 1x10"
3 10'4
inor-X
4 10'5 1x108
5 10'6
oX
6 5x1 O’7 2x107
7 2.5x10'7 4x107
8 1.25x1 O'7 8x107
9 6.25x1 O'8 1.6x108
10 3.12x10'8 3.2x10s
11 1.56x1 O'8 6.4x108
12 7.81x10'° 1.28x109
13 3.91x10'° 2.56x109
14 1.95x10'° 5.12x10°
15 9.77x10’° 1.02x10’°
16 4.88x10'° 2.05x10'°
17 2.44x10'° 4.1x10'°
18 1.22x10'° 8.19x10'°
19 6.1x10" 1.64x10"
20 3.05x10" 3.28x10"
21 1.53x10" 6.55x10"
22 7.63x10'2 1.31 x1 O’2
Table 3.1: Titration table of diluting factors and respective pfu/ml 
3.2.2.13 Supernatant Rescue Assay
The viruses used in all the applications above are replication deficient and although they 
can express the transgenes they carry they cannot replicate themselves. However 
propagation of these viruses takes place in 293 cells, which contain stably integrated E1 
viral genes. Therefore it is not impossible for wild type, replication efficient virus to 
appear as a result of homologous recombination with the genes that are provided by 293 
cells. Any viral preparations which contain replication-efficient virus should be 
decontaminated and discarded.
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One way to detect the presence of the wild type virus is PCR amplification using primers 
that hybridise with the deleted E1 sequences. An alternative and more sensitive detection 
system is the supernatant rescue assay (Dion et al, 1996) according to which the wild type 
can be rescued from the supernatant of cells exposed to high MOIs of recombinant virus 
containing very limited numbers of wild type virus.
3x106 HeLa cells were plated on tissue culture dishes (primary plates). A 25cm2 flask was 
seeded with HeLa cells and incubated in parallel. The following day one of the tissue 
culture plates was apirated, washed with PBS and trypsinised with 1.5ml trypsin and cells 
were resuspended in 8.5 ml RCA medium. Cells were counted on a haemocytometer and 
based on the determined concentration the tissue culture dishes were infected with an MOI 
of 30. An appropriate number of dishes were infected by the virus, so that a total 109 pfus 
were tested in total.
6 hours later 4ml of RCA medium was added to each dish and incubation continued. The 
next day the 25cm2 flask with the HeLa cells was split (1:3) into a 75cm2 flask. These cells 
were cultured with grow-all medium. The following day these cells were used to 
inoculate the wells of a 24-well plate with 0.5ml 4x104cells/ml (secondary plate). After 
overnight incubation the wells were aspirated and washed with PBS. Meanwhile the 
supernatants of the primary plates were centrifuged at 160 x g for 5 minutes. 300pl 
supernatant of each was transferred to three wells of the secondary plate, which was then 
incubated for 6 hours. The supernatant was then replaced by maintenance medium and 
incubation continued. 3 days later plates were examined for the presence of plaques or 
CPE. The medium was changed and incubation was carried on for three more days when 
wells were finally evaluated.
3.3 RESULTS
3.3.1 DEVELOPMENT OF ADENOVIRAL VECTOR
Plasmid pAE1-cl is a product of ligation between two BamHI -Bglll digested plasmids, 
pAE1sp1A (Microbix) and pCI-neo (Promega) (see Materials). It contains adenoviral 
sequences 22 -5790 bp (0-16 mu) with a deletion of E1 sequences 342-3528 bp (1-9.8 mu). 
Both wild type and mutant pig-h3 cDNA were cloned into plasmid pAE1-cl.
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3.3.1.1 Cloning into pAE1-cl
The main strategy that was followed for the cloning of (3ig-h3 into the pALTER-MAX vector 
was applied in this case. pig-h3 cDNA (wild type or mutant) was cut off pALTER-MAX with 
double digestion using the enzymes Xhol and Mlul. pAE1-cl was digested with the same 
enzymes, which give rise to different overhangs and allow positional cloning. This 
eliminates the need for dephosphorylating the plasmid vector, since self-ligation is 
impossible. The restriction sequences of the above enzymes are shown below:
Xhol 5’...CTCGAG...3’ -► 5\..C-0H P-TCGAG...3’
3\..GAGCTC...5’ 3,...GAGCT-P 0H-C...5’
Mlul 5’...ACGCGT...3’ -> 5’...A-0H P-CGCGT...3’
3’...TGCGCA ...5’ 3\..TGCGC-P “ -A.-.S*
The standard ligation and transformation procedures were carried out and positive clones 
were confirmed by restriction analysis with a single and double digestion, as illustrated in 
figure 3.1, below.
Figure 3.1: pAE1-cl containing (3ig-h3
Lane 1 -1 kb DNA ladder. Lane 2 - Xhol 8t Mlul digestion produces 7.7kb plasmid and 2.2kb insert. 
Lane 3 - Xhol digestion linearises the 9.9kb vector. Lane 4 - uncut vector
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3 .3 .1 .2  Scaling up of pJM17
pJM17 carries the entire Ad5d1309 genome (3.7-100 mu). It can be used to construct 
replication defective AD5 vectors with inserts in the early region 1 (E1) and deletion in the 
E3 region. The plasmid itself is noninfectious since it contains an insertion at 1339bp (3.7 
m.u.) in Ad5 sequences which makes the resulting viral genome too large to package. 
pJM17 must be cotransfected with a left end shuttle plasmid, such as pAE1-cl, to generate 
infectious vectors of a packable size by in vitro recombination. The inserts in E1 region, 
derived from the shuttle vector, can be up to 5.2kb.
To produce a stock, the plasmid was cloned into DH5a cells and plasmid preparations were 
carried out using the QIAGEN plasmid MAXI prep kit. Due to its large size (40kb), it was 
prepared with a method that eliminates the chances of recombination. After 
transformation of competent cells, a single colony was transferred to a 5ml liquid culture, 
which after 8 hours was used to subculture (1:100) the overnight culture to be used for the 
AAAXI preparation.
Despite this, approximately 50% of the plasmid preparations of this large vector had 
recombined as demonstrated by restriction digestion with Hindlll (Gibco BRL) (Figure 3.2). 
Only those preparations that gave the expected restriction pattern were retained for 
further use.
Figure 3.2: Hindlll digestion of various pJM17 maxi preps
Lane 1 -1 kb DNA ladder. Lanes 2-4 - normal pJM17. Lanes 5-7 - recombined pJM17
3.3.1.3 Optimising cotransfection
In order to determine the amount of plasmid DNA required to achieve efficient 
transfection of 293 cells, the cotransfection protocol was carried out initially with 
different amounts of a single plasmid, pMV12. This is a 13.0 Kb plasmid vector which 
carries the LacZ gene and encodes the enzyme |3-galactosidase. Expression of this reporter
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gene can be monitored by production of blue colour following the reaction with the 
substrate X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactoside).
50% confluent 293 cells cultured in 25cm2 flasks were transfected with 2, 5 and 8(ig of 
plasmid DNA pMV12 which had been prepared with the QIAGEN Plasmid MAXI Purification 
Kit. After carrying out the X-gal assay all the cells were stained blue with the intensity of 
the staining increasing in proportion with the amount of pMV12 plasmid that was used for 
the transfection (figure 3.3). Since all of the cells appeared blue with the 5pig of pMV12, 
this amount of plasmid was used for the following experiments.
Figure 3.3: Control co-transfection with pMV12
Cells were stained with X-gal for blue colour detection of Lad  expression. A. 2\x% of plasmid, B. 
5|ig and C. 8jig
3 .3 .1 .4  Co-transfection w ith pJM17 and pAE1-cl
The construction of the recombinant adenovirus is a result of recombination between the 
homologous adenoviral genome sequences on plasmids pJM17 and pAE1-cl. The principle 
of the co-transfection technique is demonstrated on the following diagram (figure 3.4).
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Figure 3.4: Mechanism of homologous recombination of pJM17 and pAE1-cl during co­
transfection
8 25cm2 flasks of 293 cells were co-transfected with 5jj.g of pJM17 and 5jig of pAE1-cl 
carrying the wild type and mutant R555W (3ig-h3 cDNA. 9 days after transfection the first 
plaques appeared and three days later 7 out of the 8 flasks had rounded cells and many 
plaques. The co-transfections with pJM17 and pAE1-cl carrying the R555Q. mutant cDNA did 
not yield any plaques although the experiment was repeated three times.
The recombinant adenoviruses from the co-transfection flasks were extracted with Arclone 
P™ and stored at -80°C. One virus with each transgene was used for the three rounds of 
plaque purification technique.
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3.3 .1 .5  Nomenclature
The product of recombination between pJM17 pAE1-cl carrying the wild type (3ig-h3 cDNA 
will be referred to as Rad|3igh3. The product of recombination between pJM17 and pAE1-cl 
carrying the mutant R555W pig-h3 cDNA will be named RadR555W.
3.3.2 Characterisation of the adenovirus
Vector systems are designed so that the vast majority generate of the product is virus with 
the appropriate insert. However, occasionally inappropriate recombination can take place 
and result in aberrant viral construct. The recombinant adenoviral genome was extracted 
and was analysed with the following methods to confirm the presence of the insert.
3 .3 .2 .2  PCR amplification
Six different viral constructs were tested for Radpigh3 and five for RadR555W. The viral 
DNA was extracted according to the method in section 3.2.2.7. The DNA of each viral 
construct was diluted 1:10 and was read spectrophotometrically at A26o- The 
concentrations varied between 1.375 and 2.2pg/^il.
The presence of the transgenes, were confirmed with PCR amplification of the pigh3 cDNA 
sequence (figure 3.5) with two different sets of primers: prom1-3prime, which amplify the 
whole 2.150kb cDNA sequence, and seq1-seq2R, which amplify a 500kb internal part of the 
cDNA sequence (543-1042bp) (see table 2.1).
2000b w
500b*
Figure 3.5: Confirmation of the presence of |3ig-h3 transgenes with PCR amplification. Gel A - 
amplification of the whole 2150bp insert sequence. Gel B - Amplification of a 500bp fragment with 
internal primers. Lane 1 - Molecular weight standard. Lane 2 - RadR555WF6. Lane 3 - RadR555WE6 
Lane 4 - RadR555WD6. Lane 5 - Rad0igh3F6. Lane 6 - Rad(3igh3C6. Lane 7 - Rad(3igh3D7. Lane 8 - 
Radpigh3F7. Lane 9 - Rad|3igh3C9. Lane 10 - Radpigh3D7. Lane 11 RadR555WE8. Lane 12 - 
RadR555WC7. Lane 13 - positive pig-h3 amplification control. Lane 14 - negative control (no DNA)
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From the PCR products on the above gels it appears that 6 out of the 11 screened viral 
constructs amplify the expected size of pig-h3 sequence: RadR555WF6, RadR555WE6,
RadR555WD6, Radpigh3F6, Rad(3igh3C6, Radpigh3D7. These constructs will be used for 
further experiments. The rest of the constructs are either the products of inappropriate 
recombination or correspond to DNA which is not of good quality. Four of the five viral 
DNA samples which did not give the expected PCR product were extracted in a separate 
round of DNA extraction. During the spectrophotometric analysis they appeared to contain 
high levels of protein (5-8mg/ml), which could potentially inhibit efficient PCR.
3.3.2.3 DNA sequencing
The extracted recombinant adenoviral genome was also subjected to DNA sequencing to 
confirm the correct sequence as well as that the in vitro mutagenesis sites have been 
maintained. The sequencing took place using the BigDye Terminator Mix as described in 
section 2.2.10.6, with the primers described on table 2.1. The resulting sequence had not 
been changed form the original cloned cDNA pig-h3 sequence and the R555W mutation was 
also confirmed (Figure 3.6).
CACCAAGAGAACGGAGCAGj 
160 170
\A G  AG AATGG AGCAdAC  
) 160
Figure 3.6: DNA sequencing confirming the mutation R555W
A. Radpigh3 with the wild type codon CGG. B. RadR555W with the mutated codon TGG
3.3.3 Recombinant adenovirus stocks
After the characterisation of the correct adenoviral constructs, one of each recombinant, 
Radpigh3 and RadR555W, were selected for up-scaling and experimental use. These 
adenoviruses were used to infect 20 175cm2 flasks and were then extracted with Arclone 
and purified with CsCl2 gradient centrifugation. The titres of the purified viruses was 
determined with end point dilution to be 1.64x1011 and 3.28x1011 pfu/ml for Radpigh3 and 
RadR555W respectively.
Propagation of replication deficient adenovirus in 293 cells, which provide the deleted 
adenoviral genes can sometimes result in stocks which contain wild type recombinants.
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These are replication competent and infectious and therefore should not be used. 
Supernatant rescue assay was carried out to detect such recombinant by incubating HeLa 
cells with the supernatant from HeLa cells exposed to high MOI of the recombinant stock. 
No wild type recombined virus was detected in the preparation.
3.3.4 Confirmation of expression of adenoviral transgene
The integration of the |3ig-h3 cDNA sequence in the recombinant adenoviral genome was 
confirmed as described in section 3.3.2. However it was important to ensure that this 
transgene was efficiently expressed when the adenovirus infected cultured cells, thereby 
mediating overexpression.
The purified adenoviruses were used to infect cultured cells, primary keratocytes and 
epithelial cells at an MOI of 100. 72 hours post infection the RNA was extracted and RT- 
PCR was carried out as described in sections 2.2.2 and 2.2.3. The 2150bp fragment of the 
pig-h3 cDNA was amplified using the Prom1-3prime primers (table 2.1).
1 2 3 4 5
2kb -►
Figure 3.7: PCR amplified 0ig-h3 fragment from RNA extracted from adenovirus infected cells
Lane 1 - Molecular Weight standard. Lane 2 - Epithelial cells infected with Radpigh3. Lane 3 - 
Keratocytes infected with Radpigh3. Lane 3 - Epithelial cells infected with RadR555W. Lane 4 - 
Keratocyte infected with RadR555W.
3.3.5 Control recombinant adenoviruses
In addition to the above recombinant adenoviruses which carry the wild type and mutant 
pig-h3 inserts, two control adenoviruses were also up-scaled, Rad35 and Rad332. Rad35, 
(kindly provided by M.G. Castro), carries the LacZ gene and Rad332 (kindly provided by 
G.W.G Wilkinson) has been constructed to express the Green Fluorescent Protein (GFP). 
These strains were required in order to test the feasibility of transfection of corneal 
epithelial cells in different systems. These were i) transformed cell lines ii) primary 
epithelial cell culture iii) ex vivo rat corneal organ culture.
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A small sample from each of these viruses was used to infect 20 175cm2 flasks at an MOI 
(Multiplicity Of Infection) = 3. They were subsequently extracted with Arclone and 
purified according to the described protocol. The titre of the purified viruses, Rad35 and 
Rad332 were determined with end point dilution to be 1.64x1011 pfu/ml and 2x108 
respectively. Supernatant rescue assay demonstrated the absence of replication 
competent virus in the preparation.
3.4 DISCUSSION
Radpigh3 and RadR555W were synthesised with homologous recombination of adenoviral 
genome containing plasmids, pJM17 and pAE1-cl, which also carried the pig-h3 cDNA. The 
co-transfection took place in the helper cell line 293.
It was originally intended to construct a third virus, which would express keratoepithelin 
with the R555Q mutation. Although the co-transfection experiment was carried out several 
times after the optimisation of the protocol with the control plasmid pMV12, it resulted 
repeatedly in no plaques and CPE. The sequence corresponding to the R555Q mutant cDNA 
of pig-h3 is cloned on plasmid pAE1-cl, but it failed to successfully recombine with the 
pJM17 plasmid to give rise to recombinant adenoviral constructs. In order to ensure that 
the plasmid preparations are suitable for transfection of mammalian cell culture, the 
plasmids were prepared again using the EndoFree™ Plasmid Maxi purification Kit (Qiagen), 
which eliminates the presence of endotoxins from bacterial lysates and gives rise to 
ultrapure plasmid DNA with improved efficiency of transfection. However this did not 
improve the efficiency of co-transfection of the R555Q plasmid either.
The integrity of the recombinant viral DNA and the presence of the transgene were 
determined with restriction digestion, PCR amplification of the cloned pig-h3 insert and 
DNA sequencing. Expression of the insert was demonstrated by RNA extraction from cells 
infected with the adenovirus and subsequent RT-PCR amplification of the pig-h3 cDNA.
Construction of the recombinant adenoviruses carrying the wild type and mutant pig-h3 
gene is a powerful tool to help our understanding of the mechanisms behind the Corneal 
Dystrophies. They enable the overexpression of pig-h3 gene constructs in ocular tissues 
which would override the corneal expression levels. This is a novel approach to the study 
of these inherited ocular diseases, since no other reports have been published to date of 
recombinant viral vectors with this transgene.
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4. CHAPTER FOUR 
Production of native recombinant keratoepithelin
4.1 Introduction
The pathologic phenotype observed in corneal dystrophies is due to the accumulation of 
aggregates in the anterior cornea and corneal stroma, which compromise the transparency 
of this tissue. Although not completely understood, these aggregates contain high amounts 
of the keratoepithelin protein. There is evidence that keratoepithelin is accumulated in 
the affected human cornea in greater amounts than in control (Klintworth et al, 1998) by 
comparing the albumin:keratoepithelin ratio. This was also demonstrated by histological 
staining where the deposits in affected corneas stain intensely for keratoepithelin 
compared with the diffuse stain in normal corneal stromal tissue (Streeten et al, 1999).
The function of this protein remains unclear, although it seems to play a role in growth 
(Skonier et al, 1994, Wang et al 2002), differentiation (Ohno et 2002), development 
(Schorderet et al, 2000, Ohno et al, 2002), wound healing (O’Brien et al, 1996, El-Sabrawi 
et al, 1998) and tumourgenicity (Skonier et al, 1994). Keratoepithelin seems to exert its 
biological effects by interacting with the transmembrane proteins on the cell surface, 
integrins (Kim et al, 2000, Bae et al, 2001).
Little is understood about the manner by which the changed amino acids on the mutant 
protein lead to the formation of deposits. Missense mutations alter protein folding and the 
affinities of subunit interactions. Protein folding, especially in the case of secretory and 
plasma membrane proteins, involves interaction with molecular chaperones and enzymes 
(Swallow and Edwards, 1997). Mutations which disrupt these interactions result in protein 
instability and loss of function. However, mutations in critical regions may not affect 
normal synthesis and stability, but disrupt normal function, e.g. mutations in binding sites 
for enzymes, ligands or other proteins. Many missense mutations lead to abnormal protein 
folding. In certain instances the effect is the excessive accumulation of abnormal protein, 
e.g. amyloid plaques in Alzheimer’s brain disease, which are composed of insoluble forms 
of lysozyme (Booth et al 1997 and Perutz 1997).
To further explore the role of the intriguing keratoepithelin molecule, a recombinant form 
was produced, corresponding to the wild type and mutant cDNA clones obtained with the 
cloning and in vitro mutagenesis. Native protein is difficult to extract from tissue and it
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usually involves harsh methods, like denaturation, which affect the protein integrity. Also 
the quantity of the extracted protein from tissue is usually low.
Recombinant protein can be a useful tool for the study and sometimes pharmaceutical 
intervention in inherited disorders. Escherichia coli is a common host for recombinant 
protein production, although other methods are available which involve mammalian cells, 
such as yeast, insect or even plant cells. The advantages for using the prokaryotic host 
Escherichia coli, are that it provides a simple, inexpensive, fast and efficient alternative to 
recombinant protein, its genetics are well understood and there is a large number of 
compatible tools available.
Recombinant keratoepithelin has been expressed and reported by other researchers 
(Billings et al, 2002, Yuan et al, 2004, Bae et al, 2002, Kim et al, 2002). In all the above 
cases a prokaryotic system was used for the expression of the recombinant protein, which 
was isolated from inclusion bodies, in an insoluble form. The formation of insoluble 
aggregates (inclusion bodies) is a common event in Escherichia coli, resulting from 
overexpression and accumulation of high concentration of recombinant protein into the 
cytoplasm or inefficient processing of the polypeptide. The protein in the inclusion bodies 
is usually misfolded and biologically inactive (Villaverde et al, 2003). It is possible to 
refold protein which has been extracted from inclusion bodies, but this a time consuming 
process which requires optimisation of the refolding conditions and usually the recovery 
yield is poor. Moreover there is the possibility that re-solubilisation can affect the 
integrity of refolded protein.
The culture conditions and cloning options of the protein expression protocol can be 
manipulated in different ways in order to improve the chances of solubility of the 
recombinant protein and extract it in its native form. The way this was carried out is 
described in the methods below. Therefore recombinant protein was expressed in 
Escherichia coli and extracted in the insoluble, native conformation and this was used to 
study its effect on corneal cells.
4.2 METHODS
The expression system used for the recombinant protein production was the pET by 
Novagen. This system provides a variety of plasmid vectors, where the DNA of interest can 
be cloned in a variety of host cells where the expression of the cloned proteins takes 
place.
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The host used was the bacterial strain BL21(DE3)pLysS. DE3 is a lysogen of A,DE3 and 
carries a copy of T7 RNA polymerase under the control of the /acl)V5 promoter (Studier et 
al, 1986). The plasmid pLysS encodes T7 lysozyme, which inhibits T7 RNA polymerase. 
The only promoter known to direct transcription of the T7 RNA polymerase gene is the 
/ocUV5, which is inducible by IPTG. This bacterial strain is used to suppress the basal 
expression of T7 RNA polymerase prior IPTG induction and therefore stabilises 
recombinants that express recombinant protein which affects cell growth and viability.
Another way to control basal expression is to use vectors with the T7/oc promoter 
(Dubendorff et al, 1991). These plasmids contain the lac operator sequence just 
downstream of the T7 promoter. They also carry the lac repressor, lad , which acts on the 
lac operator. When this type of plasmid is used with the DE3 lysogens, the lac repressor 
acts both on the /acl)V5 promoter in the host chromosome to prevent RNA polymerase 
transcription and the l i la c  promoter to block transcription of the inserted gene. When 
using T7lac promoter the expression in pLysS host can be reduced.
E. coli codon usage is different from mammalian cells, especially codons Arg, lie, Leu, Gly 
and Pro are rarely used and heterologous target proteins can be difficult to express 
correctly. To compensate for this, pLysS expresses the rare codon tRNA’s on the same 
backbone as T7 lysozyme.
To enhance the solubility and folding of the recombinant protein BL21(DE3)pLysS 
transformed cells were not cultured overnight. Alternatively culture periods were not 
more than 5 hours long and the temperature of up-scale growth and induction was 30°C. 
Also BugBuster reagent in combination with rLysozyme were used, which can increase 
solubilisation of the extracted proteins.
The antibiotic ampicillin was replaced with carbenicillin, which can be used to select for 
plasmids containing ampicillin resistance. The reason for this is because ampicillin 
selection tends to be lost in cultures because secreted p-lactamase and the drop in pH that 
accompanies bacterial fermentation both degrade the antibiotic. For the same reasons 
extended periods of culture were avoided. Increased degradation of ampicillin results in 
increase of the number of cells in culture which do not have resistance and therefore lack 
the desired recombinant plasmid.
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4.2.1 Cloning
The (3ig-h3 cDNA was PCR-amplified with appropriate primers to give rise to a fragment, 
where restriction endonuclease sites were inserted at either ends. Both this PCR product 
and the chosen plasmid vector underwent restriction digestion with the same restriction 
enzyme(s). Following this the digested fragments were ligated. All these steps were 
carried out as described in section 2.2.8 with the modifications mentioned in 4.3 section 
below.
4.2.2 Mini preparation of protein with Ni-NTA resin
A fresh colony of transformed BL21(DE3)pLysS competent cells was inoculated in 5ml of LB 
medium containing 50jig/ml carbenicillin and 34pg/ml chloramphenicol. The cells were 
incubated at 37°C orbital shaker at 250 rpm until O D 6oo = 0.5-0.7. A 500pl sample was 
taken for uninduced control, the cells were pelleted at 15,000 x g for 1 minute, 
resuspended in 50pl 1x SDS sample buffer and frozen until SDS-PAGE was carried out. The 
rest of the culture was induced with 1mM IPTG and was incubated at 30°C for 4 hours. The 
culture (3ml) was centrifuged at 15,000 x g for 1 minute to harvest the cells. The 
supernatant was discarded and the pellet was frozen at -20°C for 10-20 minutes. The cells 
were then thawed and resuspended in 100pl 1x Ni-NTA Bind buffer. 5KU rLysozyme were 
added to the cells and incubated at 30°C for 15 minutes. The cells were lysed by vortexing 
and 2.5U Benzonase nuclease were added and the contents of the tube were mixed. 
Separation of the insoluble and soluble fractions of the cells took place by centrifugation 
at 15,000 x g for 10 minutes. The supernatant, soluble part, was transferred to a fresh 
tube and the pellet was retained. 20pl of the 50% slurry of Ni-NTA His-Bind resin was 
added to each tube and proteins were mixed with the resin by shaking at 150 rpm 4°C for 
30 minutes. The tubes were then centrifuged for 10 seconds at 15,000 x g to pellet the 
resin. 10jil supernatant was kept on ice and the rest was discarded. The resin was washed 
twice with 100jlxI 1x Ni-NTA Wash buffer and centrifuged at 15,000 x g. 10pl of each wash 
supernatant was kept on ice. The recombinant protein was eluted three times with 20jllI of 
1x Ni-NTA Elute buffer. At each elution step the sample was centrifuged at 15,000 x g for 
10 seconds and the supernatant was removed to a fresh tube.
4.2.3 Large scale protein production
4.2.3.1 IPTG Induction
A fresh colony of transformed BL21(DE3)pLysS competent cells was inoculated in 3ml of LB 
medium containing 50pg/ml carbenicillin and 34pg/ml chloramphenicol. The culture was
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grown at 37°C in an orbital shaker until O D 6oo = 0.5. This culture was used to inoculate 100 
ml LB medium with the above antibiotic concentration. The cells were incubated at 30°C 
shaker until O D 6oo = 0.5 - 1.0. The cells were split in two 50ml cultures and one of them 
was induced with 0.6mM IPTG and the other culture was the uninduced control. 
Incubation took place at 30°C shaking at 250rpm for 4 hours.
4.2.3.2 Total cell protein (TCP)
Prior to harvesting cells, 1ml of each culture was transferred to 1.5ml centrifuge tube and 
spun at 10,000 x g for 1 minute. The supernatant was discarded and the pellet was 
allowed to dry by inversion. Excess liquid was tapped on a paper towel. The pellet was 
resuspended in 100pl PBS and 100pl 4x SDS buffer was added and the sample was passed 
through a 27 gauge needle several times to reduce viscosity. Heating took place for 3 
minutes at 85°C to denature the proteins and the total cell protein fraction was stored at - 
20°C until analysed with SDS-PAGE.
4.2.3.3 Soluble cytoplasmic fraction
The cells from the two 50ml cultures were harvested by centrifugation at 10,000 x g at 4°C 
for 10 minutes. The supernatant was discarded and the pellet was allowed to drain by 
inverting the centrifuge tube. The cells were resuspended in 5ml room temperature 
BugBuster protein extraction reagent (Novagen) by gently pipetting with a Pasteur pipette. 
5KU rLysozyme, 125U Benzonase Nuclease and 250pl protease inhibitor coctail set III were 
added and the lysate was incubated for 20 minutes at room temperature on a roller. The 
insoluble cell debris was removed by centrifugation at 16,000 x g 4°C for 20 minutes. The 
supernatant was transferred to a fresh tube and the pellet was kept to extract the 
insoluble fraction. A sample of the supernatant was used for analysis by mixing with an 
equal volume of 4x SDS buffer, heating at 85°C for 3 minutes and storing at -20°C. The rest 
of the cytoplasmic fraction was retained for further purification.
4.2.3.4 Insoluble cytoplasmic fraction
The pellet from the previous step was resuspended in 5ml BugBuster reagent by pipetting 
repeatedly with a Pasteur pipette. 5KU rLysozyme were added and the sample was mixed 
by vortexing. It was then incubated for 5 minutes at room temperature. 6 volumes of 1:10 
diluted BugBuster (in dH20) were added and the mixture was mixed on a vortex for 1 
minute. The inclusion bodies were collected with centrifugation at 5,000 x g 4°C for 15 
minutes. The supernatant was discarded and the pellet was resuspended in half the 
original volume of the diluted 1:10 BugBuster, vortexed and centrifuged as before. The
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supernatant was removed and this resuspension and step was repeated. This time the 
insoluble fraction was centrifuged at 16,000 x g 4°C for 15 minutes. The supernatant was 
discarded and the inclusion bodies present in the pellet were:
i) For SDS-PAGE: resuspended in 1.5ml 1% SDS sample buffer with heating and vigorous 
mixing. 100pl were removed and combined with 100pl 4x SDS sample buffer, heated at 
85°C for 3 minutes and stored at -20°C.
ii) For purification: resuspended in 10ml 1x Binding Buffer with 6M urea. The solution was 
incubated on ice for 1 hour to dissolve the protein and centrifuged at 16,000 x g 4°C for 30 
minutes. The supernatant was passed through a 0.45p membrane.
4.2.4 Protein purification
The recombinant protein was constructed to carry a His-Tag sequence which enabled the 
purification with the following methods.
4.2.4.1 His-Bind column chromatography
After removing the His-Bind column cap, the storage buffer and the lower Luer plug were 
removed. The column was equilibrated with 10ml of 1x Binding buffer. After the Binding 
buffer was allowed to drain the column was loaded with the cell extract. This was allowed 
to flow through and the column was washed with 10ml of 1x Binding buffer and then with 
10ml of 1x Wash buffer. The protein was eluted with 5ml of 1x Elution or Strip buffer. 
The eluate may be captured in fractions.
4.2.4.2 Ni-NTA His-Bind batch purification under native conditions
1ml of Ni-NTA His-bind slurry was mixed with 4ml 1x Ni-NTA Bind buffer. The resin was 
allowed to settle by gravity and the 4ml of supernatant were removed carefully with a 
pipette. 4ml of lysate was added to the His-Bind slurry and mixed by shaking at 200 rpm at 
4°C for 1 hour. The mixture was loaded to a column with the bottom outlet capped. The 
cap was removed and the flowthrough was collected. The protein was washed twice with 
4ml 1x Ni-NTA wash buffer and the fraction was collected. Finally the protein was eluted 
from the resin with 2ml 1x Ni-NTA elution buffer and the eluate was collected in a clean 
tube.
4.2.5 Buffer exchange with Vivaspin 20
After being purified from the Ni-NTA resin the recombinant protein was in the Elution 
buffer, which has a high concentration of imidazole (250mM). The protein must be 
suspended in an appropriate buffer, which will not alter its conformation and solubility.
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For this buffer exchange the Vivaspin 20 concentrator tubes were used. These are tubes 
which comprise of a removable upper chamber and a lower chamber, separated by a 
membrane, in this case a 10,000 MWCO PES membrane. The initial solution is applied to 
the upper chamber and after centrifugation the salts, contaminants and solid particles 
flow with the buffer to the lower chamber. The macromolecules are collected in an 
impermeable concentrate pocket integrally moulded below the membrane surface, 
thereby eliminating the risk of dryness. After a three wash cycle with the desired buffer 
99% of the initial salt content is removed. The buffer was exchanged according to the 
following protocol.
All the steps were carried out in a Laminar Flow Cabinet to ensure sterility of the protein. 
The upper chamber was filled with sterile dH20 and centrifuged at 6,000 x g for 4 minutes. 
The dH20 was decanted from the lower chamber. The protein sample was placed in the 
top chamber and centrifuged at 3,000 x g for 5 minutes. The flowthrough was discarded 
and the chamber was filled with 15ml of the final buffer, centrifuged at 6,000 x g for 10-20 
minutes. This step was repeated twice and the purified recombinant protein was 
recovered from the bottom of the concentrate pocket and stored at the appropriate 
conditions (See method development).
4.2.5 SDS-Polyacrylamide Gel Electrophoresis (PAGE)
4.2.5.1 Assembly of the gel casting apparatus
The glass plates were cleaned with ethanol and dried with a paper towel to ensure even 
surface for the new gel. Two glass plates of different height (usually the shorter being 
non-transparent white) were assembled with the appropriate thickness spacers matching 
the thickness of the comb, which is determined by the sample volume to be loaded on the 
gel. The assembly was placed in a cassette, taller glass plate facing out, to hold it 
together while the gel was poured.
4.2.5.2 Preparation of the gels
The discontinuous system was used, where a non-restrictive large pore gel (stacking) was 
layered on a separation gel (resolving). Each gel was made with a different buffer and the 
resolution obtained was much greater than using a single separating gel.
A 10% resolving gel was prepared (see materials) and poured in the set of plates up to 1.5 
cm from the top of the shorter plate. The gel was overlaid with ethanol to ensure a flat 
surface and exclude air bubbles. Setting time was determined from a remaining sample of
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gel mixture in a universal tube. The stacking gel was prepared (see Materials), the ethanol 
was removed and the stacking gel was poured. The comb was inserted to form the sample 
wells and the gel was allowed to set for 10 minutes.
4.2.5.3 Preparation of the protein sample
Laemmli Sample buffer (Biorad) containing 5% (3-mercaptoethanol was used to mix with the 
protein sample in a 2:1 ratio. The SDS in this buffer denatures proteins by wrapping 
around the polypeptide backbone and the p-mercaptoethanol reduces disulfide bridges. 
The sample mixed with the Laemmli buffer was denatured by heat at 95°C for 5 minutes 
and loaded onto the gel.
4.2.5.4 Assembly of the electrophoresis apparatus
The plates containing the gel were removed from the gel casting cassette and were 
clamped on the electrophoresis tank. The area behind the gel was filled with Running 
buffer (1x Tris/glycine/SDS, BioRad) and the assembly was checked for leakage. The 
electrophoresis tray was half-filled with the same buffer. The comb was removed from the 
gel and 5pl of the denatured protein samples were loaded onto the wells. The tank was 
covered and the electrodes were connected to the power pack and run at 35 mA (for two 
gels) until the sample buffer blue dye runs off the gel.
4.2.5.5 Coomasie blue staining
The gel was removed from the glass plates and placed in a plastic tray where it was 
stained with Coomassie Brilliant Blue R-250 Stain by shaking for Vi - 2 hours. The gel was 
de-stained with Coomassie Brilliant Blue R-250 Destain by agitating overnight.
4.2.5.6 Image capture
The gel was photographed with either a digital camera or scanned with an EPSON 
Expression 1680 Pro series scanner. Captured images were analysed with the image 
acquisition and analysis software, Labworks.
4.2.6 Western Blotting
The separated proteins after SDS-PAGE can be transferred to a solid membrane for 
Western Blotting analysis, which is detection of specific proteins by antibody-antigen 
interaction.
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4.2.6.1 Protein transfer
1 nitrocellulose membrane and 5 filter papers (Biorad) per gel were cut at 8.4x6 cm and 
they were soaked in Transfer Buffer (1x IEF cathode buffer, BioRad) for 5 minutes. The gel 
was removed from the glass and it was put briefly in Transfer buffer. Three filter papers 
were placed on the transfer surface of the Biometra electro-transfer machine, the 
membrane was placed on top of them and then the gel and the remaining two filter 
papers. The proteins were transferred to the membrane under electric current 120 mA for 
30 minutes.
The proteins on the membrane can be visualised by staining with Ponceau S solution for 2 
minutes and the stain can be effectively removed by rinsing with water.
4.2.6.2 Blocking
Before the antibody was allowed to interact with the protein, all sites which did not 
contain blotted protein from the gel were non-specifically blocked with non-fat dry milk 
(Santa Cruz Biotechnologies). This eliminated the non-specific binding of the antibody.
The membrane was placed in a 50ml centrifuge tube, with that side which came in contact 
with the gel during the transfer facing the inside of the tube. The membrane was blocked 
with 10% milk in PBS containing 50mM NaF and 0.05% Tween 20 for 30 minutes on a roller 
at room temperature.
4.2.6.3 Antibody binding
To detect the antigen blotted on the membrane a primary antibody was added at the 
appropriate dilution. The dilution was made with PBS 50mM NaF and 0.05% Tween 20 5% 
milk. 5ml of the primary antibody dilution was incubated with the membrane on a roller 
for 2 hours. The mouse monoclonal anti - polyhistidine antibody (anti-His-Tag) was used 
for the detection of the recombinant protein at a 1:2000 dilution. This antibody is 
prepared by conjugation of horseradish peroxidase and therefore eliminates the need for 
secondary antibody.
4.2.6.4 Washing
The excess antibody was washed away with PBS 50mM NaF and 0.05% Tween 20. The 
membrane was washed 5-6 times with 20ml of this buffer and excess buffer was blotted on 
paper towel by inverting the tube.
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4.2 .6 .5  Chemiluminescence
After washing, Western Blotting Luminol Reagent (Santa Cruz Biotechnology) was used for 
chemiluminescent detection of the peroxidase conjugate on the anti-His-Tag antibody, 
which was bound on the recombinant protein. An equal volume of Reagent A and B was 
mixed and incubated with the membrane for 1 minute.
4 .2 .6 .6  X-ray film exposure and development
The membrane was covered with cling film, ensuring that there are no trapped air bubbles 
and was secured with tape on one side of the exposure cassette. X-ray film was inserted in 
the cassette and exposed to the light given off by the chemiluminescent membrane for 30 
minutes.
The X-ray film was then removed from the cassette and incubated with Kodak Developer 
and Repleniser (Sigma) according to the intensity of the forming bands, washed in water 
and fixed with Kodak Fixer and Replenisher (Sigma) for 5 minutes.
4.3 METHOD DEVELOPMENT AND RESULTS
4.3.1 Cloning
Initially the vector pET-23c was chosen for cloning with the wild type and mutant |3ig-h3 
cDNA. This is a 3.7 kb plasmid which carries the T7 promoter. It adds a 6-His-tag repeat 
downstream of the insert DNA. The recipient plasmid and DNA insert were ligated 
following Xhol and Hindlll restriction digestion.
4.3.1.1 Preparation of insert DNA
The following primers were designed for the amplification of mutant and wild type (3ig-h3 
to insert these restriction sites at the termini.
m ndlll
Forward primer: 5’ GTCCAAGCTTCATGGCGCTCTTCGTG 3’
Reverse primer: 5' CTTC^T CG AG AT GCTT CAT CCTCTC 3’
Xhol
The glycerol stocks of clones pALTER-MAX (3ig-h3, pALTER-MAX R555Q1 and pALTER-MAX 
R555W31 were subcultured on LB agar plates containing 20pg/ml chloramphenicol.
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Plasmids were extracted according to the method in section 2.2.9.6. PCR amplification 
took place with the above primers using the Extensor Long PCR kit, as described in section 
2.6. The annealing temperature was increased to 60°C to reduce background, which 
appeared with the use of a different thermal cycler (Figure 4.1).
1 2  3 4
2 kBu
Figure 4.1: PCR amplification at 60°C annealing
Lane 1 - Molecular weight marker. Lane 2 - Wild type (3ig-h3. Lane 3 - R555Q mutant pig-h3. Lane 
4 - R555W mutant J3ig-h3
The PCR products were purified with the Qiagen PCR purification kit and subjected to dual 
restriction digestion at the newly incorporated Hindlll and Xhol sites (see section 2.2.8.5).
4 .3.1.2 Preparation pf pET vector
1pg of plasmid pET-23c was used to transform JM109 competent cells and a glycerol stock 
was made. A culture was set up and a plasmid preparation was extracted with the QIAGEN 
plasmid mini purification kit (2.2.9.6).
The extracted pET-23c was digested with Hindlll and Xhol and subsequently cleaned with 
the PCR purification kit.
4 .3.1.3 Ligation
The two DNA fragments were ligated at a 1:1 ratio at room temperature for 2 hours and 
were subsequently used to transform JM109 competent cells. The transformed cells were 
incubated on LB agar plates containing 50pg/ml ampicillin. 6 colonies were selected from 
each plate and these were cultured overnight and the corresponding plasmids were 
extracted.
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4.3 .1 .4  Characterisation of the clones
The extracted plasmids were subjected to restriction digestion with Xhol and Hindlll to 
confirm the presence of the insert, (3ig-h3 cDNA, 2.1 kb (Figure 4.2).
1 2 3 4 5 6 7 8 9 10 11 12 13
A k b ^  
2 kb*'
Figure 4 .2 : Endonuclease res tric tio n  d igestion
Lane 1 - Molecular weight marker. Lane 2 - Wild type clone 1. Lane 3 - Wild type clone 2. Lane 4 - 
Wild type clone 3. Lane 5 - Wild type clone 4. Lane 6 - Wild type clone 5. Lane 7 - Wild type clone 
6. Lane 8 - R555Q clone 1. Lane 9 - R555Q clone 2. Lane 10 - R555Q clone 3. Lane 11 - R555Q
clone 4. Lane 12 - R555Q clone 5. Lane 13- R555Q clone 6.
From Figure 4.2, the clones that appear to have the correct restriction pattern were: Wild 
type clones 1, 2, 3, 5 and 6 and R555Q mutant clones 2, 3, 4 and 5.
These clones were sequenced in the upstream region with the T7 promoter primer
(Novagen) to confirm correct incorporation into the plasmid genome. The sequences were 
amplified with the BigDye Terminator Mix and and sequenced in a 377 DNA sequencer 
according to the method in section 2.11.6.
Figure 4.3: DNA sequencing with T7 promoter. The start codon ATG is present and the integrity 
of the following (3ig-h3 sequence was confirmed
: g a c a a g c  t t c a t g g c  g c  t c t t c g t g c g g c t g c  t g g c  t c t c g c
140110 120 130
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4 .3 .1 .5  Protein expression and analysis
One of each clone with pET-23c vector carrying the wild type, R555Q. and R555W mutant 
pig-h3 cDNA was used to transform 20pl of competent BL21 (DE3) cells. The cells were 
plated on LB agar containing 50pg/ml ampicillin and 34pg/ml chloramphenicol and 
incubated overnight at 37°C. Then the protein was expressed as described in section 
4.2.3, but only the soluble fraction of the culture was extracted to determine expression 
of native recombinant protein. This fraction was purified using the His-Bind Columns and 
Buffer kit (Novagen). The eluted proteins were separated with SDS-PAGE and they were 
allowed to interact with the anti-His-tag antibody during western blot analysis (Figure 4.4).
1 2 3 4 5 6 7
60 KD
Figure 4.4: Protein expression and purification. A. SDS PAGE and B. Western Blotting. Lane 1 - 
Supernatant, soluble extract. Lane 2 - Flowthrough. Lane 3 - Eluate fraction 1. Lane 4 - Eluate 
fraction 2. Lane 5 - Eluate fraction 3. Lane 6 - Eluate fraction 4. Lane 7 - Protein ladder
4 .3 .1 .6  Results
The recombinant protein which was expressed in the pET-23c-BL21(DE3)pLysS vector-host 
combination system was isolated from the soluble fraction of the culture. This 
demonstrates that the conditions favour expression of protein in its native form. Although 
this protein was eluted from the column, from the SDS-PAGE gel it is evident that other 
proteins were present in this final fraction. Only one species from these proteins 
interacted with the anti His-Tag antibody and therefore contained the His-tag repeat 
sequence.
It is unknown what the other proteins could be. The possibility of these proteins being the 
products of proteolytic degradation is small, because in this case, at least some of them 
would react with the anti His-Tag antibody. Moreover protease inhibitors were used during
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the extraction of the protein from the culture. The basis of purification was the affinity of 
the His-Tag sequence on the recombinant proteins with the column. However none of 
these proteins interact with the anti-His tag antibody, which suggests that they react non- 
specifically with the column or that they are proteins associated and co-purified with the 
recombinant protein.
It was attempted to wash protein bound to the column under more strigent conditions and 
the imidazole concentration was increased from 60mM to 100mM, but this did not 
eliminate the presence of the multiple bands in the eluted fractions.
4.3.2 Cloning
Plasmid pET16-b was initially used because it was readily available and had already been 
used for other recombinant protein constructs our laboratory. To test whether the protein 
yield and quality could be improved, a different vector-host system was used. The vector 
pET-16b was chosen because it offers a number of advantages compared to pET-23c, as 
shown on the following table.
pET-23c PET-16b
3.7Kb 5.7Kb
T7 promoter T7/oc promoter
COOH-terminal His-Tag NH2-terminal His-Tag
6-repeat His 10-repeat His
No protease cleavage Factor Xa
Transcription vector Translation vector
Table 4.1: Comparison between the two prokaryotic expression vectors
The expression vector incorporates the His-Tag sequence at the N-terminal end of the 
recombinant which is thought to be less critical in terms of function and folding than the 
C-terminus. This vector also carries the protease cleavage site, Factor Xa sequence, 
where the added his-Tag repeat can be removed after protein purification. PET-16b is a 
translation vector and thus contains a highly efficient ribosome binding site for the 
expression of target genes without prokaryotic ribosomal binding site.
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4.3.2.1 Preparation of insert DNA
The following primers were designed for the amplification of mutant and wild type (3ig-h3 
to insert a single restriction site, Xhol, at either termini.
Xhol
I
Forward primer: 5’ TTACTCGAGCTGGGCCCCGCCGCGACCCTG 3’
Reverse primer: 5’ ATT(^TCGAGCTAATGCTTCATCCTCTCTAA 3’
Xhol
These primers amplify the pig-h3 cDNA from nucleotide 93 to 2096 and remove the 23 
amino acid long NH2-terminal secretory sequence. The resulting protein can therefore be 
extracted from the harvested cells and minimise the export to the cytoplasm.
PCR amplification took place with the above primers using the Extensor Long PCR kit, as 
described in section 2.6. A variety of annealing temperatures were attempted ranging 
form 60°C to 75°C to reduce the background smear, which suggests non-specific DNA 
amplification (Figure 4.5). Also the cycling conditions were changed; the number of cycles
was reduced from 33 to 30 and the extension time from 5 to 3 minutes (Figure 4.5, Lanes
7-21).
m b w q b w q b w  q  b w q b  w q  b w q b  w  q
Figure 4.5: Effect of increased annealing temperatures on PCR product
M Molecular weight marker. B - Wild type pig-h3 cDNA. W - R555W mutant pig-h3 cDNA. Q - 
R555Q mutant cDNA. Lanes 1 - 3: 60°C. Lanes 4 - 6: 63°C. Lanes 7 - 9: 60.6°C. Lanes 10 - 12: 62°C. 
Lanes 13 -15: 66°C. Lanes 16 - 18: 70°C. Lanes 19 -21: 75°C.
From the above figure the temperature which seems to result in optimum PCR products is 
70°C. The fragments which were amplified at this temperature were used for cloning with
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the expression vector. Therefore they were digested with Xhol and cleaned with the PCR 
purification kit.
4.3.2.2 Preparation pf pET vector
100ng of pET-16b (Novagen) were digested with Xhol and the vector was subjected 
dephosphorylation with CIAP (see section 2.2.8.6), in order to eliminate the possibility of 
self ligation and selection for clones which lack the insert (3ig-h3 cDNA. The enzymes and 
different buffers were removed from the dephosphorylated plasmid with the QIAGEN PCR 
purification kit.
4.3.2.3 Ligation
Insert and vector were ligated at a 3:1 molar ratio at room temperature for 2 hours and 
were subsequently used to transform JM109 competent cells. The transformed cells were 
incubated overnight at 37°C on LB agar plates containing 50pg/ml ampicillin. The number 
of the resulting colonies was low, especially the plate corresponding to clones with wild 
type (3ig-h3 had only one colony. The available colonies were cultured and the 
recombinant plasmids were extracted.
4.3.2.4 Characterisation of the clones
The extracted plasmids were subjected restriction digestion with Xhol to confirm presence 
of the insert DNA and dual digestion with Xhol and BamHI to check the orientation of the 
insert. BamHI cuts the |3ig-h3 sequence 340bp downstream the Xhol ligaton site and the 
double digestion with Xhol and BamHI should result in 3 fragments of 5.7Kb (vector), 1.7Kb 
and 340bp (insert), as in figure 4.6.
1 2 3 4 5
Figure 4.6: Restriction digestion of cloned DNA
Lane 1 - Molecular Weight marker. Lane 2 - Wild type cDNA cloned to pET-16b. Lanes 3 and 5 - 
mutant cloned cDNA. Lane 4 - Mutant cloned cDNA with the correct restriction pattern. Note: the 
lower 340bp band was present in the gel, but cannot be visualised on the captured picture.
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From the above gels it can be deduced that although the ligation of pET-16b with the 
mutant (3ig-h3 cDNAs was successful, no positive clones were produced with the wild type 
insert. The ligation between the wild type (3ig-h3 and pET-16b was repeated with varying 
the insert : molar ratios and extending the incubation time to AYi hours. None of these 
changes resulted in any colonies when the transformed cells were cultured on agar plates. 
It is possible that something in the DNA preparation of |3ig-h3 could hinder the ligation 
reaction. Therefore fresh preparations of both insert and vector were made.
A variety of high fidelity PCR systems were used for the amplification of wild type |3ig-h3 
cDNA under a gradient of temperatures (50-65): Gene amp XL PCR Kit (Perkin Elmer), Long 
Extensor PCR buffers and Pfx polymerase (Invitrogen), Platinum Pfx DNA polymerase kit 
(Invitrogen). The first two systems failed to produce any bands, whereas the Platinum Pfx 
kit gave rise to many non-specific bands, even at high temperatures.
2Kb
Figure 4 .7 : Gradient amplification with Platinum Pfx DNA polymerase
Each lane represents annealing at a different temperature. Lane 1 - 50°C. Lane 2 - 51 °C. Lane 3 - 
54°C. Lane 4 - 59°C. Lane 5 - 62°C. Lane 6 - 64°C. Lane 7 - 65°C. Lane 8 - Molecular Weight 
Marker. Lane 9 - 65°C. Lane 10 - 66°C. Lane11-68°C. Lane 12 - 71°C. Lane 13 - 73°C. Lane 14- 
74°C. Lane 15 - 75°C.
The Platinum Pfx PCR system was further optimised with the addition of 0.5x Enhancer 
solution, which enables primers to anneal to problematic DNA sequences. The addition of 
this reagent reduced the multiple bands and resulted in the amplification of a single 
fragment of 2Kb at 65°C.
1 2 3 4 5 6 7 8 8 9 10 11 12 13 14 15
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1 2  3 4 5  6 7 8 9  10 11
2Kb
Figure 4.8: Optimised Platinum Pfx amplification of 0ig-h3
Each lane represents annealing at a different temperature. Lane 1 - Molecular Weight Marker. 
Lane 2 - 50°C. Lane 3 * 51°C. Lane 4 - 54°C. Lane 5 - 57°C. Lane 6 - 59°C. Lane 7 - 61°C. Lane 8 - 
63°C. Lane 9 - 64°C. Lane 10 - 65°C. Lane 11 - negative control (no DNA)
Therefore wild type pig-h3 was amplified at 65°C with the forward and reverse primers 
which employ the Xhol restriction sites at both termini. After being digested and purified 
as described previously (sections 4.3.2.1 - 4.3.2.2), the pET-16b vector and insert DNA 
were ligated at 1:1, 3:1 and 3:1 molar ratios respectively at 4°C overnight. Each ligation 
was used to transform 50pl competent JM109 cells. After overnight incubation on LB agar 
plates it was observed that the majority of the colonies corresponded to the 3:1 
insert: vector molar ratio.
8 colonies were randomly selected for plasmid extraction and characterisation of the DNA 
with restriction digestion.
1 2 3 4 5 6 7 8
1.7Kb
fragment
Figure 4.9: Xhol and BamHI restriction digestion of pET-16b-pig-h3 clones 
Lane 1 - Molecular Weight Marker. Lane 2 - Clone 1. Lane 3 - Clone 2. Lane 4 - Clone 3. Lane 5 - 
Clone 4. Lane 6 - Clone 5. Lane 7 - Clone 6. Note: the lower 340bp band was present in the gel, 
but cannot be visualised on the captured picture. Lane 8 - Clone 7.
1.65 K
0.35Kb
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The above gel (Figure 4.9) shows that clone 6 (lane 7) has the correct restriction pattern, 
result of successful ligation.
The positive clones were sequenced in the upstream region with the T7 promoter primer 
(Novagen) to confirm correct incorporation into the plasmid genome and with pig-h3 
primer Seq 3 (see table 2.1) to check the sequence at the mutagenic codon 555.
3 TC CTCAT A T S C T C  GAG C TGGQC CCC GC CGC GAC CC ' 
110 120 130 140
GC CAC CAAG AG AAC GG AGCAG AC TC TT GG G AG A' 
170 180 190
b
TCCGAG CCC TGC CACCAAGAG AAT GG AGCAG AC T CT T GG G AG /  
150 160 170 180 190
C TGC CAC CAAG AG AACAG AGCAG ACT CTTGGGAGA' 
160 170 180
Figure 4.10: DNA sequencing with T7 and pig-h3 Seq3 primers
A. Sequencing with T7 primer. Note the ATG codon (yellow band) provided by the plasmid is in frame 
with the first codon of pig-h3 DNA, CTG (green band). R555 codons are highlighted by the pink bands B. 
Wild type 555 codon (CGG). C. R555W mutant codon (TGG). D. R555Q mutant codon (CAG)
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4.3.2.5 Protein expression and analysis
One of each clone of pET-16b vector carrying the wild type, R555Qand R555W mutant (3ig- 
h3 cDNA was used to transform BL21(DE3) cells and recombinant protein was induced as 
described in section 4.2.3. The soluble and insoluble fractions were extracted and the 
soluble part was purified with the His-Bind pre-charged columns and buffer kit. Western 
blotting with the His-Tag antibody demonstrated that the recombinant protein was present 
in both the soluble and insoluble fractions. The IPTG controlled expression of the 
recombinant protein was illustrated by comparing the induced and uninduced culture 
extracts from the total cell protein (TCP), soluble and insoluble fractions in the Western 
Blot below.
12 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Figure 4.11: Comparison of the extracted proteins between IPTG induced and uninduced
culture fractions
Lane 1 - Protein Weight Marker. Lane 2 - TCP wild type clone uninduced. Lane 3 - TCP wild type 
clone induced . Lane 4 - TCP R555Q clone uninduced. Lane 5 - TCP R555Q induced. Lane 6 - TCP 
R555W uninduced. Lane 7 - TCP R555W induced. Lane 8 - Soluble wild type uninduced. Lane 9 - 
Soluble wild type induced. Lane 10 - Soluble R555Q uninduced. Lane 11 - Soluble R555Q induced. 
Lane 12 - Soluble R555W uninduced. Lane 13 - Soluble R555W induced. Lane 14 - Insoluble wild type 
clone uninduced. Lane 15 - Insoluble wild type clone induced. Lane 16 - Insoluble R555Q clone 
uninduced. Lane 17 - Insoluble R555Q. clone induced. Lane 18 - Insoluble R555W clone induced. 
Lane 19 - Insoluble R555W clone uninduced.
The proteins were separated with SDS-PAGE and stained with Coomassie Blue, where it 
became obvious that there was no protein in the eluate.
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1 2  3 4  5 6 7 8 9  10
Figure 4 .1 2 : SDS-PAGE o f p u rifie d  re c o m b in a n t p ro te in
Lane 1 - Protein Weight Marker. Lane 2 - Soluble extract. Lane 3 - Soluble extract filtered with 
0.45|i filter. Lane 4 - Flowthrough. Lane 5 - Wash 1. Lane 6 - Wash 2. Lane 7 - Eluate 1. Lane 8 - 
Eluate 2. Lane 9 - Eluate 3. Lane 10 - Eluate 4.
4.3.3 Protein mini prep with Ni-NTA His-Bind resin
Since the pre-packed columns failed to recover the recombinant protein, a different 
method was used for the purification of His-tagged protein. The Ni-NTA His bind resin, 
which allows extraction and purification from small samples of culture and therefore 
simplifies the optimisation of the recombinant protein production. The protocol for mini 
protein preparation was carried out (see section 4.2.2) and the Ni-NTA His-Bind resin was 
used to purify recombinant protein from both the soluble and the insoluble fraction (under 
non-denaturing conditions) (figure 4.13).
70 kD
1 2 3 4 5 6 7 8 9 10 11 12 13
l r  "• *rr ~
2 3 4 5 6 7 8 9 10 11 12 13
70 kD> __
t "
A --------------------------  B
Figure 4.13: Proteins extracted with Ni-NTA His-Bind resin mini prep
A. SDS-PAGE and B. Western Blot. Lane 1 - Protein marker. Lane 2 - Soluble Flowthrough. Lane 3 - 
Soluble Wash 1. Lane 4 - Soluble Wash 2. Lane 5 - Soluble Eluate 1. Lane 6 - Soluble Eluate 2. Lane 7 - 
Soluble Eluate 3. Lane 8 - Insoluble Flowthrough. Lane 9 - Insoluble Wash 1. Lane 10 - Insoluble Wash 2. 
Lane 11 - Insoluble Eluate 1. Lane 12 - Insoluble Eluate 2. Lane 13 - Insoluble Eluate 3.
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SDS-PAGE and Coomasie Blue staining of the protein samples demonstrated that there is a 
double protein species around 70KD in the eluate as well as some lower molecular weight 
bands (Figure 4.13). A double keratoepithelin species has been reported previously 
(Skonier et al, 1994 and Hashimoto et al, 1997) and corresponds to 66 and 69kD. Western 
Blotting of the electrophoresed proteins confirmed the isolation of recombinant His-Tagged 
protein in the eluate. However, some of the native protein failed to stay bound to the 
resin and was detected in the flowthrough and wash samples.
Apart from the soluble fraction, considerable amounts of the protein were present in the 
insoluble fraction of the cell culture. Since the protein in the soluble fraction was enough 
for extraction and in vitro experimental use, the insoluble fraction was not harvested in 
the following Maxi preparations.
143
4.3.4 Large Scale recombinant protein production
The three recombinant proteins were expressed according to the protocol described in 
section 4.2.3 and purified with the Ni-NTA His-Bind resin (see 4.2.4). SDS-PAGE and 
Western blotting demonstrated the efficiency of recombinant protein purification in figure 
4.14.
M 1 2 3 4 5 6 7 8 9  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
70kD^
i t — let
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
70 kD^ m  m m m - mm ^  _
B
Figure 4.14: Large scale recombinant protein purification
A. SDS-PAGE, B. Western Blot. Lane 1 - Lysate Wild type uninduced. Lane 2 - Lysate Wild type 
induced. Lane 3 - Lysate R555W uninduced. Lane 4 - Lysate R555W induced. Lane 5 - Lysate R555Q 
uninduced. Lane 6 - Lysate R555Q induced. Lane 7 - Wild type flowthrough. Lane 8 - Wild type 
wash 1. Lane 9 - Wild type wash2. Lane 10 - Wild type eluate 1. Lane 11 - Wild type eluate 2. 
Lane 12 - Wild type eluate 3. Lane 13 - Wild type eluate 4. Lane 14 - R555W flowthrough. Lane 15 
- R555W wash 1. Lane 16 - R555W wash 2. Lane 17 - R555W eluate 1. Lane 18 - R555W eluate 2. 
Lane 19 - R555W eluate 3. Lane 20 - R555W eluate 4. Lane 21 - R555Q flowthrough. Lane 22 - 
R555Q wash 1. Lane 23 - R555Q wash 2. Lane 24 - R555Q eluate 1. Lane 25 - R555Q eluate 2. Lane 
26 - R555Q eluate 3. Lane 27 - R555Q eluate 4.
4.3.5 Optimisation of recombinant protein processing after purification
After the protein was eluted from the Ni-NTA His-Bind column, it was essential to change 
the buffer to avoid protein precipitation and potential loss of function. It was empirically 
determined that the purified protein should be processed straight after coming off the
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column. Storage of the eluate at -20°C and subsequent thawing resulted in precipitation of 
the protein.
The buffer was changed using the Vivaspin 20 concentrators (see section 4.2.5). The 
buffer originally used for the resuspension of the recombinant proteins was chosen from 
previous references of recombinant keratoepithelin preparation. Kim et al, reported in 
2000 the isolation of keratoepithelin from inclusion bodies, which was stored in 20mM Tris- 
HCl, pH 7.8, 50mM NaCl buffer at -20°C. Therefore native purified was stored in 10mM 
Tris-HCl, pH 7.4, 50mM NaCl, 10% glycerol at -20°C. The pH was lowered to be closer to 
the protein’s natural isoelectric point, which has been determined with IEF to be 6.0 
(Srivastava et al, 1999) and between 6.20 and 6.71 (Escribano et al, 1994). Although this 
protein was stored in 0.5ml aliquots to avoid multiple freeze-thaw cycles, precipitates 
were visible upon thawing of the aliquots for the first time. The precipitates did not 
dissolve when the sample was incubated at 37°C for Vi hour.
Eventually the buffer which enabled the storage of these recombinant proteins in low 
temperatures and eliminated precipitation was the following: 10mM Tris-HCl pH 7.4,
50mM NaCl, 1mM DTT, 50% (v/v) glycerol. The high concentration of glycerol in this buffer 
allows storage at -80°C where the protein can remain stable and reduces freezing extend 
and freeze-thaw intervals. DTT can reduce the formation of disulfide bonds between 
protein molecules and further prevent precipitation. The purified protein concentration 
after buffer exchange was determined with the BCA assay to be 0.6-0.7 mg/ml.
4.4 DISCUSSION
Although not initially straightforward, the recombinant keratoepithelin was successfully 
produced from the prokaryotic E. coli strain BL21(DE3)pLysS. The prokaryotic expression 
system was used because of the ease and efficiency it brings to the process of constructing 
a recombinant protein. The difference in codon usage was compensated with the presence 
of pLysS plasmid, which encodes rare prokaryotic aminoacids.
Cloning of the protein coding sequence to expression vector pET-16b resulted in better 
yield of recombinant protein and in fewer multiple bands in the final eluted protein. The 
10-His repeat which was added at the NH2-terminal end of the recombinant protein to aid 
detection and purification can be removed with proteolytic digestion with Factor Xa.
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The presence of T7/oc promoter on pET-16b in combination with the tacUV5 promoter in 
BL21(DE3)pLysS ensure a tight regulation of recombinant protein expression. This was 
demonstrated during electrophoresis of the proteins extracted form induced cultures, 
compared to those derived from cultures grown in the absence of IPTG.
Recombinant keratoepithelin was present in the cell culture both in the insoluble and 
soluble form after IPTG induction. The levels of the protein in the soluble fraction were 
sufficient to carry out extraction and purification. Therefore denaturing and refolding of 
insoluble protein was avoided.
Despite the amino acid (555) difference between the three recombinant proteins the 
pattern during protein expression, extraction and purification was the same in all variants. 
It has already been reported that mutations found in the 5q31 corneal dystrophies do not 
significantly affect the molecular properties of keratoepithelin (Kim et al, 2002).
The potential native recombinant keratoepithelin brings into the study of corneal 
dystrophies is can be immense. It can be a useful tool for carrying out a number of 
biological assays on cultured cells and comparing between the effects of the wild type and 
mutant proteins. It can serve for a variety of biochemical analyses, such as solution 
scattering, which can provide information about the three dimensional shape the protein 
assumes in solution, and BIACORE, which can demonstrate the way it interacts with other 
proteins.
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5. CHAPTER FIVE 
Effects of recombinant keratoepithelin on cell behaviour
5.1 INTRODUCTION
Cell culture offers possibilities to screen for effects of compounds and macromolecules in a 
controlled way and under a wide variety of conditions. Culture systems have been 
developed to allow the study of single cellular functions under controlled environmental 
conditions. In vitro systems exclude the influence of other organs and the circulatory and 
immune system, thus providing the possibility to study direct effects on a cell population. 
However the absence of these organ-related influences prevent the cell culture model 
from being an identical reflection of the in vivo cells. In this chapter corneal cell culture 
systems were used in combination with the recombinant keratoepithelin proteins to 
enhance our understanding of the cellular effects of these proteins.
Various transformed immortalised corneal keratocytes (Stuart et al, 1997, Zorn-Kruppa et 
al, 2004) and epithelial cells (Chiambaretta et al, 2002, Gao et al, 2002) have been 
described by different researchers. However, the transformation, which confers the cells 
with the proliferative capacity, may lead to changes in the genetic expression profile and 
therefore behaviour of these cells. For the purpose of minimising the genotypic and 
phenotypic alterations of the corneal cells primary cell cultures were preferentially used.
Recombinant keratoepithelin has been employed in cell culture experiments previously, 
but the effects seem to vary and depend on the cell type used. Its anti-adhesion effect on 
A459, HeLa and W1-38 cells (Skonier et al, 1994) seems to contradict the cell-adhesive 
effect it exerts on human astrocytoma cells (Kim et al, 2003) and HUVEC (Nam et al, 
2003). This differential effect has been attributed to the ability of this protein to interact 
with different integrins on the surface of different cells to mediate the same effect. For 
example, migration is mediated through ocvp3 integrin in human umbilical cord endothelial 
cells (Nam et al, 2003), whereas in skin keratinocytes through cc3pi interacting motifs (Bae 
et al, 2 0 0 2 ).
Keratoepithelin seems to be derived from the corneal epithelium (Escribano et al, 1994, 
Akhtar et al, 1999, Ridgway et al, 2000), therefore epithelial cells are of particular 
interest. The accumulations of granular and amyloid deposits in anterior dystrophies have 
been localised in the epithelium (Akhtar et al, 1999), Bowman’s layer (Ridgway at al,
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2000), extracellular stoma (Klintworth et al, 1998) and intracellular in keratocytes (Akhtar 
et al, 1999). The corneal keratocytes are not only affected in corneal dystrophies but may 
also contribute to the deposition of stromal keratoepithelin.
The effects of wild type and mutant keratoepithelin were studied in cultured primary 
corneal epithelial cells and keratocytes. Four different areas were examined: migration, 
adhesion, proliferation and apoptosis. The results of these assays may indicate the way 
this protein interacts with the corneal cells to maintain tissue integrity in normal corneas 
and abolish it in the case of dystrophies.
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5.2 METHODS
5.2.1 Coating of culture dishes with collagen Type I
Flasks and multiwell plates that were going to be used for culturing corneal epithelial cells 
were previously coated with collagen Type I. 10pg of collagen were used per cm2 of 
culture area. 0.1% calf skin collagen Type I (Sigma) was diluted 1:10 with 0.1M acetic acid 
and was incubated with the culture flask for 2-5 hours at 37°C. The collagen solution was 
then aspirated and the dishes were air dried in a laminar flow safety cabinet. Coated 
surfaces were rinsed twice with PBS before using for cell culture.
5.2.2 Primary Cell Culture
Human corneal epithelial cells and keratocytes were isolated form human corneas but the 
large number of cells needed for the assays could not be generated from the rarely 
available human corneas. Primary epithelial cells and keratocytes were predominantly 
isolated from bovine corneas, although the same methods were used to process both 
human and bovine corneas.
Freshly enucleated bovine eyes were obtained from a local abattoir and transported to the 
laboratory on ice. Extraneous muscle and other tissue were dissociated from the globe and 
the eyes were submerged in 2% v/v Betadine solution in PBS for 2 minutes and rinsed 
briefly in sterile PBS.
5.2.2.1 Epithelial cells
A primary corneal epithelial cell culture involves the removal of the epithelial sheet from 
the anterior corneal surface and its attachment on the bottom of a culture dish. To do this 
corneal trephine sections were removed (using a 1 mm diameter sterile trephine) from the 
corneo-limbal area and were placed on the surface of a well of a 6 -well plate, epithelial 
side facing the bottom of the dish. The surface of the well had previously been scraped 
with a sterile blade to ensure firmer attachment of the explant and prevent it from 
floating after application of the culture medium. Approximately 5 explants were placed 
per well of a 6 -well plate and they were incubated at 37°C for 20 minutes to dry the excess 
liquid and allow them to attach to the dish. One drop of Keratinocyte serum-free 
supplemented medium (Invitrogen) (see Materials) was applied on each explant and 
incubation was carried out overnight at 37°C in a 5% CO2 humidified incubator. The next 
day 1ml prewarmed Keratinocyte Serum-free medium was added to each well and 
incubation was continued until the epithelial cells were observed to migrate out of the 
explant on to the culture surface, usually 1 -2 weeks. The explant was then removed and
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the medium was replaced with fresh and primary cells were incubated until confluent. 
The same explant was placed on to a new well for culturing cells from the deeper layers of 
the epithelium, where less differentiated epithelial cells, closer to the limbal area, are 
normally residing.
Cell cultures that reached confluence were aspirated, washed once with PBS and were 
detached with fresh prewarmed 0.05% trypsin & 0.53mM EDTA (Invitrogen) by incubating at 
37°C for no more than 5 minutes. The trypsin was neutralised with the addition of PBS 
containing 10% FCS and cells were centrifuged at 300 x g for 5 minutes. The pellet was 
resuspended in fresh Keratinocyte serum-free supplemented medium and cells were 
dispensed onto collagen I coated flasks. Medium was renewed every 3 days and cells were 
subcultured before reaching confluence with this method in a 1 : 3  ratio.
5.2.2.2 Keratocytes
For the extraction of keratocytes from the intact cornea the epithelium was scraped off 
using a sterile scarpel. The cornea near the limbal area was removed from the rest of the 
eye by cutting approximately 1mm inside the limbal margin. 5 corneas were placed in a 
sterile 50ml pot and were incubated with 10ml of 4mg/ml collagenase in Minimal Essential 
Medium (MEM) at 37°C overnight. The cell suspensions were centrifuged at 100g for 5 
minutes and the pellet was resuspended in 1ml MEM. The number of cells was calculated 
using a haematocytometer and cells were seeded in 25cm2 culture flasks at 7x105 
cells/flask in 10ml DMEM/F10 medium (see Materials).
Cell cultures were allowed to grow at 37°C in a 5% C02 humidified incubator. When 
confluency was reached the medium was aspirated and the cells were rinsed in PBS. 
0.05% trypsin St 0.53mM EDTA was used to dissociate the cells form the culture surface by 
incubating at 37°C for approximately 5 minutes. The cells were then resuspended in fresh 
DMEM/F10 medium and were subcultured in a 1:3 ratio.
5.2.3 Confirmation of culture purity
Cell cultures were observed for their morphologic characteristics and immunostained for 
confirmation of purity. Cultures were fixed with 4% paraformaldehyde for 20 minutes and 
washed twice with PBS for 5 minutes. They were then incubated with 0.2% Triton X-100 
(v/v in PBS) for 20 minutes at room temperature and washed twice with PBS. Cells were 
immunohistochemically stained with cytokeratin, which is an epithelial cell marker. 
Epithelial cells should stain positive for cytokeratin whereas keratocytes should stain
150
negative. The cytokeratin polyclonal mouse primary antibody (Sigma) and the goat anti­
mouse FITC conjugated IgG (Sigma) secondary were used at 1/150 dilution.
5.2.4 Adhesion Assay
(Modified from Vaughan-Thomas et al, 2001)
Multiwell plates were coated with recombinant proteins diluted in PBS at 37°C for 2 hours. 
The plates were rinsed twice with PBS and uncoated surfaces were blocked with PBS 
containing 2% heat-inactivated BSA for 1 hour at 37°C. The plates were rinsed again and 
were used for the adhesion assay. 105 cells were seeded per cells per well of 24 well plate 
or 2x104 cells per well of 96-multiwell plate. The cells were allowed to attach on the wells 
by incubation at 37°C for 40 minutes. Unattached cells were removed by washing twice 
with PBS. The attached cells were quantified with the hexosaminidase assay (Landegren 
U, 1984).
5.2.4.1 Hexosaminidase assay
This assay allows estimation of cell numbers by using a chromogenic substrate (p- 
nitrophenyl-N-acetyl-p-D-glucosaminide) for a ubiquitous lysosomal enzyme, 
hexosamindase. The attached cells were incubated for 1 hour at 37°C in 50mM citrate 
buffer pH 5.0 containing 3.75mM p-nitrophenyl-N-acetyl-|3-D-glucosaminide and 0.25% 
Triton X-100. The reaction was stopped and colour was developed by addition of 50mM 
glycine buffer pH 10.4 containing 5mM EDTA. The absorbance was measured at 405 nm in 
a Dynex MRX Revelation microplate reader (Dynex Technologies).
5.2.5 Proliferation Assay
Cells were seeded at a 104 cells/well density in 24 well plates the day before the start of 
the assay. After overnight incubation the medium was aspirated and replaced with fresh 
medium containing the recombinant proteins. The cells were viewed under an Olympus 
IX70 inverted light microscope at x4 objective. Pictures of the cultured cells were 
captured with the SPOT Advanced software equivalent to a 2220x2960pm area. Pictures 
were taken at 0 , 24, 48 and 72 hours after the replacement of the medium from the same 
area of the multi-well plate. Cell numbers per captured image were quantified using the 
AnalySIS software.
5.2.6 Migration Assay
Cells were seeded onto a 24-well plate at a density 105 cells/well and were allowed to 
attach overnight. The next day a straight scrape wound was made across the monolayer of
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each well with a sterile yellow pipette tip. The medium then aspirated to remove any 
floating cells and replaced with fresh prewarmed, containing the appropriate 
concentration of recombinant protein. The cells were viewed under an Olympus 1X70 
inverted light microscope at x4 objective. Pictures of the cultured cells and the scrape 
wound were captured with the SPOT Advanced software equivalent to a 2220x2960jim 
area. Pictures were taken at 0, 8 , 16 and 24 hours post wounding and the average 
distance between the separated cells was measured along the same 2 2 0 pm region using 
the Image Pro Plus software.
5.2.7 Apoptosis Assay
Cell apoptosis was detected with the TACS™ Annexin V-FITC kit (R8tD Systems). The 
principle of this assay is that in early apoptotic cells phosphatidylserine, which is usually in 
the intracellular part of cytoplasmic membrane, gets exposed to the outer surface of the 
membrane. This event is thought to be important in the macrophage recognition of these 
cells. Annexin V binds to phosphatidylserine and allows colourimetric detection of the 
apoptotic cells with the FITC conjugate. DNA-binding dye Propidium Iodide can be used in 
conjunction to differentiate late apoptotic cells, which should have lost membrane 
integrity and stain for both this and Annexin V (Martin et al, 1995). Therefore early 
apoptotic cells should stain only with Annexin VI (interacting with phosphatidylserine on 
cell membrane), whereas the ones that are at the later stages of apoptosis and would stain 
both with Annexin VI and Propidium Iodide (interacting with DNA).
Cells were seeded at a density 105 cells/well, in a 24-well format, cultured overnight and 
the medium was aspirated. Fresh medium was added containing the recombinant proteins 
and a positive apoptosis control was included: 50mM etoposide (Sigma). Cells were 
harvested and processed with the TACS™ Annexin V-FITC detection kit at the following 
time points: 0, 24, 48 and 72 hours after addition of the proteins.
100^ 1 Annexin V Incubation reagent was prepared for each sample of 105 cells containing 
10jil 10x Binding Buffer, 10jul Propidium Iodide, 1pl Annexin V-FITC and 79jil dH20 and the 
mixture was kept in the dark on ice. Cells were aspirated and trypsinised with 10Ojal 0.25% 
Trypsin-EDTA (Invitrogen) for 2-5 minutes. The action of trypsin was stopped with addition 
of 900jil PBS 10% FCS (for epithelial cells) or DMEM/F10 medium (for keratocytes). Cells 
were centrifuged at 500 x g for 5-10 minutes at room temperature. The pellet was washed 
by resuspension with ice-cold PBS and centrifuged again as above. The PBS was removed 
and cells were gently resuspended in 100pl of the Annexin V Incubation reagent and were
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kept in the dark at room temperature for 15 minutes. 200pl 1x Binding buffer was added 
to each sample and samples were analysed in a BD Facscalibur Flow Cytometer. Results 
were analysed in WinMDI 2.8 software.
5.2.8 Experimental design
Two different recombinant protein concentrations were used for all assays, 50ng/ml and 
500ng/ml. The control was 50ng/ml BSA diluted in the same buffer which was used for the 
recombinant proteins. The flasks cultured with primary and immortalised epithelial cells 
were always coated with collgen I, apart from the case of the adhesion assay.
5.2.9 Data analysis
All assays were carried out at least twice in triplicate unless otherwise stated. Data were 
analysed for Gaussian distribution, for analysis of variance (ANOVA) with Dunnett test to 
compare control with experimental values using Prism software. T test was used when 
needed to compare the difference between two sets of results.
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5.3 RESULTS
5.3.1 Primary corneal cell culture
The method described in section 5.2.2 was the optimum for the culture and growth of 
corneal epithelial cells. Lack of scraping the culture surface resulted in floating of the 
corneal explants after addition of the culture medium. Use of keratinocyte serum-free 
medium minimised the proliferation of corneal keratocytes which may have come out of 
the explant. The combination of serum-free medium and low calcium concentration has 
been described previously for the impeding effect they have on cell differentiation (Martin 
et al, 1991) and have been optimised for the culture of corneal epithelial cells (Hackworth 
et al, 1990). Often the epithelial cells derived from the first time an explant was laid on a 
culture surface appeared to be resistant to trypsinisation, where long periods of exposure 
to the enzyme failed to lift the cells of the surface. Cells that were dissociated from the 
culture surface by a cell scraper failed to assume viability when subcultured. 
Interestingly, epithelial cells derived from the second and third rounds of explant usage 
did not exhibit any difficulties in detachment during trypsin treatment.
Primary epithelial cell cultures were characterised by staining for cytokeratin 3 and 12 
(Figure 5.1.C). A human corneal epithelial cell line, CRL11516 (ATCC) was used as positive 
control for the interaction with the cytokeratin marker (Figure 5.1.D). This cell line was 
propagated following the same method (5.2.2) used for primary epithelial cells.
Primary keratocytes were easier than epithelial cells to culture. The cell turnover using 
the collagenase method was greater and faster than that of epithelial cells. A 75cm2 flask 
would contain 6x106 keratocyte cells compared with 7x105 epithelial cells. Part of this 
diversity is due to the difference in cell size between the two cell types (Figure 5.1).
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Figure 5.1: Corneal cells
A. Epithelial sheet derived from bovine corneal explant. B. Confluent primary epithelial monolayer 
C. Cytokeratin staining of primary bovine epithelial cells. D. Cytokeratin staining of human corneal 
epithelial cell line. E. Primary bovine keratocytes (White line on the bottom right side corresponds 
to 200 microns)
5.3.2 Summary of the assay results
The following table summarises the results from the assays that were carried out to 
determine the effects of wild type and mutant recombinant proteins on primary epithelial 
and keratocyte cell culture.
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Protein Cell type Adhesion Proliferation Migration | Apoptosis
WT Epithelia + + 0 0
Keratocytes + 0 0 0
R555Q Epithelia + 0 0 +
Keratocytes 0 0 0 +
R555W Epithelia + + 0 +
Keratocytes 0 0 0 +
Table 5.1: Summary of the results of recombinant keratoepithelin
Symbols: + more effect than the control cells, - less effect than the control cells, o similar to the 
control
5.3.3 Adhesion Assay
Although no standard curves were drawn to correlate the A405 readings of the 
hexosaminidase assay to cell numbers, Landegren U. demonstrated in 1984 the linear 
relationship of cell populations ranging from 8 x1 0 2 to 1 0 5 cells and the corresponding A405 
readings for 5 different cell types (Hepatocytes; CTLL-2, a T cell growth dependent mouse 
cell line; Jurkat, a human T leukaemia cell line; Raji, a Burkitt lymphoma cell line and 
peripheral blood lymphocytes). The number of cells used in the adhesion assay is within 
this range and believed to correspond proportionally to the 405nm absorbance readings. 
The corresponding A405 readings to the above cell populations varied between 0.05 and 20, 
which is also within the ranges of the readings obtained during the cell adhesion assays. 
This assumes similar hexosaminidase content between cells of different type.
5.3.3.1 Epithelial cells
Both wild type and mutant keratoepithelin recombinant proteins seem to promote 
epithelial cell adhesion better than the control (p<0.001) (Figure 5.2). There is no 
significant difference between the two concentrations of the same protein or between the 
mutant and wild type proteins (Figure 5.2.A). The highest value of absorbance of the 
attached cells was 4.53 ±0.33 in the presence of 50 ng wild type protein compared to 2.97 
±0.71 in the control.
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Wild type
50ng 500ng Control
R 555Q  m utant
Control
R555W mutant
*  *
5 n
50ng 500ng Control
(D)
Figure 5.2: Epithelial cell adhesion on recombinant protein
A. Effect of wild type (WT) and mutant recombinant keratoepithelin. B. Effect of wild type 
keratoepithelin. C. Effect of R555Q mutant recombinant protein. D. Effect of R555W mutant 
recombinant protein. Columns represent mean values of the repeated experiments and error bars 
are ±SEM. *p<0.001
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5.3.3.2 Keratocytes
The adhesion of primary keratocytes was significantly higher in the presence of the wild 
type keratoepithelin (p<0.001) compared to control. One-way Anova and Turkey’s multiple 
comparison test confirmed that the significant difference was present only between the 
wild type protein treated (50 and 500 ng) and the control cells (p<0.05). However, 
although higher adhesion to mutant proteins it was not significantly different compared to 
the control (Figure 5.3). As in the case of the epithelial cell adhesion, there was no 
statistical difference of the absorbance readings between the two protein concentrations. 
The lowest absorbance corresponded to keratocytes attached to 500ng R555W.
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Figure 5.3: Keratocyte adhesion on recombinant protein
A. Effect of wild type (WT) and mutant recombinant keratoepithelin. B. Effect of wild type 
keratoepithelin. C. Effect of R555Q mutant recombinant protein. D. Effect of R555W mutant 
recombinant protein. Columns represent mean values of the repeated experiments and error bars 
are ±SEM. * p<0.001
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5.3.4 Proliferation assay
To allow for the variation of the cell density amongst different wells, the % of cell growth 
was calculated for every time point and plotted against time from the following equation:
% cell growth = (Nt - N0)/Nt x 100 
where Nt = the number of cells for this time point, N0 = the number of cells at time point 0 
hours.
5.3.4.1 Epithelial cells
Epithelial cell proliferation was significantly higher after 72 hours of culture in the 
presence of 50 ng wild type recombinant (p<0.001) and 500ng R555W mutant proteins 
(p<0.01) according to the results of the one-way ANOVA with the Dunnett’s post test. T 
test with Welch’s correction also shows significant difference between the control and 500 
ng of wild type (p=0.0027) and 50ng of R555Q (p=0.0319). The mean cell growth increase 
in the presence of wild type keratoepithelin was 50.27 ±1.93% compared to 35.59 ±6.26% 
in the control. The highest increase of proliferation took place in the presence of 500 ng 
R555W mutant protein (54.68 ±6.26%), whereas the R555Q protein resulted in 46.97 ±8.79% 
increase of cell growth.
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Figure 5.4: Epithelial cell proliferation
A. Effect of wild type (WT) and mutant recombinant keratoepithelin. B. Effect of wild type 
keratoepithelin. C. Effect of R555Q mutant recombinant protein. D. Effect of R555W mutant 
recombinant protein. Points represent mean values of the repeated experiments and error bars are 
±SEM. *p<0.001
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5.3.4.2 Keratocytes
The proliferation of keratocytes did not seem to be altered in the presence of the 
recombinant proteins in the culture medium (Figure 5.5).
100
90
80 ♦ WT 50ng 
— R555Q 50ng 
 R555W 50ng
WT 500ng
8 40
*  30
20 -  
10 -
R555Q 500ng 
— R555W 500ng 
+ Control
0
0 24 48
Time (hours)
72
Figure 5.5: Keratocyte proliferation
Effect of wild type (WT) and mutant recombinant keratoepithelin. Points represent mean values of 
the repeated experiments and error bars are ±SEM.
5.3.5 Migration assay
The data from the migration assay were derived from the average distance between the 
cultured cells after the introduction of a scrape wound. In order to eliminate the variation 
between different widths of wound, the actual distance covered by the cells was 
estimated for every time point with the following formula:
Where D0 is the distance (width of wound) measured at 0 hours (at the moment the wound 
was induced and after the protein was added) and Dt is the distance measured at the 
particular time point.
5.3.5.1 Epithelial cells
The corneal epithelial cells treated with wild type and mutant keratoepithelin did not 
exhibit any significant changes in their migration pattern (Figure 5.6) compared with the 
control cells. However, there was a significant difference between the migration 
mediated by the wild type and mutant proteins. Cells cultured with wild type 
keratoepithelin migrated the furthest distance: 521 ±64.58 microns whereas the 500ng of 
mutant proteins resulted in the least distances migrated: 348.3 ±14.9 and 393 ±54.19
Distance migrated = D0 - Dt
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microns for R555W and R555Q. respectively. The difference between the wild type and 
each of these two means is significant (p<0.05) as determined with the t test. In the 2 
hour time point there seems to be a difference in the distance migrated between the two 
different concentrations of the recombinant protein, especially in the case of R555W 
mutant. However, this difference could not be determined statistically. It is noteworthy 
to mention that this migration experiment had a 60-75% power (estimated by GraphPad 
StatMate 2.00) to detect a true difference between means of 200 microns. The mean 
migration distance of the cells treated with 500ng R555W does not change between the 16 
and 24 hour time points due to one repeat which did not migrate in this time interval. 
Therefore this does not represent a finding consistent in all the repeats.
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Figure 5 .6: E p ithelia l ce ll m igration
Effect of wild type (WT) and mutant recombinant keratoepithelin. A. Line chart. B. Column chart 
of all the treatments. C. Treatment with wild type protein. D. Treatment with R555Q mutant 
protein. E. Treatment with R555W protein. Points and columns represent mean values of the 
repeated experiments and error bars are ±SEM.
5.3.5.2 Keratocytes
The keratocyte migration was not affected by the presence of the recombinant proteins 
and in contrast to the picture of the epithelial cells, no significant differences exist 
between different protein treatments. However the minimum distance migrated 
corresponds to the cells cultured with 500ng R555W mutant protein, consistent with 
epithelial cells. Therefore the measurements of the migrated distance from the repeated 
experiments were as indicated in figure 5.7.
169
800 
"g 700
1o 600
|  500 
®
2 400 o>
E 300 
a>
c 200
3
a  100 
0
—•—WT50ng
R555Q 50ng 
R555W50ng 
WT 500ng 
- x R555Q 500ng 
R555W500ng 
—i— Control
8 16 
Time (hours)
(A)
800 -i
(/)c 700 -
so 600
1
■o 500 -£
400 \O)
E 300 j
0)oc 200 J
2X
Q 100
0
% Jfi i
16
Time (h o u rs )
(B)
24
EWT50ng
■ R555Q 50ng
□ R555W 50ng
□ WT 500ng
■ R555Q 500ng
□ R555W 500ng
■ Control
Figure 5.7: K eratocyte m igration
Effect of wild type (WT) and mutant recombinant keratoepithelin. A. Line chart. B. Column chart. 
Points and columns represent mean values of the repeated experiments and error bars are +SEM.
5.3.6 Apoptosis assay
Flow cytometry provided two types of information about the viability of the cells that have 
been processed. One is based on the fluorescence, which corresponds to the number of 
the cells that take up the Annexin V-FITC and Propidium Iodide stains. The other, more 
basic information is based on the forward and side scatter, which correspond to the size 
and granularity of the cells. Generally apoptotic cells decrease in size and increase in 
granularity.
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The Annexin V- Propidium Iodide apoptosis assay of corneal keratocytes and epithelial cells 
indicated that are differences in the viability of cells cultured with the different types of 
proteins. There seemed to be an increase of the number of cells that stained for Annexin 
V-FITC and Propidium Iodide in the presence of mutant recombinant proteins (figure 5.8). 
The fluorescence dotplots of the cells which were treated with etoposide and were 
therefore predominantly apoptotic were shifted towards the left and the top (figure 5.8.E) 
compared to the control cells (figure 5.8.D), corresponding to higher Annexin V-FITC and 
Propidium Iodide counts. Cells treated with R555W (figure 5.8.B) and R555Q. (figure 5.8.C) 
mutant proteins appeared to have a considerably higher proportion of Annexin V-FITC and 
Propidium Iodide PE emission compared to the wild type protein (figure 5.8.A). In the 
following dot plots this is illustrated with the tendency of the cells treated with the 
mutant proteins and etoposide to accumulate more left on the Annexin V-FITC axis and 
higher on the Propidium iodide axis.
wAnnexin V - FTTC
Figure 5.8: Keratocytes apoptosis assay
Keratocytes were cultured for 72 hours. A. Cells with wild type keratoepithelin. B. Cells with 
R555W mutant recombinant protein. C. Cells with R555Q mutant recombinant protein. D. Control 
cells. E. Etoposide treated cells
171
However these differences could not be quantified due to failure of the processed cells to 
distribute on the forward-side scatter and the Annexin V-Propidium Iodide graphs as 
distinct populations. The reason for this is unknown especially since the cytometer was 
calibrated according to the parameters of the corneal cells before the assay was carried 
out. Therefore the apoptosis assay needs to be repeated to include further optimisation 
and correction for any residual overlap of fluorescent spectra through the cytometer 
optical filters.
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5.4 Discussion
The results that were presented in this chapter demonstrated the feasibility of the use of 
the recombinant proteins in cell culture experiments in order to extract information about 
the effects they exert on cells. These proteins seem to modulate the behaviour of primary 
corneal epithelial cells and keratocytes. These two cell types are in close proximity to the 
aggregates in corneal dystrophies and are affected as it has been shown ultrastructurally 
(Akhtar et al, 1999, Ridgway et al, 2000) during the accumulation of the deposits.
Wild type recombinant keratoepithelin promoted the adhesion of both epithelial cells and 
keratocytes. This is not surprising since keratoepithelin has been described as a cell- 
adhesive molecule (Kim et al, 2003) due to its ability to promote adhesion for many 
different cell types, including dermal fibroblasts (LeBaron et al, 1995, chondrocytes (Ohno 
et al, 1999), keratinocytes (Bae et al, 2002), human astrocytoma cells (Kim et al, 2003), 
periodontal ligament cells (Doi et al, 2003) and HUVEC (Nam et al, 2003). Corneal cells 
have also been tested previously for adhesion to recombinant wild type and mutant 
keratoepithelin (Kim at al, 2002) and they are thought to interact with keratoepithelin 
through the integrins (Kim et al 2000). However the effects between mutant and wild 
type recombinant proteins on human corneal epithelial cell adhesion reported by the 
above researchers were similar. Keratoepithelin-facilitated keratocyte adhesion was also 
described by Yang et al, 2004. The reduced adhesion of keratocytes to the mutant 
proteins may reflect the effect of the R555 mutations on the protein’s interaction with 
specific integrins on the surface of keratocytes.
The epithelial cell proliferation was increased in response to mutant and wild type 
keratoepithelin, whereas keratocyte proliferation was not affected by the recombinant 
proteins. Other cells have responded to wild type keratoepithelin by increased 
proliferation, such as skin keratinocytes (Bae et al, 2002) and renal proximal tubular 
epithelial cells (Park et al, 2004). These cells also migrate more effectively in the 
presence of keratoepithelin, something was which not demonstrated with the epithelial 
cells and keratocytes in this chapter. However there is a significant difference between 
the migration effect of wild type and R555W mutant protein, which has been consistently 
associated with retarded cell migration (figures 5.6 and 5.7).
The staining of epithelial cells and keratocytes differs in the presence of wild type and 
mutant recombinant protein and it suggests that there may be an increase in apoptosis 
facilitated by the mutant proteins. Morand et al (2003) demonstrated with Annexin V
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staining and fluorescence microscopy that transfection of corneal epithelial and HeLa cells 
with mutant f3ig-h3 constructs results in apoptosis. Also wild type J3ig-h3 may be important 
for the regulation of cell apoptosis by providing soluble RGD peptides (Kim et al, 2003).
The recombinant proteins did not have the same effects on epithelial cells and 
keratocytes. It is possible that these proteins interact via different types of integrins on 
the cell surface of these cells and facilitate different effects. Since keratoepithelin is an 
extracellular matrix protein it is possible it mediates extracellular environmental signals to 
the cells, especially keratocytes, which co localise in the stroma. The fact that these 
signals may affect the gene expression profile of the cells is supported by the increasing 
number of references, which implicate (3ig-h3 gene with the regulation of cell cycle 
(Genini et al, 1996; Tsujimoto et al, 1999; Zhao et al, 2002; Golembineski et al, 2002; 
Schneider et al, 2002).
Throughout all of the assays it was not possible to establish a concentration-dependent 
effect of the recombinant proteins on the corneal cells. This could be due to the 
concentration of recombinant proteins that were used in the assays (50-500ng/ml). Some 
researchers use much higher concentrations (10-50pg/ml) (Yuang et al, 2004). Although 
cell number availability prevented the use of a variety of protein concentrations, it would 
be beneficial to attempt a greater range of concentrations, such as 10ng-100jig/ml.
The recombinant proteins carry an NH2-terminal Histidine repeat, which facilitated their 
purification. Although insertion of this exogenous sequence to the NH2-terminal part of 
the recombinant protein is less likely to interfere with the biological activity, it is unknown 
how it may affect the conformation of the recombinant protein. This sequence can be 
removed by proteolytic digestion with Factor Xa to test whether the recombinant protein 
effects on corneal cells alter.
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6. CHAPTER SIX
The effects of recombinant adenoviruses carrying the 0ig-h3 gene on cell behaviour
6.1 INTRODUCTION
The expression of the |3ig-h3 gene in the cornea seems to take place in the corneal 
epithelium (Escribano et al, 1994, Akhtar et al, 1999, Ridgway et al, 2000), but the 
possibility of keratocytes expressing this gene has not been ruled out, especially after the 
observation of the presence of aggregated deposits in the keratocyte cytoplasm (Akhtar et 
al, 1999). Overexpression of the wild type and mutant pig-h3 in cultured cells would be a 
useful indicator of the way that corneal cell behaviour is modulated by these genes.
Adenoviruses can be used to achieve high levels of transgene expression in a variety of cell 
types and tissues (Shering et al, 1997; Brown et al, 1997; Castro et al, 1997). Corneal 
adenoviral gene transfer has taken place repeatedly before, but the majority of the 
references report transfection of the endothelium (George et al, 2000), which has been 
easier to target than the epithelium. However, the feasibility of gene transfer to the 
corneal epithelial cells in culture was demonstrated by Tsubota et al, (1998). Corneal 
epithelial and conjunctival cell lines were transfected with adenovirus concentrations as 
low as 3.2x10'5 MOI. The optimum transfection was achieved with 50 MOI of replication 
deficient recombinant adenovirus. Abraham et al, (1995) also achieved rabbit epithelial 
cell line transfection with a recombinant adenovirus in vitro and in vivo transfection of the 
epithelium amongst other ocular tissues by viral intracameral and vitreal injection. 
Adenoviral transfection of corneal stromal keratocytes was achieved by intrastromal 
injection of adenoviral packaged DNA constructs carrying the E-GFP reporter gene (Carlson 
EC et al, 2004).
Adenoviruses were therefore used for the transfer of pig-h3 constructs in corneal cells in 
order to establish the effects of the overexpression of the wild type and the dystrophy- 
causing R555W mutant gene and whether there are any differences between them.
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6.2 METHODS
The methods that were used in this chapter were described in section 5.2 of Chapter 4. 
Instead of recombinant proteins the replication deficient recombinant adenoviruses were 
added to the cells to be assayed: Radpigh3, RadR555W and control adenovirus Rad35. The 
cells were infected at an MOI1 of 50.
The following modifications were made to the methods described in section 5.2:
6.2.1 Adhesion assay
The cells that were going to be tested for their adhesion were first cultured in a density of 
105 cells per well in a 24 multiwell plate and incubated overnight at 37°C in a 5% C02 
humidified incubator. The next day the medium was aspirated and the cells were infected 
with the respective recombinant adenoviruses. The adenoviruses were added to fresh 
medium and applied on the cultured cells. The cells were incubated overnight and the 
next day their medium was aspirated and replaced with fresh prewarmed medium. The 
following day the cells were treated with trypsin and were tested for their ability to 
adhere to the surface of multiwell plates by following the method described in section
5.2.4.
6.2.2 Proliferation assay
Cells were seeded at a 104 cells/well density in 24 well plates the day before the start of 
the assay. After overnight incubation the medium was aspirated and replaced with fresh 
containing the recombinant adenoviruses. Pictures were taken immediately after this for 
the 0 hours time point. The following day the medium was replaced with fresh and 
pictures were taken at 24, 48 and 72 hours. Determination of cell number and image 
analysis took place as described n section 5.2.5
6.2.3 Migration assay
Cells were seeded onto a 24-well plate at a density 105 cells/well and were allowed to 
attach overnight. The next day the medium was changed and replaced with fresh 
containing the recombinant adenoviruses. The cells were incubated for 24 hours with the 
viruses and then a straight scrape wound was made across the monolayer with a sterile 200 
[A pipette tip. The medium was replaced to remove the virions and any floating cells and 
the migration of cells was monitored and analysed as described in section 5.2.6
1 MOI = Number of virions per target cell
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6.2.4 Apoptosis assay
Cells were seeded at a density 105 cells/well, in 24-well format, cultured overnight and 
the medium was aspirated. Fresh medium was added containing the recombinant 
adenoviruses. Cells were harvested and processed with the TACS™ Annexin V-FITC 
detection kit at the following time points: 0, 24, 48 and 72 hours after addition of the 
adenoviruses, according to the method in section 5.2.7.
6.2.5 Data analysis
All assays were carried out at least twice in triplicate unless otherwise stated. Data were 
analysed for Gaussian distribution, for analysis of variance (ANOVA) with Dunnett test to 
compare control with experimental values using Prism software. T test was used when 
needed to compare the difference between two sets of results.
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6.3 RESULTS
6.3.1 Confirming the feasibility of gene transfer using the recombinant adenoviruses
The recombinant adenoviruses were used as vehicles to transport the genes of interest 
inside the cultured cells. In order to confirm the ability of these adenoviruses to transfer 
and express the transgenes in foreign cells, the Rad35 control adenovirus was used to 
infect corneal epithelial cells at MOI of 10 and 100. 48 hours post infection the cells were 
fixed and stained according to the X-gal assay (section 3.2.2.4). The feasibility of 
adenoviral gene transfer was demonstrated in figure 6 . 1 , where the control adenovirus 
successfully transferred the Lac Z gene to the cells and expressed p-galactosidase. This 
enzyme was assayed by addition of X-gal, which when cleaved by p-galactosidase produces 
the blue stain observed in the pictures (Figure 6.1).
Figure 6.1: Gene transfer with recombinant adenoviruses
X-gal assay of Rad35 infected cells. A. 10 MOI B. 100 MOI
6.3.2 Summary of the assay results
The following table summarises the results from the assays that were carried out to 
determine the effect of wild type and R555W mutant transgenes overexpression in primary 
epithelial and keratocyte cells.
Transgene Cell Type Adhesion Proliferation Migration Apoptosis
WT Epithelia + 0 0
Keratocytes 0 0 0
R555W Epithelia 0 + +
Keratocytes + 0 +
Table 6.1: Summary of the results of pig-h3 overexpression
Symbols: + more effect than the control cells, - less effect than the control cells, o similar to the 
control
178
6.3.3 Adhesion assay
6.3.3.1 Epithelial cells
The epithelial cells that were transfected with Rad|3igh3, which carries the wild type (3ig- 
h3 gene adhered better to plastic wells than the cells that were transfected with the 
control adenovirus Rad35 (p<0.001) (Figure 6.2). Epithelial cells transfected with the 
recombinant adenovirus carrying the mutant pigh-h3 gene, RadR555W, attached to plastic 
less efficiently (Mean A4 0 5  = 0.94 ±0.24) than cells transfected with Rad(3igh3 (Mean A4 0 5  = 
1.26 ±0.51 )(figure 6.2).
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Figure 6.2: Corneal epithelial cell adhesion
Cells transfected with Rad0igh3 adhered more efficiently than cells treated with the control 
adenovirus Rad35. Columns represent mean values of the repeated experiments and error bars are 
+SEM. *p<0.001
6.3.3.2 Keratocytes
The opposite response was observed with keratocytes which were allowed to adhere to 
plastic wells after transfection with the recombinant adenoviruses (Figure 6.3). The cells 
transfected with the mutant adenovirus, RadR555W adhered better (p<0.001) than the 
cells transfected with the control virus. However the wild type (3igh3 did not promote or 
inhibit the adhesion of keratocytes compared to the control cells (p>0.05).
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Figure 6.3: Corneal keratocyte adhesion
Cells transfected with RadR555W adhered more efficiently than cells treated with the control 
adenovirus Rad35. Columns represent mean values of the repeated experiments and error 
bars are ±SEM. * p<0.001
6.3.4 Proliferation assay
Data were analysed as described in section 5.3.4
6.3.4.1 Epithelial cells
The differences in the proliferation pattern of epithelial cells were significant at the 72 
hours time point. The proliferation of epithelial cells overexpressing the mutant pig-h3 
was higher than the cells transfected with the control adenovirus (p<0.001). The 
percentage of cell increase of the epithelial cells transfected with Radpigh3 was also 
higher (p<0.05) than the Rad35 infected cells. However it is evident from figure 6.4 that 
the rate of proliferation of the cells transfected with the control adenovirus decreases 
after the 48-hours time point. This might imdicate that the epithelial cell proliferation is 
compromised in the presence of the adenovirus, which is a phenomenon already described 
for other epithelial cells, such as lung (Teramoto et al, 1995). In this case the question 
why the recombinant adenoviruses carrying the wild type and mutant pig-h3 genes do not 
have the same effect on the cells remains. For this purpose the non-viral control cell 
measurements were included in the graph in figure 6.4, which do not appear to be 
significant different from the virally treated cells.
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Figure 6.4: Corneal epithelial cell proliferation
Cells transfected with the two recombinant adenoviruses carrying the 3igh3 gene proliferate better 
than the Rad35 transfected cells. Points represent mean values of the repeated experiments 
and error bars are ±SEM.
6.3.4.2 Keratocytes
The proliferation of keratocytes was not different for the different transfection with 
adenoviruses (figure 6.5). The same pattern which was observed with the recombinant 
proteins effect on these cells. It is noteworthy that the viability of the keratocytes, unlike 
the epithelial cells, was not affected by the adenoviruses.
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Figure 6.5: Corneal keratocyte proliferation
There is no difference between the different adenoviral treatments. Points represent mean values 
of the repeated experiments and error bars are +SEM.
6.3.5 Migration assay
The migration assay was carried out four times in triplicate, but it was difficult to draw 
any conclusions about the efficiency of these cells to migrate. Two problems were 
encountered which made assaying the migration problematic. First, there were many 
wells in which the cells did not migrate after the introduction of the wound. Secondly, the 
wound caused some of the cells to go further apart, thereby creating a gap in the area, 
which was photographed for the estimation of the migration rate. These problems 
appeared equally in the cells transfected with the adenoviruses carrying the (3ig-h3 genes 
and the control Rad35 adenovirus and therefore were more likely to be attributed to the 
effect of the recombinant adenoviruses on the cells rather than the effect of the pig-h3 
transgenes. The following graphs represent the migration of cells where the scrape wound 
was possible to measure for each time point. Data were analysed as described in section
Due to the great variation among the wells of each treatment (figure 6.6) the data were 
not significantly different for any time point and the graph represents the general trend of 
the transfected cells.
5.3.5.
6.3.5.1 Epithelial cells
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Figure 6.6: Corneal epithelial cell migration
There is no significant difference between the migration of cells with different adenoviral 
treatments. Points represent mean values of the repeated experiments and error bars are ±SEM.
6.3.5.2 Keratocytes
The proportion of keratocytes, which formed “gaps” in the area where the wound was 
introduced, was higher than that of epithelial cells. Therefore it was possible to retrieve 
even less measurements, which makes the data even less meaningful.
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Figure 6.7: Corneal keratocyte migration
Measurements were too variable to compare or draw any conclusions
Points represent mean values of the repeated experiments and error bars are ±SEM.
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6.3.6 Apoptosis assay
The limitations that were encountered whilst carrying out the apoptosis assay with the 
flow cytometry were summarised in section 5.3.6. However both the epithelial cells and 
keratocytes which were transfected with RadR555W adenovirus seem to have a larger 
population that is apoptotic. This corresponds to higher levels of Annexin V and Propidium 
Iodide staining compared to Radpigh3 and Rad35 transfected cells (figure 6.8).
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Figure 6.8: Apoptosis assay
Dot plots of the Annexin V-Propidium Iodide staining of adenovirally treated cells. A-D. Epithelial 
cells. E-H. Keratocytes. AEtE. Radpigh3. B&F. RadR555W. C&G. Rad35. DaH: Etoposide
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6.4 DISCUSSION
Recombinant adenoviruses allow transfer of cloned genes into cultured cells and strong 
expression with the aid of a constitutive promoter, in this case CMV. The efficiency of 
transfection is high even with low titres of the virus (figure 6.1) and allows examination of 
the effect the gene of interest has on the cells in culture. In this chapter corneal 
epithelial cells and keratocytes were transfected with recombinant adenoviruses carrying 
the wild type and R555W mutant pig-h3 genes, as well as a control adenovirus carrying the 
Lac Z reporter gene. These results gave us valuable information about the way the pigh3 
gene may interact with the cells whilst expressed by them.
The corneal epithelial cells overexpressing wild type pig-h3 adhered significantly better to 
culture dishes than cells treated with the control adenovirus. The adhesion of cells when 
the mutant gene was overexpressed was decreased compare to the wild type. This might 
be associated with morphological/functional changes that could take place in these cells 
due to the presence of the mutant pig-h3 gene. The keratocytes reflected the opposite 
picture, where the adhesion was decreased in the presence of the wild type pigh-h3 gene. 
This could suggest that this increase is associated with the expression of the R5555W 
mutant gene. It is also interesting that when the keratocytes were exposed to the 
recombinant proteins they exhibited the reverse picture than when overexpressing the 
respective genes. Keratocytes adhered more efficiently in the presence of wild type 
protein, whereas in adenoviral transfection better adhesion was associated with R555W 
mutant transgene overexpression.
The proliferation patterns of epithelial cells and keratocytes during overexpression of the 
pigh3 genes were similar with the ones observed with the effects of recombinant proteins. 
The use of recombinant adenoviruses affected the viability of the cells as well as the rate 
of proliferation. The fact that the epithelial cells transfected with the control adenovirus 
showed a decrease in their growth rate, especially after 48 hours of culture, might be 
attributed to the virus itself. Decrease in the proliferation rate and increase in the 
apoptosis have been associated with control recombinant adenovirus transfection in some 
cell types (Teramoto et al, 1999 and 1995). However it is interesting that the recombinant 
adenoviruses carrying the pig-h3 transgene did not have the same effect on epithelial cell 
proliferation. (3igh3, like TGF-p, which induces it, is thought to regulate the proliferation 
of different cell types in varying ways to achieve homeostasis (Doi et al, 2003, Grilliari et 
al, 2000, Skonier et al, 1994). Therefore expression of the pigh3 gene could contribute to 
the increasing rate of epithelial cell proliferation.
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The migration assays did not provide much information about the ability of the transfected 
cells to migrate. Too many cells failed to migrate and in many cases started lifting off 
from the area where the scrape wound was created. Since this was a phenomenon which 
affected all cells irrespective of the virus that was used to transfect them and was absent 
when the cells were treated with the recombinant proteins, it could be associated with the 
characteristics the cells assume after infection with the adenoviruses.
The preliminary data from the Annexin V-Propidium Iodide assay suggested an increase of 
apoptosis in both cell types when the mutant R555W transgene was overexpressed (Figure 
6.7). The cells with the wild type pig-h3 gene did not appear to have the same extent of 
apoptotic stained cells. Human corneal epithelial cell apoptosis was monitored by Morand 
et al, (2003) when the cells were transfected with mammalian expression plasmids 
carrying the R555W and R124C, but not with the wild type pig-h3 gene. The epithelial 
cells transfected with the control adenovirus appeared in some case to have a similar 
extent of apoptosis with the R555W mutant pig-h3 overexpressing cells (figure 6.8.C). This 
could further support the observation of decreased epithelial cell proliferation as an 
adenovirally-related effect. Non-virally treated negative control cells should be included 
upon repetition of the apoptosis assay for the quantification of the effects of the mutant 
and wild type transgenes.
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7. CHAPTER SEVEN - GENERAL DISCUSSION
The stromal corneal dystrophies are a group of bilateral, autosomal dominant disorders. In 
most of the conditions there are signs at an early age on corneal examination. This is often 
well before symptoms develop. Some of them can be difficult to treat, since they keep re­
appearing, even after corneal transplantation.
Accumulation of amyloid or hyaline material is a common finding in dystrophic corneas, 
however, the gene that appears to be mutated in a variety of superficial stromal 
dystrophies is pig-h3. Both this gene and its protein were discovered not long before they 
were associated with corneal dystrophies.
The role of keratoepithelin is still largely undefined in the normal cornea - as well as in 
other tissues where it is known to be expressed and act upon other cellular components. It 
also remains unknown how the normal role of keratoepithelin is affected by the mutations, 
occurring on hotspots on the gene. The association between keratoepithelin and 
subepithelial and stromal deposits has been shown with immunohistochemistry (Klintworth 
et al, 1998, Korvatska et al 1999 and 2000) in the corneas of affected individuals.
There is strong evidence that pig-h3 is important in the epithelium as observed by light and 
electron microscopy (Ridgway et al, 2000). The histological and ultrastructural findings 
indicate accumulation of deposits in the epithelial cell layer. Immunofluoresence has 
located the site of expression of pig-h3 in the ocular tissues. Keratoepithelin was found to 
be expressed in the corneal epithelium (Escribano et al, 1994), but also by corneal 
keratocytes (Korvatska et al, 1999).
The epithelial origin of the dystrophies can explain the recurrence of the disease in grafts 
from healthy donors. The epithelium on the donor cornea is renewed and derived from the 
recipient limbal stem cells. Therefore in the grafted cornea only the cells of the epithelial 
layer will carry the mutation for pig-h3, which seems to be enough for the recurrence of 
the characteristic accumulations in the epithelial/anterior stromal area.
In order to study the role of keratoepithelin in corneal dystrophies, the pig-h3 cDNA was 
manipulated with the tools of recombinant DNA technology and molecular biology. The pig- 
h3 cDNA was synthesised with RT-PCR from total RNA extracted from human skin 
fibroblasts. It was subsequently cloned to a variety of plasmid vectors for the appropriate
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manipulations. In vitro mutagenesis gave rise to two mutant versions one with each 
mutation corresponding to the corneal dystrophies Thiel Behnke and Granular, R555Q. 
(Okada et al, 1998) and R555W (Munier et al, 1997) respectively. Based on these cloned 
constructs three native recombinant proteins were synthesised as well as two replication 
deficient recombinant adenoviruses, expressing the wild type and R555W mutant J3ig-h3 
genes. The recombinant normal and mutant genes were expressed in bovine corneal 
epithelial and keratocyte cell culture and the effects of recombinant mutant and wild type 
proteins were also examined. The species difference (human cDNA versus bovine cell 
culture) is not thought to pose an obstacle since keratoepithelin is highly conserved 
between species (90-93%) (Gibson et al, 1996, Hashimoto et al, 1996 and Skonier et al,
1994). Moreover the human constructs can be used in future eclectic experiments on 
human cell and organ culture. The following tables (7.1 and 7.2) summarise the effects of 
the recombinant proteins and synthetic adenoviruses on corneal cell adhesion, migration, 
proliferation and apoptosis and highlight the similarities and differences between them.
Before drawing any conclusions about the cellular responses to wild type and mutant 
recombinant protein and transgenes delivered to the cells with the recombinant 
adenoviruses it is essential to establish the difference between the way these different 
constructs mediate their effects. The recombinant proteins remain in the extracellular 
space and may interact with the surface of the cells, possibly via integrins, to affect cell 
behaviour. The recombinant adenoviruses transport the recombinant pig-h3 gene in the 
cell cytoplasm where it is expressed with the constitutive CMV-IE promoter. Therefore the 
effects of the recombinant adenovirus transfection correspond to the overexpression of the 
wild type and mutant pig-h3 in corneal epithelial cell and keratocytes.
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Construct Assays Epithelial cells Keratocytes
Adhesion Promoted almost equally 
with all proteins*
Promoted with WT and less 
with the mutants. 
Significant difference 
between WT and R555W
Recombinant
Proliferation Upregulated with all 
proteins, especially WT* 
and R555W*
No effect
proteins Migration Fastest with WT protein 
slowest with R555W. 
Significant difference 
between WT and R555W
No effect
Apoptosis Suspected apoptosis with 
the two mutants
Suspected apoptosis with 
the two mutants
Adhesion Promoted with Rad(3igh3* 
and less efficiently with 
RadR555W
Promoted with RadR555W* 
and less efficiently with 
Radpigh3
Recombinant
adenoviruses
Proliferation Upregulated with 
RadR555W and less 
efficiently with Radpigh3. 
Significant difference 
between RadR555W and 
Rad35
No effect
Migration No conclusion No conclusion
Apoptosis Suspected apoptosis with 
the mutant
Suspected apoptosis with 
the mutant
Table 7.1: Summary of the effects of recombinant keratoepithelin and pg-h3 gene 
overexpression.
WT Wild type. * Significant difference with the control cells
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Epithelial cells Keratocytes
Similarities Adhesion increases with wild type 
protein and virus
No effect on proliferation by either 
protein or virus
Proliferation increases with R555W 
mutant protein and virus
Apoptosis possibly increases with 
mutant proteins and viruses
Apoptosis possibly increases with 
mutant proteins and viruses
Differences Adhesion increases with mutant 
protein but not virus
Adhesion increases with wild type 
protein but not virus
Proliferation increases with wild 
type virus but not protein
Adhesion increases with mutant virus 
but not protein
Table 7.2: Comparison of the effects of recombinant protein and transgene overexpression 
(virus). Table summarises the main similarities and differences between the effects of recombinant 
protein and adenoviral transgene overexpression.
It is important to link the observations summarised in tables 7.1 and 7.2 with the 
physiology of the normal cornea and the clinical presentation of corneal dystrophies. In 
the case of extracellular protein-induced effects it is essential to remember that these 
observations were derived from cultured cells in the absence of other corneal-specific 
factors and aggregated deposits, which would accompany the dystrophies.
Epithelial cell adhesion does not seem to change in response to extracellular effect 
between normal and mutant protein. Similarly, no difference was exhibited in the 
migration and proliferation of corneal keratocytes in the presence of recombinant 
proteins. The keratocyte adhesion does not change significantly between wild type and 
mutant recombinant proteins but seems to be inversely proportional to R555W mutant 
concentration. This may suggest a putative alteration in the keratocyte response to 
mutant keratoepithelin in the Granular dystrophy affected corneal stroma.
Epithelial cell proliferation does not appear different between wild type and R555W 
mutant proteins, but it decreases in the presence of R555Q protein. This protein may also 
induce epithelial cell apoptosis as was suggested from the Annexin V assay. These two 
effects could be related to the erosions, which are associated with Thiel Behnke 
dystrophy, as well as the irregular and degenerate epithelium with vacuolated cells,
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aggregates of cytokeratin filaments and areas of poor attachment to the substratum 
(Ridgway et al, 2000). The superficial layers of the epithelial cells have weak inter­
connections and seem ready to detach from the rest of the epithelium in this dystrophy.
The epithelial cells seem to migrate slower in the presence of R555W mutant protein than 
the wild type, this could potentially affect the centripetal migration (Shapiro et al, 1981) 
of epithelial cells and the renewal rate of the corneal epithelium in Granular dystrophy. 
The suggestion that epithelial cells and keratocytes have increased apoptosis both when 
cultured with the recombinant proteins and when transfected with the recombinant 
adenoviruses could explain the generation of keratocytes and epithelial cells which were 
observed ultrastructurally in patients with primary and recurrent Granular dystrophy 
(Akhtar et al, 1999). Apoptosis is a complex process which involves numerous pathways. 
Keratoepithelin may induce apotosis by interacting with surrounding cells, directly, by 
binding to cellular receptors or through other members of the extracellular matrix. It has 
been suggested that mutated keratoepithelin could induce apoptosis through an integrin- 
related pathway.
Overexpression of mutant R555W gene results in increase of the proliferation of corneal 
epithelial cells. The levels of keratoepithelin in patients with Granular dystrophy are more 
plentiful than in unaffected individuals (Klintworth et al, 1998) and this has been 
suggested to take place due to polymerisation of the protein into insoluble fibrils. Could it 
be possible that if epithelial cell proliferation is increased in vivo in response to the 
mutant gene, that this would result in higher expression, and therefore extracellular 
accumulation of keratoepithelin?
Purified keratoepithelin can bind to collagen I & IV, fibronectin, fibrillin, laminin (Billings 
et al, 2002, Kim et al, 2002) and it has been found to co-localise with the deposits in the 
dystrophic stroma (Korvatska et al, 1999). The abnormal proteoglycans and disorganisation 
of collagen fibrils observed in electron microscope pictures (Akhtar et al, 1999) could 
result from the deposits and abnormal interaction with the mutant protein. However 
different R124 and R555 mutant recombinant proteins did not appear to exhibit different 
biochemical and molecular properties than the wild type protein (Kim et al, 2002).
Keratoepithelin is one of the major proteins in the normal cornea, where it is present in 
the full size as well as in a variety of proteolysis products. Although the reason for this is 
not known, it is interesting that in both amyloid and non-amyloid dystrophies the pattern
192
of the different isoforms changes, maybe due to abnormal proteolysis (Korvatska et al, 
1999). However, fibroblasts extracted from the affected corneas did not produce any 
aberrant isoforms of keratoepithelin in culture.
The fact that the formation of the deposits in the corneal dystrophies is tissue specific was 
supported by the Schmitt-Bernard et al (2002) when they demonstrated that amyloid 
deposits where absent in the skin of Lattice dystrophy patients. Adult skin is one of the 
tissues where pig-h3 is transcribed and secreted by dermal fibroblasts (LeBaron et al,
1995). The deposits could be a result of cornea specific protein-protein interactions as 
happens in the case of choroideremia, another ocular disease where the mutated protein 
interacts with a retinal specific Rab27 protein in order to produce the disease (Seabra et 
al, 1995). Alternatively, abnormal protein processing by corneal specific proteases could 
be responsible for the deposits.
The results that were presented in this thesis and the recombinant constructs that were 
created could be used to explore further the role of keratoepithelin in the corneal 
dystrophies.
The transfected with overexpressing (3ig-h3 transgene corneal cells can be used as a model 
to examine their ultrastructure with electron microscopy. The differences between cells 
that overexpress wild type and mutant genes can be compared as well as the differences 
from control cells which are not transfected. Especially interesting aspect of this analysis 
would be investigating the formation or secretion of amyloid and granular aggregates. The 
availability of the recombinant proteins can also serve as a powerful tool to enhance our 
understanding on the mechanism of interaction of keratoepithelin with other important 
corneal proteins, especially those that have been identified to be part of the dystrophic 
aggregates, e.g. cytokeratin 19, immunoglobulins etc.
The air interface model of organ corneal culture is probably the most efficient model for 
studying whole corneas ex vivo without compromising the organ integrity (Foreman et al,
1996) where the overall structure and stratification are maintained. Other models of 
corneal organ culture, where the cornea is submerged in medium, result in loss of 
epithelial cell layer, epithelial and stromal oedema and keratocyte deterioration. (Richard 
et al, 1991). This system allows the simultaneous study of all five corneal layers, even 
when the target is one of them, such as the epithelium. Therefore the interaction 
between different cell layers is possible and the effects of certain structures (e.g. limbus)
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can be observed (e.g. in wound healing studies when cells migrate to the wound from the 
basal and peripheral areas). Overexpression in the organ culture model can be achieved 
with the recombinant adenoviruses, thereby creating a cultured model for the study of the 
corneal dystrophies. The induced changes in the following areas resulting from expression 
of different mutant constructs could be determined in an attempt to understand the 
aetiology between different types of dystrophies: cell morphology, epithelial adhesion, 
extracellular deposits and wound healing.
(3ig-h3 is induced by TGF-p (Skonier et al 1992), a growth factor which plays an important 
role in growth and differentiation. TGF-p exerts its effects on wounded or developing 
tissues by the controlled regulation of a number of genes. It induces the expression and 
secretion of matrix proteins whereas it has been reported to inhibit the rate of corneal re- 
epithelialisation (Foreman et al, 1996) and epithelial cell proliferation (Mishima et al, 
1992). The temporal expression of pig-h3 mRNA during corneal healing and development 
(Rawe et al, 1997) especially in the early stages (El-Shabrawi et al, 1998) indicates that 
keratoepithelin plays a role in the synthesis of new tissue, which it could regulate. The 
role of pig-h3 during wound healing can also be studied in the cornea by infecting pre- and 
post wounded corneas with the recombinant adenoviral constructs.
The adenoviruses may “mask” some of the effects of the pig-h3 overexpression due to the 
effects they impose on the cultured cells, determined from the control virus Rad35. 
Decrease in the proliferation rate and increase in the apoptosis have been associated with 
control recombinant adenovirus transfection in some cell types (Teramoto et al, 1999 and
1995). This problem could be avoided by following either of these two non-viral 
approaches: transfecting the cells with mammalian expression plasmids, in which the wild 
type and mutant pig-h3 constructs are already cloned or by transducing the recombinant 
protein in intact cells in culture or tissue by fusing it with the TAT sequence (Guo et al, 
2004).
The interaction between cell and extracellular matrix components plays a crucial role in 
cell proliferation, apoptosis and tumourigenesis. Keratoepithelin, being a component of 
the extracellular matrix has been investigated regarding its role in human diseases 
(O’Brien et al, 1996, Gilbert et al, 1998, Schneider et al, 2002). Like its inducer TGF-|3, 
pig-h3 has been implicated with regulation of gene expression in a variety of cell types 
(see section 1.5.7). It is possible that application of recombinant keratoepithelin causes a 
change in the gene expression profile of the cultured cells. The identification of possible
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genes up- or down-regulated in response to wild type and mutant keratoepithelin could be 
assessed with microarray analysis.
The experimental procedures carried out during this project offered some valuable 
information about the difference of the effects of wild type and mutant (3ig-h3 gene and 
protein on corneal keratocytes and epithelial cells. These results and recombinant tools 
can be used to further improve our understanding in both the role of keratoepithelin in 
corneal dystrophies and the mechanism by which these disorders arise.
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MATERIALS
1. PLASMIDS
pAE1-cl (7.7kb) A combination of two different plasmids: pAE1sp1A (Microbix) and pci 
(Promega). Both plasmids were digested with BamHI and Bglll and pCI was inserted into 
the polycloning restriction enzyme site of pAE1sp1A. Ampicillin resistant.
Multiple cloning site: Nhel
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Figure 1: pCI-neo Vector
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Figure 2: pAE1sp1A vector
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Figure 3: pJM17 vector
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Figure 4: pMV12 vector
pALTER-MAX (5.5kb) Chloramphenicol resistant and /or ampicillin resistant
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Figure 5: pALTER-MAX vector
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pCR®2.1-T0P0 (3.9kb) Kanamycin and ampicillin resistant
pCR®2.1-TOPO
3.9 kb
Figure 6: pCR® 2.1-TOPO vector
pET-23c (3.67kb) ampicillin resistant
Figure 7: pET-23c vector (Novagen)
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pET-16b (5.7kb) amplicillin resistant
Figure 8: pET16b vector (Novagen)
2. BACTERIAL CELLS
JM109 (Promega)
ES301 mutS (Promega)
DH5a (Molecular Medicine Dept., University of Manchester)
TOPOF’ (Invitrogen)
BL21(DE3)pLysS (Novagen)
3. CELL LINES
293 cells (Molecular Medicine Dept., University of Manchester)
HeLa (Molecular Medicine Dept., University of Manchester)
CRL11516 Human corneal epithelial cell line (ATCC)
4. REAGENTS AND CHEMICALS
All reagents used were Molecular Biology/Cell Culture grade purchased from Sigma and 
AnalaR BDH, unless otherwise stated.
5. NUCLEIC ACIDS
Primers and muagenic oligonucleotides MWG
DNA ladder 100bp MBI Fermentas
2 0 0
Gene ruler 1kb 
Mass Ruler
MBI Fermentas 
FMI Fermentas
6. KITS
AMV Reverse Transcription System
Premix
MegaMix
Extensor Long PCR
Thermo Sequenance II Dye Terminator 
TOPO TA Cloning 
Cycle Sequencing Kit
Altered Sites Mammalian Mutagenesis System
QIAGEN Plasmid Mini Kit
QIAGEN Plasmid Maxi Kit
QIAGEN PCR Purification kit
TACS™ Annexin V-FITC detection kit
Promega
Advanced Biotechnologies 
Helena Biosciences 
Advanced Biotechnologies
Invitrogen
Amersham Pharmacia Biotech Inc
Promega
Qiagen
Qiagen
Qiagen
RfitD Systems
7. ENZYMES
Alul New England Biolabs
CIAP Alkaline Phosphatase Gibco BRL
Hindlll New England Biolabs
Mlul New England Biolabs
PFU Taq Stratagene
Spel New England Biolabs
T4 DNA ligase Gibco BRL
Xbal New England Biolabs
Xhol New England Biolabs
rLysozyme Novagen
Benzonase Nuclease Novagen
RNAse 1 Invitrogen
8. PROTEIN EXPRESSION AND ANALYSIS REAGENTS
BugBuster Novagen
Protease Inhibtor Set III Calbiochem
Coomassie Brilliant Blue R-250 Stain and Destain BioRad 
Laemmli sample buffer BioRad
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BioRad 
BioRad 
Sigma
Santa Cruz Biotechnology
9. MOLECULAR BIOLOGY SOLUTIONS 
Anglian Buffer (10x)
166mM Ammonium sulphate 
670mM Tris HCl (pH 8.0)
37mM Magnesium Chloride
1.7mg/m BSA
10x TBE
10.8% Trizma base 
5.5% Orthoboric Acid 
0.4% 0.5M EDTA 
make up to total with H20
0.5M EDTA (pH8.0)
186g EDTA 
800ml dH20
measure pH with 5M NaOH until pH 8.0, 
then make up to 1 Lt checking pH at 990ml.
1M Tiis Hcl pH 8.0
121.4g Tris 
800ml H20
pH until 8 with HCl and make up to 1 Lt 
TE buffer
10mM Tris HCL pH 8.0 
1mM EDTA pH 8.0
Loading Buffer
5ml 10xTBE 
49ml Glycerol
10x Tns/glycine/SDS buffer 
10x Tris/CAPS cathode buffer 
Ponceau S
Western Blotting Luminol Reagent
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0.1ml 10% (v/v) SDS 
Bromophenol Blue 
Xylene cyanol
Ethidium Bromide (10mg/ml)
1g EthBr 
100ml dH20  
Stir until dissolved 
Store in dark at 4°C
10. BIOCHEMISTRY REAGENTS 
4x Sample buffer
3.04g Tris base 
8g SDS
40ml glycerol 
30ml dH20
pH to 6.8 with concentrated HCl 
add 20ml (3-mercaptoethanol 
make up to 100ml with dH20  dH20
10% Resolving gel
(For 2 gels)
4ml H20
3.3ml 30% acrylamide mix 
2.5ml 1.5M Tris (pH 8.8)
0.1ml 10% SDS
0.1ml 10% ammonium persulfate 
4|il TEMED
Stacking gel
(For 2 gels)
2.7ml H20
670jil 30% acrylamide mix 
500pl 1.0M Tris (pH 6.8)
40pl 10% SDS
40pl ammonium persulfate
203
4jil TEMED
11. BACTERIAL CULTURE MEDIA 
LB broth
10g Tryptone 
5g Yeast Extract 
5g NaCl
make up to 1L with dH20  
Autoclave
LB agar
10g Tryptone 
5g Yeast Extract 
5g NaCl
make up to 1L with dH20  
Autoclave with 15g Agar
Allow temperature to drop to 45°C before adding antibiotics 
Pour to plates, allow to set, cover and store at 4°C.
soc
2g Tryptone 
0.5g Yeast Extract 
1ml 1M NaCl 
0.25ml 1MKCI 
97ml dH20
Stir to dissolve and autoclave 
Allow to cool to room temperature 
Add 1ml 1M MgCl2 1M MgS04 
1 ml 2M glucose 
Check pH is 7.0
Filter-sterilise through 0.2fim filter 
Store in 20ml aliquots at room temperature
IPTG (0.1M)
1.2g IPTG
dissolve to 50ml dH20
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Filter-sterilise through a 0.2jim filter 
Store in 5ml aliquots at -20°C
X-gal
100mg
dissolve to 2ml with N,N’-dimethylformamide 
Store in 0.5ml aliquots in the dark at -20°C
12. Tissue Culture Media 
293 medium
500ml Minimum Essential Medium Eagle
50ml Fetal Calf Serum
5ml MEM Non Essential Amino Acids
5ml 2mM L-glutamine
5ml Penicillin Streptomycin
Grow all
500ml DMEM
50ml Horse Serum
25ml Newborn Calf Serum
5ml MEM Non Essential Amino Acids
5ml Sodium pyruvate
5ml 2mM L-Glutamine
RCA medium
500ml DMEM 
10ml FCS
5ml MEM Non Essential Amino Acids 
5ml Sodium Pyruvate 
5ml 2mM L-Glutamine
Maintainance medium
500ml DMEM 
50ml FCS
5ml 2mM L-Glutamine 
5ml Penicillin-Streptomycin
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Freezing medium for 293 cells and HeLa
50% Dulbecco’s Modified Eagle’s Mediium 
10% Dimethyl sulphoxide (DMSO)
40% Fetal Calf Serum
Keratinocyte serum free medium
Keratinocyte serum-free medium (Invitrogen)
5ng/ml human EGF
0.05mg/ml bovine pituitary extract
0.005mg/ml insulin
500ng/ml hydrocortisone
5ml 2mM L-Glutamine
DMEM/F10 medium
100ml DMEM 
100ml F-10 medium 
10ml FCS
10ml Donor Horse Serum
1ml DMSO
1ml 1mg/ml insulin
20pl 1mg/ml cholera toxin
2ml 2mM L-glutamine
2ml Penicillin-Streptomycin
Caesium Chloride purification Buffers
Buffer A
10mM Tris pH7.5 
1mM Magnesium Chloride 
135mM Sodium Chloride
Buffer B
Buffer A + 10% glycerol
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13 ORGAN CULTURE SOLUTIONS AND MEDIA
All solutions (apart from Betadine) and media were passed trough a 0.2pm filter
20% Betadine
20ml Betadine 
80ml sterile PBS
5% Betadine
5ml Betadine 
95ml sterile PBS
Antibiotics and Glutamine solution
1g streptomycin sulphate 
1g kanamycin sulphate 
600mg benzylpenicillin 
1.46g L-glutamine 
dH20  to 100ml
Sodium Bicarbonate
7.4g Sodium bibarbonate 
in 100ml dH20
DMEM 1% agar 1% gelatin
2gr Agar 
2gr Gelatin
Mixed with 100ml dH20  and autoclaved 
Then add 20ml 10xDMEM
10ml 7.4% salt solution 
2ml antibiotics and glutamine solution 
1ml Fungizone 
dH20 to 200ml
DMEM 20% FCS 
20ml 10x DMEM 
40ml FCS
10ml 7.4% salt solution
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2ml Antibiotics and glutamine 
1ml Fungizone 
127ml dH20
MEM with 20% FCS
20ml 10xMEM 
40ml FCS
10ml 7.46t% salt solution 
2ml Antibiotics fit glutamine 
1 ml fungisone 
2ml ddH20
Serum-free Trowell’s T8
97ml Trowell’s T8 medium
2ml Antibiotics and glutamine solution
1 ml Fungizone
13. FIXATION AND STAINING SOLUTIONS 
4% paraformaldehyde
Dissolve 40g paraformaldehyde in 300ml H20  
heated at 60-70°C. Add NaOH until solution clears.
Dissolve 15.5g Na2HP04-2H20  and 34g sucrose in 500ml H20.
Filter dissolved paraformaldehyde into ice-cold phosphare buffer. 
Adjust pH to 7.4 and make volume up to 1 Lt.
Phosphate Buffer
8g NaCl 
0.2g KCl 
1.44g Na2HP04 
0.24g KH2P04 
in 800ml H20
Adjust pH to 7. 4 with HCl 
Add H20  to 1 Lt 
Sterilise by autoclaving
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X-gal staining solution
42mg Potassium Ferrocyanide 
32mg Potassium Ferricyanide 
8mg Magnesium Chloride 
20mg X-gal in 500pl DMSO 
make to 20ml with Phosphate Buffer
209
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